Omega Healthcare Investors (OHI) 10-K 27 Feb 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Feb. 13, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	OMEGA HEALTHCARE INVESTORS INC
Entity Central Index Key	888491
Trading Symbol	ohi
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Current Fiscal Year End Date	-19
Entity Filer Category	Large Accelerated Filer
Entity Well-Known Seasoned Issuer	Yes
Entity Common Stock Shares Outstanding		138,617,823
Entity Public Float			$4,670,627,910.40
Document Type	10-K
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Real estate properties
Land and buildings	$3,223,785	$3,099,547
Less accumulated depreciation	-821,712	-707,410
Real estate properties - net	2,402,073	2,392,137
Investment in direct financing leases	539,232	529,445
Mortgage notes receivable	648,079	241,515
Real estate properties, total	3,589,384	3,163,097
Other investments	48,952	53,054
Total investments held, continuing operations	3,638,336	3,216,151
Assets held for sale - net	12,792	1,356
Total investments	3,651,128	3,217,507
Cash and cash equivalents	4,489	2,616
Restricted cash	29,076	31,759
Accounts receivable - net	168,176	147,504
Other assets	68,776	62,830
Total assets	3,921,645	3,462,216
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit	85,000	326,000
Term loan	200,000	200,000
Secured borrowings	251,454	298,531
Unsecured borrowings - net	1,842,049	1,199,887
Accrued expenses and other liabilities	141,815	137,695
Total liabilities	2,520,318	2,162,113
Stockholders' equity:
Common stock $.10 par value authorized - 200,000 shares, issued and outstanding - 127,606 shares as of December 31, 2014 and 123,530 as of December 31, 2013	12,761	12,353
Common stock - additional paid-in capital	2,136,234	1,998,169
Cumulative net earnings	1,147,998	926,649
Cumulative dividends paid	-1,895,666	-1,637,068
Total stockholders' equity	1,401,327	1,300,103
Total liabilities and stockholders' equity	$3,921,645	$3,462,216

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, except Per Share data, unless otherwise specified
Statement Of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$0.10	$0.10
Common stock, shares authorized	200,000	200,000
Common stock, shares issued	127,606	123,530
Common stock, shares outstanding	127,606	123,530

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenues
Rental income									$388,443	$375,135	$314,592
Income from direct financing leases									56,719	5,203
Mortgage interest income									53,007	29,351	30,446
Other investment income - net									6,618	9,025	5,422
Total operating revenues	131,321	130,665	121,800	121,001	111,137	103,301	102,515	101,761	504,787	418,714	350,460
Expenses
Depreciation and amortization									123,257	128,646	112,983
General and administrative									25,888	21,588	21,330
Acquisition costs									3,948	245	909
Impairment on real estate properties									3,660	415	272
Provisions for uncollectible mortgages, notes and accounts receivable									2,723	2,141
Total operating expenses									159,476	153,035	135,494
Income before other income and expense									345,311	265,679	214,966
Other income (expense)
Interest income									44	41	29
Interest expense									-119,369	-100,381	-95,527
Interest - amortization of deferred financing costs									-4,459	-2,779	-2,649
Interest - refinancing (costs) gain									-3,041	11,112	-7,920
Total other expense									-126,825	-92,007	-106,067
Income before gain (loss) on assets sold									218,486	173,672	108,899
Gain (loss) on assets sold - net									2,863	-1,151	11,799
Net income available to common stockholders	$56,990	$61,713	$46,817	$55,829	$47,206	$38,137	$49,058	$38,120	$221,349	$172,521	$120,698
Basic:
Net income (in dollars per share)	$0.45	$0.48	$0.37	$0.45	$0.39	$0.32	$0.42	$0.34	$1.75	$1.47	$1.12
Diluted:
Net income (in dollars per share)	$0.44	$0.48	$0.37	$0.45	$0.38	$0.32	$0.42	$0.34	$1.74	$1.46	$1.12
Weighted-average shares outstanding, basic (in shares)									126,550	117,257	107,591
Weighted-average shares outstanding, diluted (in shares)									127,294	118,100	108,011

CONSOLIDATED_STATEMENTS_OF_STO

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)	Common Stock Par Value	Common Stock Par Value	Common Stock Par Value	Common Stock Additional Paid-in Capital	Common Stock Additional Paid-in Capital	Common Stock Additional Paid-in Capital	Cumulative Net Earnings	Cumulative Dividends Paid	Total
In Thousands, unless otherwise specified		Executives	Directors		Executives	Directors
Balance (103,410 common shares, 112,393 common shares, 123,530 common shares for 2011, 2012, 2013 respectively) at Dec. 31, 2011	$10,341			$1,471,381			$633,430	($1,236,668)	$878,484
Issuance of common stock:
Grant of restricted stock (428 shares respectively to company executives for 2012 and 13 shares at $20.29 per share, 15 shares at $30.33 per share, 12 shares at $35.79 per share to company directors for 2012, 2013 and 2014 respectively.)		43	1		-43	-1
Amortization of restricted stock				5,880					5,880
Vesting of restricted stock (grants 72 shares for 2012, 126 shares for 2014 to company executives )		7			-1,247				-1,240
Dividend reinvestment plan (5,063 shares at $22.11 per share, 1,930 shares at $28.94 per share, 2,084 shares at $34.32 per share for 2012, 2013, 2014 respectively)	506			111,408					111,914
Grant of stock as payment of directors fees (9 shares at an average of $22.17 per share, 6 shares at an average of $31.21 per share, 6 shares at an average of $35.52 per share for 2012, 2013, 2014 respectively)	1			199					200
Equity Shelf Program (3,398 shares at $23.47 per share, 6,504 shares at $30.48 per share net of issuance costs, 1,848 shares at $34.33 per share, net of issuance costs for 2012, 2013, 2014 respectively)	340			77,278					77,618
Net income							120,698		120,698
Common dividends ($1.69 per share, $1.86 per share, $2.02 per share for 2012, 2013, 2014 respectively)								-182,225	-182,225
Balance (112,393 common shares, 123,530 common shares, 127,606 common shares for 2012, 2013, 2014 respectively) at Dec. 31, 2012	11,239			1,664,855			754,128	-1,418,893	1,011,329
Issuance of common stock:
Grant of restricted stock (428 shares respectively to company executives for 2012 and 13 shares at $20.29 per share, 15 shares at $30.33 per share, 12 shares at $35.79 per share to company directors for 2012, 2013 and 2014 respectively.)			2			-2
Amortization of restricted stock				5,817					5,817
Restricted stock shares surrendered for tax withholding (193 shares)	-19			-5,755					-5,774
Dividend reinvestment plan (5,063 shares at $22.11 per share, 1,930 shares at $28.94 per share, 2,084 shares at $34.32 per share for 2012, 2013, 2014 respectively)	193			55,632					55,825
Grant of stock as payment of directors fees (9 shares at an average of $22.17 per share, 6 shares at an average of $31.21 per share, 6 shares at an average of $35.52 per share for 2012, 2013, 2014 respectively)				187					187
Equity Shelf Program (3,398 shares at $23.47 per share, 6,504 shares at $30.48 per share net of issuance costs, 1,848 shares at $34.33 per share, net of issuance costs for 2012, 2013, 2014 respectively)	650			193,149					193,799
Issuance of common stock(2,875 shares at $29.48 per share)	288			84,286					84,574
Net income							172,521		172,521
Common dividends ($1.69 per share, $1.86 per share, $2.02 per share for 2012, 2013, 2014 respectively)								-218,175	-218,175
Balance (112,393 common shares, 123,530 common shares, 127,606 common shares for 2012, 2013, 2014 respectively) at Dec. 31, 2013	12,353			1,998,169			926,649	-1,637,068	1,300,103
Issuance of common stock:
Grant of restricted stock (428 shares respectively to company executives for 2012 and 13 shares at $20.29 per share, 15 shares at $30.33 per share, 12 shares at $35.79 per share to company directors for 2012, 2013 and 2014 respectively.)			1			-1
Amortization of restricted stock				8,382					8,382
Vesting of restricted stock (grants 72 shares for 2012, 126 shares for 2014 to company executives )		13			-3,590				-3,577
Dividend reinvestment plan (5,063 shares at $22.11 per share, 1,930 shares at $28.94 per share, 2,084 shares at $34.32 per share for 2012, 2013, 2014 respectively)	208			71,279					71,487
Grant of stock as payment of directors fees (9 shares at an average of $22.17 per share, 6 shares at an average of $31.21 per share, 6 shares at an average of $35.52 per share for 2012, 2013, 2014 respectively)	1			199					200
Equity Shelf Program (3,398 shares at $23.47 per share, 6,504 shares at $30.48 per share net of issuance costs, 1,848 shares at $34.33 per share, net of issuance costs for 2012, 2013, 2014 respectively)	185			61,796					61,981
Net income							221,349		221,349
Common dividends ($1.69 per share, $1.86 per share, $2.02 per share for 2012, 2013, 2014 respectively)								-258,598	-258,598
Balance (112,393 common shares, 123,530 common shares, 127,606 common shares for 2012, 2013, 2014 respectively) at Dec. 31, 2014	$12,761			$2,136,234			$1,147,998	($1,895,666)	$1,401,327

CONSOLIDATED_STATEMENTS_OF_STO1

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parentheticals) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Balance (in shares)	123,530,000	112,393,000	103,410,000
Restricted stock shares surrendered for tax withholding (in shares)		193,000
Dividend reinvestment plan (in shares)	2,084,000	1,930,000	5,063,000
Dividend reinvestment plan (in dollars per share)	$34.32	$28.94	$22.11
Grant of stock as payment of directors fees (in shares)	6,000	6,000	9,000
Grant of stock as payment of directors fees (in dollars per share)	$35.52	$31.21	$22.17
Equity shelf program (in shares)	1,848,000	6,504,000	3,398,000
Equity Shelf Program, (in dollars per share)	$34.33	$30.48	$23.47
Issuance of common stock (in shares)		2,875,000
Issuance of common stock, (in dollars per share)		$29.48
Common dividends (in dollars per share)	$2.02	$1.86	$1.69
Balance (in shares)	127,606,000	123,530,000	112,393,000
Executives
Grant of restricted stock (in shares)			428,000
Vesting of restricted stock, granted shares	126,000		72,000
Directors
Grant of restricted stock (in shares)	12,000	15,000	13,000
Grant of restricted stock (in dollars per share)	$35.79	$30.33	$20.29

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities
Net income	$221,349	$172,521	$120,698
Adjustment to reconcile net income to cash provided by operating activities:
Depreciation and amortization	123,257	128,646	112,983
Provision for impairment on real estate properties	3,660	415	272
Provision for uncollectible mortgages, notes and accounts receivable	2,723	2,141
Amortization of deferred financing and debt extinguishment costs (gain)	7,500	-8,333	10,569
Accretion of direct financing leases	-9,787	-770
Restricted stock amortization expense	8,592	5,942	5,942
(Gain) loss on assets sold - net	-2,863	1,151	-11,799
Amortization of acquired in-place leases - net	-4,986	-5,083	-5,312
Other			-663
Change in operating assets and liabilities - net of amounts assumed/acquired:
Accounts receivable, net	-2,264	867	-246
Straight-line rent receivables	-20,956	-26,899	-25,404
Lease inducements	2,656	3,080	3,369
Effective yield receivable on mortgage notes	-2,878	-1,757	-2,235
Other operating assets and liabilities	11,537	8,028	97
Net cash provided by operating activities	337,540	279,949	208,271
Cash flows from investing activities
Acquisition of real estate - net of liabilities assumed and escrows acquired	-131,689	-32,515	-396,623
Investment in direct financing leases		-528,675
Placement of mortgage loans	-529,548	-3,378	-11,969
Proceeds from sale of real estate investments - net	4,077	2,292	29,023
Capital improvements to real estate investments	-17,917	-31,347	-29,436
Proceeds from other investments	13,589	30,962	15,355
Investments in other investments	-9,441	-36,655	-9,737
Collection of mortgage principal	122,984	485	12,684
Net cash used in investing activities	-547,945	-598,831	-390,703
Cash flows from financing activities
Proceeds from credit facility borrowings	900,000	511,000	712,000
Payments on credit facility borrowings	-1,141,000	-343,000	-726,500
Proceeds from term loan		100,000
Receipts of other long-term borrowings	842,148	59,355	400,000
Payments of other long-term borrowings	-242,544	-114,642	-190,686
Payments of financing related costs	-17,716	-3,234	-17,124
Receipts from dividend reinvestment plan	71,487	55,825	111,914
Payments for exercised options and restricted stock - net	-3,577	-5,774	-1,240
Net proceeds from issuance of common stock	61,981	278,373	77,618
Dividends paid	-258,501	-218,116	-182,190
Net cash provided by financing activities	212,278	319,787	183,792
Increase in cash and cash equivalents	1,873	905	1,360
Cash and cash equivalents at beginning of year	2,616	1,711	351
Cash and cash equivalents at end of year	4,489	2,616	1,711
Interest paid during the period, net of amounts capitalized	110,919	100,716	94,841
Non-cash investing activities:
Assumed debt obligations			80,946
Assumed other assets/liabilities			13,640
Total non-cash real estate acquisition related items			$94,586

ORGANIZATION_AND_BASIS_OF_PRES

ORGANIZATION AND BASIS OF PRESENTATION	12 Months Ended
	Dec. 31, 2014
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION
	Organization
	Omega Healthcare Investors, Inc. (“Omega,” “we,” “our” or the “Company”) a Maryland corporation, is a self-administered real estate investment trust (“REIT”).  From the date that we commenced operations in 1992, we have invested primarily in income-producing healthcare facilities, which include long-term care skilled nursing facilities (“SNFs”), assisted living facilities (“ALFs”), independent living facilities and rehabilitation hospitals.
	We have one reportable segment consisting of investments in healthcare related real estate properties.  Our business is to provide financing and capital to the long-term healthcare industry with a particular focus on SNFs located in the United States.  Our core portfolio consists of long-term lease and mortgage agreements.  All of our leases are “triple-net” leases, which require the tenants to pay all property related expenses.  Our mortgage revenue derives from fixed-rate mortgage loans, which are secured by first mortgage liens on the underlying real estate and personal property of the mortgagor.
	Substantially all depreciation expenses reflected in the consolidated statements of operations relate to the ownership of our investment in real estate.  At December 31, 2014, we have investments in 568 healthcare facilities located throughout the United States, including five facilities that are currently closed/held-for-sale.
	On October 30, 2014, we, along with our newly formed subsidiaries, OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership, L.P. (“Omega Operating Partnership”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Aviv REIT, Inc. (“Aviv”) and Aviv Healthcare Properties Limited Partnership, L.P. (the “Aviv Operating Partnership”). The Merger Agreement provides for the merger of Aviv with and into the Merger Sub (the “Merger”), with the Merger Sub surviving as a wholly-owned subsidiary of Omega. At the effective time of the Merger, and subject to the terms and subject to the conditions set forth in the Merger Agreement, each outstanding share of Aviv common stock shall be converted into the right to receive 0.90 of a share of Omega common stock. In connection with the Merger, holders of limited partnership units of the Aviv Operating Partnership will receive units of the Omega Operating Partnership based on the same exchange ratio as provided for Aviv common stock in the Merger Agreement. Holders of Omega Operating Partnership units will have the right to tender their units for redemption at a redemption price equal to the fair market value of the Company’s common stock. The Company may generally elect to pay the redemption price for tendered Omega Operating Partnership units in cash or in shares of the Company common stock. We expect to complete the Merger early in the second quarter of 2015, subject to the terms and conditions of the Merger Agreement. We expect to issue approximately 45.5 million shares of Omega’s common stock and 10.3 million Omega Operating Partnership units as a result of the Merger.
	All disclosures related to the number of beds are unaudited.
	Consolidation
	Our consolidated financial statements include the accounts of (i) Omega and (ii) all direct and indirect wholly owned subsidiaries of Omega.  All inter-company accounts and transactions have been eliminated in consolidation of the financial statements.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Accounting Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
	Fair Value Measurement
	The Company measures and discloses the fair value of nonfinancial and financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace.  Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions.  This hierarchy requires the use of observable market data when available.  These inputs have created the following fair value hierarchy:
		●	Level 1 - quoted prices for identical instruments in active markets;
		●	Level 2 - quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and
		●	Level 3 - fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	The Company measures fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at fair value.  When available, the Company utilizes quoted market prices from an independent third party source to determine fair value and classifies such items in Level 1.  In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, the Company consistently applies the dealer (market maker) pricing estimate and classifies the asset or liability in Level 2.
	If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads and/or market capitalization rates.  Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement.  As a result, the asset or liability could be classified in either Level 2 or Level 3 even though there may be some significant inputs that are readily observable.  Internal fair value models and techniques used by the Company include discounted cash flow and Monte-Carlo valuation models.
	Purchase Accounting/Real Estate Investments and Depreciation
	We record the purchase of properties to net tangible and identified intangible assets acquired and liabilities assumed at their fair value.  In making estimates of fair value for purposes of recording the purchase, we utilize a number of sources, including independent appraisals that may be obtained in connection with the acquisition or financing of the respective property and other market data.  We also consider information obtained about each property as a result of our pre-acquisition due diligence, marketing and leasing activities as well as other critical valuation metrics such as capitalization rates and discount rates used to estimate the fair value of the tangible and intangible assets acquired (Level 3).  When liabilities are assumed as part of a transaction, we consider information obtained about the liabilities and use similar valuation metrics (Level 3).  In some instances when debt is assumed and an identifiable active market for similar debt is present, we use market interest rates for similar debt to estimate the fair value of the debt assumed (Level 2).  The Company determines fair value as follows:
		●	Land is determined based on third party appraisals.
		●	Buildings and site improvements acquired are valued using a combination of discounted cash flow projections that assume certain future revenue and costs and consider capitalization and discount rates using current market conditions as well as replacement cost analysis.
		●	Furniture and fixture is determined based on third party appraisals.
		●	Intangible assets acquired are valued using a combination of discounted cash flow projections as well as other valuation techniques based on current market conditions for the intangible asset being acquired. For additional information regarding above and below market leases assumed as part of an acquisition see “In-Place Leases” below.
		●	Other assets acquired and liabilities assumed are typically valued at stated amounts, which approximate fair value on the date of the acquisition.
		●	Assumed debt balances are valued by discounting the contractual cash flows using a current market rate of interest rate, with the computed discount/premium amortized over the remaining term of the obligation assumed.
	The costs of significant improvements, renovations and replacements are capitalized.  In addition, we capitalize leasehold improvements when certain criteria are met, including when we supervise construction and will own the improvement.  Expenditures for maintenance and repairs are charged to operations as they are incurred.
	Depreciation is computed on a straight-line basis over the estimated useful lives ranging from 20 to 40 years for buildings and improvements and three to 10 years for furniture, fixtures and equipment.  Leasehold interests are amortized over the shorter of the estimated useful life or term of the lease.
	As of December 31, 2014 and 2013, we had identified conditional asset retirement obligations primarily related to the future removal and disposal of asbestos that is contained within certain of our real estate investment properties. The asbestos is appropriately contained, and we believe we are compliant with current environmental regulations. If these properties undergo major renovations or are demolished, certain environmental regulations are in place, which specify the manner in which asbestos must be handled and disposed.  We are required to record the fair value of these conditional liabilities if they can be reasonably estimated. As of December 31, 2014 and 2013, sufficient information was not available to estimate our liability for conditional asset retirement obligations as the obligations to remove the asbestos from these properties have indeterminable settlement dates. As such, no liability for conditional asset retirement obligations was recorded on our accompanying consolidated balance sheets as of December 31, 2014 and 2013.
	Lease Accounting
	At the inception of the lease and during the amendment process, we evaluate each lease to determine if the lease should be considered an operating lease, sales-type lease, or direct financing lease.  We have determined that all of our leases except for the four New Ark Investment, Inc. (“New Ark”) leases entered into in 2013 should be accounted for as operating leases.  The four New Ark leases are accounted for as direct financing leases.
	For leases accounted for as operating leases, we retain ownership of the asset and record depreciation expense, see “Purchase Accounting/Real Estate Investments and Depreciation” above for additional information regarding our investment in real estate leased under operating lease agreements.  We also record lease revenue based on the contractual terms of the operating lease agreement which often includes annual rent escalators, see “Revenue Recognition” below for further discussion regarding the recordation of revenue on our operating leases.
	For leases accounted for as direct financing leases, we record the present value of the future minimum lease payments (utilizing a constant interest rate over the term of the lease agreement) as a receivable and record interest income based on the contractual terms of the lease agreement.  The New Ark lease agreements include annual rent escalators; see “Revenue Recognition” below for further discussion regarding the recording of interest income on our direct financing leases.  As of December 31, 2014, $3.4 million of unamortized direct costs related to originating the direct financing leases have been deferred and recorded as “other assets” in our consolidated balance sheets.
	In-Place Leases
	In-place lease assets and liabilities result when we assume a lease as part of a facility purchase.  The fair value of in-place leases consists of the following components as applicable (1) the estimated cost to replace the leases, and (2) the above/below market cash flow of the leases, determined by comparing the projected cash flows of the leases in place at the time of acquisition to projected cash flows of comparable market-rate leases (referred to as Lease Intangibles).  Lease Intangible assets and liabilities are classified as lease contracts above and below market value, respectively in “other assets” and “accrued expenses and other liabilities,” and amortized on a straight-line basis as decreases and increases, respectively, to rental revenue over the remaining term of the underlying leases.  Should a tenant terminate its lease, the unamortized portion of the Lease Intangible is written off.
	As of December 31, 2014 and 2013, we had $20.4 million and $26.5 million, respectively, of below market leases and $2.4 million and $3.5 million, respectively, of above market leases recorded on our consolidated balance sheets.  We expect net amortization of the in-place leases to increase rental income by:
			(in millions)
	2015		$	4.3
	2016			3.1
	2017			2
	2018			1.7
	2019			1.5
	Thereafter			5.4
	Total		$	18
	For the years ended December 31, 2014, 2013 and 2012, we have amortized $5.0 million, $5.0 million and $5.3 million, respectively as a net increase to rental revenue.
	Asset Impairment
	Management periodically, but not less than annually, evaluates our real estate investments for impairment indicators, including the evaluation of our assets’ useful lives.  The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance and legal structure.  If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities.  Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets.  An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value.  The fair value of the real estate investment is determined by market research, which includes valuing the property as a nursing home as well as other alternative uses.  All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset.
	If we decide to sell real estate properties or land holdings, we evaluate the recoverability of the carrying amounts of the assets.  If the evaluation indicates that the carrying value is not recoverable from estimated net sales proceeds, the property is written down to estimated fair value less costs to sell.  Our estimates of cash flows and fair values of the properties are based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers.
	For the years ended December 31, 2014, 2013 and 2012, we recognized impairment losses of $3.7 million, $0.4 million and $0.3 million, respectively.  The impairments are primarily the result of closing facilities or updating the estimated proceeds we expect to receive for the sale of closed facilities.  For additional information, see Note 3 – Properties and Note 4 – Assets Held For Sale.
	Loan and Direct Financing Lease Impairment
	Management evaluates our outstanding mortgage notes, direct financing leases and other notes receivable.  When management identifies potential loan or direct financing lease impairment indicators, such as non-payment under the loan documents, impairment of the underlying collateral, financial difficulty of the operator or other circumstances that may impair full execution of the loan documents or direct financing leases, and management believes it is probable that all amounts will not be collected under the contractual terms of the loan or direct financing lease, the loan or direct financing lease is written down to the present value of the expected future cash flows.  In cases where expected future cash flows are not readily determinable, the loan or direct financing lease is written down to the fair value of the collateral.  The fair value of the loan or direct financing lease is determined by market research, which includes valuing the property as a nursing home as well as other alternative uses.
	We currently account for impaired loans and direct financing leases using (a) the cost-recovery method, and/or (b) the cash basis method.  We generally utilize the cost-recovery method for impaired loans or direct financing leases for which impairment reserves were recorded.  We utilize the cash basis method for impaired loans or direct financing leases for which no impairment reserves were recorded because the net present value of the discounted cash flows expected under the loan or direct financing lease and/or the underlying collateral supporting the loan or direct financing lease were equal to or exceeded the book value of the loans or direct financing leases.  Under the cost-recovery method, we apply cash received against the outstanding loan balance or direct financing lease prior to recording interest income.  Under the cash basis method, we apply cash received to principal or interest income based on the terms of the agreement.  As of December 31, 2014 and 2013, we had loan loss reserves totaling $0 and $2.0 million, respectively.  As of December 31, 2014 and 2013, we had no reserves for direct financing leases.  In 2014 and 2013, we received recovery on previously written-off loans relating to an existing operator’s note from the receivership of approximately $46 thousand and $0.2 million, respectively.  In 2012, we did not record provisions for loan losses or charge-offs related to our mortgage or note receivable portfolios.
	For additional information, see Note 5 – Direct Financing Leases, Note 6 – Mortgage Notes Receivable and Note 7 – Other Investments.
	Cash and Cash Equivalents
	Cash and cash equivalents consist of cash on hand and highly liquid investments with a maturity date of three months or less when purchased.  These investments are stated at cost, which approximates fair value.  The majority of our cash and cash equivalents are held at major commercial banks.
	Restricted Cash
	Restricted cash consists primarily of funds escrowed for tenants’ security deposits required by us pursuant to certain contractual terms (see Note 9 – Lease and Mortgage Deposits).
	Accounts Receivable
	Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts.  Contractual receivables relate to the amounts currently owed to us under the terms of the lease agreement.  Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement.  Straight-line receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts due to us contractually.  Lease inducements result from value provided by us to the lessee at the inception or renewal of the lease and amortized as a reduction of rental revenue over the non cancellable lease term.
	On a quarterly basis, we review our accounts receivable to determine their collectability. The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement. If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance. In the case of a lease recognized on a straight-line basis or existence of lease inducements, we generally provide an allowance for straight-line accounts receivable and/or the lease inducements when certain conditions or indicators of adverse collectability are present.
	A summary of our net receivables by type is as follows:
		December 31,
		2014				2013
		(in thousands)
	Contractual receivables		$	4,799			$	2,941
	Effective yield interest receivables			6,232				5,333
	Straight-line receivables			143,652				123,486
	Lease inducements			13,571				16,228
	Allowance			(78	)			(484	)
	Accounts receivable – net		$	168,176			$	147,504
	In 2014, we wrote-off (i) $0.8 million of straight-line rent receivables associated with a lease amendment to an existing operator for two facilities that were transitioned to a new operator and (ii) $2.0 million of effective yield interest receivables associated with the termination of a mortgage note that was due November 2021.  See Note 6 – Mortgage Notes Receivable for additional information related to the early termination of the November 2021 mortgage note.
	We continuously evaluate the payment history and financial strength of our operators and have historically established allowance reserves for straight-line rent adjustments for operators that do not meet our requirements.  We consider factors such as payment history, the operator’s financial condition as well as current and future anticipated operating trends when evaluating whether to establish allowance reserves.
Deferred Financing Costs
External costs incurred from placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method.  The deferred financing costs are included in “other assets” in our consolidated balance sheets.  Amortization of financing costs totaling $4.5 million, $2.8 million and $2.6 million in 2014, 2013 and 2012, respectively, is classified as “interest - amortization of deferred financing costs” in our consolidated statements of operations.  When financings are terminated, unamortized deferred financing costs, as well as charges incurred for the termination, are expensed at the time the termination is made.  Gains and losses from the extinguishment of debt are presented within income from continuing operations in the accompanying consolidated financial statements.
Revenue Recognition
We have various different investments that generate revenue, including leased and mortgaged properties, as well as other investments, including working capital loans.  We recognize rental income and other investment income as earned over the terms of the related master leases and notes, respectively.  Interest income is recorded on an accrual basis to the extent that such amounts are expected to be collected using the effective interest method.  In applying the effective interest method, the effective yield on a loan is determined based on its contractual payment terms, adjusted for prepayment terms.
Substantially all of our operating leases contain provisions for specified annual increases over the rents of the prior year and are generally computed in one of three methods depending on specific provisions of each lease as follows: (i) a specific annual increase over the prior year’s rent, generally between 2.0% and 3.0%; (ii) an increase based on the change in pre-determined formulas from year to year (e.g. increases in the Consumer Price Index); or (iii) specific dollar increases over prior years.  Revenue under lease arrangements with minimum fixed and determinable increases is recognized over the non-cancellable term of the lease on a straight-line basis.  The authoritative guidance does not provide for the recognition of contingent revenue until all possible contingencies have been eliminated.  We consider the operating history of the lessee, the payment history, the general condition of the industry and various other factors when evaluating whether all possible contingencies have been eliminated.  We do not recognize contingent rents as income until the contingencies have been resolved.
In the case of rental revenue recognized on a straight-line basis, we generally record reserves against earned revenues from leases when collection becomes questionable or when negotiations for restructurings of troubled operators result in significant uncertainty regarding ultimate collection.  The amount of the reserve is estimated based on what management believes will likely be collected.  We continually evaluate the collectability of our straight-line rent assets.  If it appears that we will not collect future rent due under our leases, we will record a provision for loss related to the straight-line rent asset.
We record direct financing lease income on a constant interest rate basis over the term of the lease.  The costs related to originating the direct financing leases have been deferred and are being amortized on a straight-line basis as a reduction to income from direct financing leases over the term of the direct financing leases.
Gains on sales of real estate assets are recognized in accordance with the authoritative guidance for sales of real estate.  The specific timing of the recognition of the sale and the related gain is measured against the various criteria in the guidance related to the terms of the transactions and any continuing involvement associated with the assets sold.  To the extent the sales criteria are not met, we defer gain recognition until the sales criteria are met.
Assets Held for Sale and Discontinued Operations
Assets that qualify as held for sale may also be considered as a discontinued operation if they meet the new criteria set by the Financial Accounting Standards Board (“FASB”) (see “Recent Accounting Pronouncements” below).  For assets that qualify as discontinued operations, we reclassify the operations of those assets to discontinued operations in the consolidated statements of operations for all periods presented and assets held for sale in the consolidated balance sheets for all periods presented.  We had three facilities and one parcel of land classified as held for sale as of December 31, 2014 with a net book value of $12.8 million.  We had three facilities and one parcel of land classified as held for sale as of December 31, 2013 with a net book value of $1.4 million.  The held for sale assets do not meet the FASB criteria to be classified as discontinued operations.
Earnings Per Share
Basic earnings per common share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of shares of common stock outstanding during the year.  All outstanding unvested share-based payment awards that contain rights to non-forfeitable dividends or dividend equivalents that participate in undistributed earnings with common stockholders are considered participating securities that shall be included in the two-class method of computing basic EPS.  Diluted EPS reflects the potential dilution that could occur from shares issuable through stock-based compensation, including stock options and restricted stock.  For additional information, see Note 19 – Earnings Per Share.
Income Taxes
We were organized to qualify for taxation as a REIT under Section 856 through 860 of the Code.  As long as we qualify as a REIT; we will not be subject to Federal income taxes on the REIT taxable income that we distributed to stockholders, subject to certain exceptions.  In 2014, we paid common dividend payments of $258.6 million which satisfies the 2014 REIT requirements relating to qualifying income. We are permitted to own up to 100% of a taxable REIT subsidiary (“TRS”).  Currently, we have one TRS that is taxable as a corporation and that pays federal, state and local income tax on its net income at the applicable corporate rates.  The loss carry forward of $1.0 million was fully reserved with a valuation allowance due to uncertainties regarding realization.  We record interest and penalty charges associated with tax matters as income tax.  For additional information on income taxes, see Note 12 – Taxes.  As of December 31, 2014 and 2013, we did not have any unrecognized tax benefits.  We do not believe that there will be any material changes in our unrecognized tax positions over the next 12 months.  We are subject to examination by the respective taxing authorities for the tax years 2007 through 2014.
Stock-Based Compensation
Stock-based compensation expense is adjusted for estimated forfeitures and is recognized on a straight-line basis over the requisite service period of the awards, see Note 15 – Stock-Based Compensation for additional details.
Recent Accounting Pronouncements
Discontinued Operations
In April 2014, we adopted the FASB Accounting Standards Update No 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (ASU 2014-08).  ASU 2014-08 changes the criteria for determining which disposals can be presented as discontinued operations and modified related disclosure requirements.  Under the new guidance, a discontinued operation is defined as: (i) a disposal of a component or group of components that is disposed of or is classified as held for sale that represents a strategic shift that has or will have a major effect on an entity’s operations and financial results or (ii) an acquired business or nonprofit activity that is classified as held for sale on the date of acquisition.  The standard states that a strategic shift could include a disposal of (i) a major geographical area of operations, (ii) a major line of business, (iii) a major equity method investment, or (iv) other major parts of an entity.
The standard expands the disclosures for discontinued operations and requires new disclosures related to individually material disposals that do not meet the definition of a discontinued operation, an entity’s continuing involvement with a discontinued operation following the disposal date and retained equity method investments in a discontinued operation.  The guidance is effective for annual periods beginning on or after December 15, 2014 and interim periods within that year.  Early adoption is permitted, and calendar year-end companies may early adopt the guidance in the first quarter of 2014, but only for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued or available for issue.  We have chosen to adopt the guidance effective January 1, 2014 and determined that the adoption had no impact on our consolidated financial statements.
Revenue Recognition
In May 2014, the FASB issued a comprehensive new revenue recognition standard that will supersede nearly all existing revenue recognition guidance under GAAP. The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. We will be required to apply the new standard in the first quarter of 2017 and are assessing whether the new standard will have a material effect on our financial position or results of operations.
Risks and Uncertainties
Our company is subject to certain risks and uncertainties affecting the healthcare industry as a result of healthcare legislation and growing regulation by federal, state and local governments. Additionally, we are subject to risks and uncertainties as a result of changes affecting operators of nursing home facilities due to the actions of governmental agencies and insurers to limit the growth in cost of healthcare services (see Note 8 – Concentration of Risk).

PROPERTIES

PROPERTIES	12 Months Ended
	Dec. 31, 2014
Real Estate [Abstract]
PROPERTIES	NOTE 3 - PROPERTIES
	Leased Property
	Our leased real estate properties, represented by 421 SNFs, 22 ALFs and 11 specialty facilities at December 31, 2014, are leased under provisions of single leases and master leases with initial terms typically ranging from 5 to 15 years, plus renewal options.  Substantially all of the single leases and master leases provide for minimum annual rentals that are typically subject to annual increases.  Under the terms of the leases, the lessee is responsible for all maintenance, repairs, taxes and insurance on the leased properties.
	A summary of our investment in leased real estate properties is as follows:
		December 31,
		2014			2013
		(in thousands)
	Buildings	$	2,745,872		$	2,631,774
	Site improvement and equipment		227,411			222,394
	Land		250,502			245,379
			3,223,785			3,099,547
	Less accumulated depreciation		(821,712	)		(707,410	)
	Total	$	2,402,073		$	2,392,137
	The future minimum estimated contractual rents due for the remainder of the initial terms of the leases are as follows at December 31, 2014:
		(in thousands)
	2015	$	380,157
	2016		387,580
	2017		395,079
	2018		381,697
	2019		364,405
	Thereafter		1,823,132
	Total	$	3,732,050
	Below is a summary of the significant transactions that occurred from 2012 to 2014.
	2014 Acquisitions/Other
	Acquisition of Four ALFs in Pennsylvania, Oregon and Arkansas
	On November 20, 2014, we completed a purchase/lease-back of four ALFs (two in Pennsylvania, one in Oregon and one in Arkansas) from an existing operator of Omega for approximately $84.2 million.  The four ALFs (with 371 total beds) were leased to the operator under a new master lease with an initial annual cash yield of 6.0%.
	We are awaiting additional information necessary, including information related to an earn-out provision in order to finalize our purchase accounting and expect the allocation process to be complete in 2015.  As of December 31, 2014, we preliminarily recorded approximately $84.2 million consisting of land ($5.1 million), building and site improvements ($76.7 million), and furniture and fixtures ($2.4 million).  We have not recorded goodwill in connection with this transaction.
	Acquisition of One SNF in Texas
	On July 1, 2014, we purchased one SNF located in Texas from an unrelated third party for approximately $8.2 million and leased it to an existing operator of Omega.  The 125 bed SNF was added to the operator’s existing master lease with an initial annual cash yield of 9.75%.  We recorded approximately $8.2 million consisting of land ($0.4 million), building and site improvements ($7.4 million), and furniture and fixtures ($0.4 million).  We have not recorded goodwill in connection with this transaction.
	Transition of Two West Virginia Facilities to a New Operator
	On July 1, 2014, we transitioned two West Virginia SNFs that we previously leased to Diversicare Healthcare Services (“Diversicare” and formerly known as Advocat) to a new unrelated third party operator.  The two facilities represent 150 operating beds.  We amended our Diversicare master lease to reflect the transition of the two facilities to the new operator and for the year ended December 31, 2014 recorded a $0.8 million provision for uncollectible straight-line accounts receivable.  Simultaneous with the Diversicare master lease amendment, we entered into a 12-year master lease with a new third party operator.
	Acquisition of Three SNFs in South Carolina and Georgia
	On June 27, 2014, we purchased two SNFs from an unrelated third party for approximately $17.3 million and leased them to an existing operator of Omega.  The SNFs, located in Georgia and South Carolina with a total of 213 beds, were combined into a new 12 year master lease with an initial annual cash yield of 9.5%.
	In the third quarter of 2014, we purchased a third SNF in South Carolina with 132 beds that was added to the master lease.  The combined purchase price, including the third SNF was $34.6 million.  We recorded approximately $34.6 million consisting of land ($0.9 million), building and site improvements ($32.1 million), and furniture and fixtures ($1.6 million).  We have not recorded goodwill in connection with this transaction.
	Acquisition of One ALF in Arizona
	On January 30, 2014, we acquired an ALF in Arizona from an unrelated third party for approximately $4.7 million. The operations of the 90 bed facility were transitioned to an existing operator of Omega.  We recorded approximately $4.7 million consisting of land ($0.4 million), building and site improvements ($3.9 million), and furniture and fixtures ($0.4 million).  We have not recorded goodwill in connection with this transaction.
	For the year ended December 31, 2014, revenue attributable to the acquired assets was approximately $3.2 million and net income attributable to the acquired assets was approximately $1.2 million recognized in the consolidated statement of operations. Acquisition costs related to the above transactions and the pending Merger with Aviv were expensed as period costs. For the year ended December 31, 2014, we expensed $3.9 million of acquisition related expenses, including costs associated with the aforementioned acquisitions.
	2013 Acquisitions/Other
	Acquisition of an ALF in Florida
	On October 2, 2013, we purchased a 97 bed ALF in Florida for $10.3 million in cash.  The ALF was added to an existing master lease.
	We completed our purchase accounting in 2014 with no change from our preliminary allocation.  As of December 31, 2013, we recorded approximately $10.3 million consisting of land ($0.6 million), building and site improvements ($9.0 million), and furniture and fixtures ($0.7 million).  We have not recorded goodwill in connection with this transaction.
	Acquisition of four SNFs in Indiana
	On October 31, 2013, we purchased four SNFs totaling 384 beds in Indiana for $22.2 million in cash.  The four SNFs were added to an existing master lease, but the terms of the lease and the purchase price were based on an existing lease agreement between the seller and the lessee which was below current market conditions.  We recorded approximately $3.0 million to below market leases as a result of the transaction for a total investment of $25.2 million.  We have not recorded goodwill in connection with this transaction.
	We completed our purchase accounting in 2014 with no change from our preliminary allocation.  As of December 31, 2013, we recorded approximately $25.2 million consisting of land ($0.7 million), building and site improvements ($21.8 million), and furniture and fixtures ($2.7 million).
	Acquisition costs related to the above transactions were expensed as period costs.  For the year ended December 31, 2013, we expensed $0.2 million of acquisition related expenses.
	Transition of 11 Arkansas Facilities to a New Operator
	On August 30, 2013, we transitioned 11 SNFs located in Arkansas that we previously leased to Diversicare Healthcare Services to a new third party operator.  The 11 facilities represent 1,084 operating beds.  We amended our Diversicare master lease to provide for reduced rent to reflect the transition of the 11 facilities to the new operator, and recorded a $2.3 million provision for uncollectible straight-line rent receivable.  Simultaneously with the amendment to the Diversicare master lease, we entered into a new master lease with the new third party operator of the 11 facilities.  The new master lease expires on August 31, 2023 and includes fixed annual rent escalators.
	2012 Acquisitions/Other
	Genesis Healthcare
	On December 1, 2012, Genesis Healthcare (“Genesis”), an existing operator to Omega, completed the purchase of Sun Healthcare Group (“Sun”), which was also an existing operator to Omega.  Prior to the purchase, Sun was our second largest tenant representing 40 facilities located in 10 states.  Prior to the purchase, we also had a master lease with Genesis representing 13 facilities located in 5 states.
	In connection with the acquisition, on December 1, 2012, we entered into a 53 facility master lease with Genesis expiring on December 31, 2025.  In 2013, we transitioned one facility to another operator reducing the number of facilities covered by the Genesis lease to 52 facilities.
	Arizona and California Acquisitions
	During the year ended December 31, 2012, we completed the acquisition of approximately $203.4 million of new investments and leased them to a new operator.  The investments involved two separate transactions to purchase 14 facilities (12 SNFs, 1 ALF and 1 combined SNF/ALF).  The combined transactions consisted of the assumption of approximately $71.9 million of indebtedness guaranteed by the Department of Housing and Urban Development (“HUD”) and payment of $131.5 million in cash. The $71.9 million of assumed HUD debt is comprised of 8 HUD mortgage loans with a blended interest rate of 5.50% and maturities between April 2031 and February 2045. The 14 facilities, representing 1,830 operating beds, are located in California (10) and Arizona (4). The transaction involved several separate master lease agreements covering all 14 facilities.
	Transaction 1 (First Closing):  On November 30, 2012, we purchased four Arizona facilities (2 SNFs, 1 ALF and 1 combined SNF/ALF) for an aggregate purchase price of $60.0 million.  The transaction consisted of the assumption of $27.6 million of indebtedness guaranteed by HUD and $32.4 million in cash.  The blended interest rate on the HUD indebtedness assumed for the Arizona facilities was 4.73%.  The four facilities were simultaneously leased back to a new operator under a new 12 year master lease.
	We recorded approximately $64.6 million consisting of land ($5.5 million), building and site improvements ($55.9 million), and furniture and fixtures ($3.2 million).  We recorded approximately $4.6 million of fair value adjustment related to above market debt assumed based on the terms of comparable debt and other market factors.  We have not recorded goodwill in connection with this transaction.
	Transaction 2 (Second Closing):  In November 2012, we entered into a Purchase and Sales Agreement to purchase and then leaseback 10 California SNFs.  On November 30, 2012, we purchased five SNFs for approximately $70.2 million.  The five SNFs were simultaneously leased back under a new 12 year master lease.
	We recorded approximately $70.2 million consisting of land ($11.5 million), building and site improvements ($55.5 million), and furniture and fixtures ($3.2 million).  We have not recorded goodwill in connection with this transaction.
	Transaction 2 (Third Closing):  On December 31, 2012, we purchased the remaining five California SNFs for an aggregate purchase price of $72.2 million (net of purchase price reduction of approximately $1.0 million related to funds escrowed by the seller to reimburse us for costs associated with refinancing some of the assumed HUD debt).  The transaction consisted of the assumption of $44.3 million of HUD indebtedness and $28.9 million in cash.  The blended interest rate on the HUD indebtedness assumed for the five California facilities was 5.97%.  The five SNFs were then leased back to the new operator under new 12 year master leases.
	We recorded approximately $77.5 million consisting of land ($13.0 million), building and site improvements ($60.8 million), and furniture and fixtures ($3.7 million).  We recorded approximately $5.4 million of fair value adjustment related to the above market debt assumed based on the terms of comparable debt and other market factors.  We have not recorded goodwill in connection with this transaction.
	Indiana Acquisitions
	In 2012, we completed four transactions in Indiana involving two existing operators and 34 facilities.  The following is a summary of the transactions:
	Transaction 1:  On June 29, 2012, we purchased one SNF encompassing 80 operating beds in Indiana for approximately $3.4 million and leased the facility to an existing operator under an existing master lease.  We recorded approximately $3.4 million consisting of land ($0.2 million), building and site improvements ($2.9 million), and furniture and fixtures ($0.3 million).  We have not recorded goodwill in connection with this transaction.
	Transaction 2:  On June 29, 2012, we purchased four facilities encompassing 383 operating beds in Indiana for approximately $21.7 million and leased the facilities to an existing operator.  We recorded approximately $21.7 million consisting of land ($1.9 million), buildings and site improvements ($18.4 million) and furniture and fixtures ($1.4 million).  We have not recorded goodwill in connection with this transaction.
	Transaction 3:  On August 31, 2012, we purchased 27 facilities (17 SNFs, four ALFs and six independent living facilities) totaling 2,892 operating beds in Indiana from an unrelated third party for approximately $203 million in cash and assumed a liability associated with the lease of approximately $13.9 million.  Simultaneous with the transaction, we also purchased one parcel of land for $2.8 million.  The purchase price of both (i) 27 facilities and (ii) the parcel of land were funded from cash on hand and borrowings from our credit facility.  The 27 facilities and land parcel were added to an existing master lease.  We recorded approximately $219.7 million consisting of land ($16.1 million), building and site improvements ($189.2 million) and furniture and fixtures ($14.4 million).  We have not recorded goodwill in connection with this transaction.
Transaction 4:  On December 31, 2012, we purchased two SNFs encompassing 167 operating beds in Indiana for approximately $9.5 million and leased these facilities to an existing operator under a new consolidated master lease.  We recorded approximately $9.5 million consisting of land ($0.6 million), building and site improvements ($8.0 million), and furniture and fixtures ($0.9 million).  We have not recorded goodwill in connection with this transaction.
Michigan Acquisition
On November 30, 2012, we purchased one ALF for $20 million from an unrelated third party and added it to an existing master lease with an existing operator.  The 171 operating bed ALF is located in Michigan.  We recorded approximately $20.0 million consisting of land ($0.4 million), building and site improvements ($18.9 million), and furniture and fixtures ($0.7 million).  We have not recorded goodwill in connection with this transaction.
Texas Acquisition
On October 31, 2012, we purchased one SNF from an unrelated third party encompassing 90 operating beds in Texas for approximately $2.7 million and leased the facility to an existing operator.  We recorded approximately $2.7 million consisting of land ($0.2 million), building and site improvements ($2.2 million), and furniture and fixtures ($0.3 million).  We have not recorded goodwill in connection with this transaction.
Acquisition costs related to the above transactions were expensed as period costs.  For the year ended December 31, 2012, we expensed $0.9 million of acquisition related expenses.
Pro Forma Acquisition Results
The facilities acquired in 2014 and 2013 are included in our results of operations from the date of acquisition.  The following unaudited pro forma results reflect the impact of the transactions as if they occurred on January 1, 2013.  In the opinion of management, all significant necessary adjustments to reflect the effect of the acquisitions have been made.  The following pro forma information is not indicative of future operations.
	Pro Forma
	Year Ended December 31,
	2014			2013
	(in thousands, except per share
	amounts, unaudited)
Revenues	$	512,370		$	432,031
Net income available to common stockholders		224,183			177,589
Earnings per share – diluted:
Net income available to common stockholders – as reported	$	1.74		$	1.46
Net income available to common stockholders – pro forma	$	1.76		$	1.5
In 2014, we closed two SNFs and recorded a $3.6 million provision for impairment related to these facilities (Level 3).  The net book value of the two SNFs that are closed but not classified as held-for-sale is approximately $1.2 million as of December 31, 2014 (Level 3).

ASSETS_HELD_FOR_SALE

ASSETS HELD FOR SALE	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
ASSETS HELD FOR SALE	NOTE 4 – ASSETS HELD FOR SALE
			Properties Held-For-Sale
			Number of			Net Book Value
			Properties			(in thousands)
	December 31, 2012 (1)			3		$	1,020
	Properties sold			-			-
	Properties added			1			336
	December 31, 2013 (2)			4			1,356
	Properties sold (3)			(3	)		(686	)
	Properties added			3			12,122
	December 31, 2014 (2)			4		$	12,792
		-1	Includes one parcel of land and two facilities.
		-2	Includes one parcel of land and three facilities.
		-3	In 2014, we sold these facilities for approximately $2.8 million in net proceeds recognizing a gain on sale of approximately $2.0 million.

DIRECT_FINANCING_LEASES

DIRECT FINANCING LEASES	12 Months Ended
	Dec. 31, 2014
Leases, Capital [Abstract]
DIRECT FINANCING LEASES	NOTE 5 – DIRECT FINANCING LEASES
	The components of investment in direct financing leases consist of the following:
			December 31,
			2014			2013
			(in thousands)
	Minimum lease payments receivable		$	4,244,067		$	4,291,067
	Estimated residual values			—			—
	Less unearned income			(3,704,835	)		(3,761,622	)
	Net investment in direct financing leases		$	539,232		$	529,445
	Properties subject to direct financing leases			56			56
	On November 27, 2013, we closed on an aggregate $529 million purchase/leaseback transaction in connection with the acquisition of Ark Holding Company, Inc. (“Ark Holding”) by 4 West Holdings Inc. At closing, we acquired 55 SNFs and 1 ALF operated by Ark Holding and leased the facilities back to Ark Holding, now known as New Ark Investment Inc. (“New Ark”), pursuant to four 50-year master leases, with rental payments yielding 10.6% per annum over the term of the leases. The purchase/leaseback transaction is being accounted for as a direct financing lease.
	The lease agreements allow the tenant the right to purchase the facilities for a bargain purchase price plus closing costs at the end of term.  In addition, commencing in the 41st year of each lease, the tenant will have the right to prepay the remainder of its obligations thereunder for an amount equal to the sum of the unamortized portion of the original aggregate $529 million investment plus the net present value of the remaining payments under the lease, and closing costs.  In the event the tenant exercises either of these options, we have the right to purchase the properties for fair market value at the time.
	The 56 facilities represent 5,623 licensed beds located in 12 states, predominantly in the southeastern United States. The 56 facilities are separated by region and divided amongst four cross-defaulted master leases.  The four regions include the Southeast (39 facilities), the Northwest (7 facilities), Texas (9 facilities) and Indiana (1 facility).  As of December 31, 2014, the following minimum rents are due under our direct financing leases for the next five years (in thousands):
	Year 1	Year 2	Year 3	Year 4	Year 5
	$47,000	$47,032	$47,482	$48,669	$49,886

MORTGAGE_NOTES_RECEIVABLE

MORTGAGE NOTES RECEIVABLE	12 Months Ended
	Dec. 31, 2014
Mortgage Notes Receivable Investments [Abstract]
MORTGAGE NOTES RECEIVABLE	NOTE 6 - MORTGAGE NOTES RECEIVABLE
	As of December 31, 2014, mortgage notes receivable relate to 13 fixed-rate mortgages on 55 long-term care facilities.  The mortgage notes are secured by first mortgage liens on the borrowers’ underlying real estate and personal property.  The mortgage notes receivable relate to facilities located in five (5) states, operated by five (5) independent healthcare operating companies.  We monitor compliance with mortgages and when necessary have initiated collection, foreclosure and other proceedings with respect to certain outstanding loans.
	The outstanding principal amounts of mortgage notes receivable, net of allowances, were as follows:
			December 31,
			2014		2013
			(in thousands)
	Mortgage note due 2014; interest at 11.00%		$	-	$	5,000
	Mortgage note due 2021; interest at 12.50%			-		5,574
	Mortgage note due 2021; interest at 11.00%			-		91,123
	Mortgage note due 2021; interest at 10.00%			-		913
	Mortgage note due 2021; interest at 10.25%			1,326		-
	Mortgage note due 2022; interest at 12.50%			-		5,310
	Four Mortgage notes due 2022; interest at 12.00%			7,395		7,313
	Mortgage note due 2023; interest at 11.00%			69,928		69,928
	Mortgage note due 2023; interest at 12.50%			-		7,782
	Mortgage note due 2023; interest at 12.50%			-		6,175
	Mortgage note due 2024; interest at 9.50%			112,500		-
	Mortgage note due 2029; monthly payment of $90,000, including interest at 9.00%			414,550		-
	Mortgage note due 2030; interest at 10.82%			15,880		15,897
	Four Mortgage notes due 2046; interest at 12.00%			26,500		26,500
	Total mortgages — net (1)		$	648,079	$	241,515
		-1	As of December 31, 2013 and 2014 we have no allowance for loan loss for any of our mortgages.
	$415 Million of Refinancing/Consolidating Mortgage Loans due 2029
	On June 30, 2014, we entered into an agreement to refinance/consolidate $117 million in existing mortgages with maturity dates ranging from 2021 to 2023 on 17 facilities into one mortgage and simultaneously provide mortgage financing for an additional 14 facilities.  The new $415 million mortgage matures in 2029 and is secured by 31 facilities totaling 3,430 licensed beds all located in the state of Michigan.  The new loan bears an initial annual cash interest rate of 9.0% and increases by 0.225% per year (e.g., beginning in year 2 the interest rate will be 9.225%, in year 3 the rate will be 9.45%, etc.).
	One of the existing mortgages that was refinanced/consolidated into the new $415 million mortgage included annual interest rate escalators and required the mortgagee to pay a prepayment penalty in the event the mortgage was retired early which resulted in us recording an effective yield interest receivable.  In connection with the refinancing/consolidating transaction which was entered into at market terms, the old mortgage was considered to be retired early since the modifications made to the terms of the mortgage were more than minor.  As of the date of the refinancing/consolidation transaction, the effective yield interest receivable was approximately $2.0 million.  We forgave the prepayment penalty associated with the retired mortgage and recorded a $2.0 million provision to write-off the effective yield interest receivable related to the retired mortgage.
	Mortgage Note due 2021
	In 2013, we entered into a $3.5 million mortgage note with an existing operator to fund renovations on one property.  The mortgage note matures in 2021 and bears interest at an initial rate of 10%, with annual escalators of 2.5%. As of December 31, 2014, the balance of the loan related to the property was approximately $1.3 million.
	Mortgage Notes due 2022
	As of December 31, 2014, the balance of the loan related to the property was approximately $7.4 million.  These mortgage loans mature on July 31, 2022 and carry an annual interest rate of 12%.
	$113 Million of Mortgage Note due 2024
	On January 17, 2014, we entered into a $112.5 million first mortgage loan with an existing operator of Omega.  The loan is secured by 7 SNFs and 2 ALFs totaling 798 operating beds located in Pennsylvania (7) and Ohio (2).  The loan is cross-defaulted and cross-collateralized with our existing master lease with the operator.  The loan bears an initial annual cash interest rate of 9.5% and matures in January 2024.
	Mortgage Note due 2023
	The $69.9 million mortgage note is secured by seven facilities located in Maryland.  The interest rate will accrue at a fixed rate of 11% per year through April 2018.  After April 2018, the interest rate will increase to 13.75% per year.  The mortgage note matures in December 2023.
	Mortgage Note due 2030
	In December 2010, we entered into a first mortgage loan with a new operator in the amount of $15.9 million.  The mortgage is secured by three SNFs, totaling 240 beds located in Florida.  The mortgage note matures in 2030 and bears interest at an initial rate of 10%, with annual escalators of 2%.
	Mortgage Notes due 2046
	In October 2011, we enter into a first mortgage loan in the amount of $25 million secured by a lien on three SNFs, totaling 352 beds located in Maryland.  In November 2012, we entered into an additional $1.5 million first mortgage loan secured by a lien on an additional 60 bed SNF located in Michigan.  The mortgages currently bear interest at 12% and increases to 13.5% in November 2018.  The mortgages mature in 2046.
	Mortgage Note due 2014 Payoff
	We provided a mortgage note to an existing operator for a property in Texas in 2011 for $5.0 million to provide bridge financing.  The note was paid off in July 2014.

OTHER_INVESTMENTS

OTHER INVESTMENTS	12 Months Ended
	Dec. 31, 2014
Receivables [Abstract]
OTHER INVESTMENTS	NOTE 7 - OTHER INVESTMENTS
	A summary of our other investments is as follows:
			December 31,
			2014		2013
			(in thousands)
	Other investment notes due 2015		$	141	$	2,318
	Other investment notes due 2021 - 2023			16,182		13,427
	Other investment note due 2014			-		62
	$31.5 million other investment note due 2017			23,500		23,750
	$2.5 million other investment note due 2014			1,640		546
	$6.0 million other investment note due 2015			5,439		5,439
	$1.3 million other investment note due 2017			1,300		1,300
	$1.5 million other investment note due 2014			-		1,456
	$0.9 million other investment note due 2015			750		-
	Notes receivable, gross(1)			48,952		48,298
	Allowance for loss on notes receivable			-		(1,977	)
	Notes receivable, net			48,952		46,321
	Other			-		2,400
	Marketable securities			-		4,333
	Total other investments		$	48,952	$	53,054
		-1	These notes bear interest at a weighted average rate of approximately 10% annually as of December 31, 2014.
	Other Investment notes due 2015
	During the year ended December 31, 2014, we wrote off approximately $2.0 million of these notes deemed uncollectible against loan loss reserves established in prior years.
	Other Investment notes due 2021 - 2023
	The 2021-2023 other investment notes relates to 17 individual notes with one operator to fund renovations on several facilities.  The loans mature between 2021 and 2023 and bear interest at an initial rate of 10% with escalators of 2.5% per year.  The maximum draw on all 17 loans is approximately $22.7 million.
	$31.5 Million Other Investment note due 2017
	In February 2014, we amended our five year 10.0% term loan agreement with an existing operator allowing for an additional draw of $3.5 million at a 10.5% interest rate.  The loan matures in January 2017.
	$6.0 Million Other Investment note due 2015
	In 2014, we amended an existing working capital note with an existing operator increasing the availability from $4.0 million to $6.0 million.  The note bears interest at 10% and matures in February 2015.
	$1.5 Million Other Investment note due 2014 Payoff
	In November 2013, we entered into a $1.5 million one year promissory note at 8.95% interest rate with an existing operator.  The loan was paid off in November 2014.
	Other
	In October 2013, the investment of $2.4 million for the construction of a new facility that we funded to an existing operator in July 2013 was cancelled. In September 2014, under the amended master lease, we agreed to accept a repayment of the amount funded in exchange for a termination of the existing operator’s obligation to pay rent after such payment. The repayment was in the form of a cash payment of $1.5 million and a promissory note in the amount of $0.9 million at 9.5% interest rate (see above “$0.9 million other investment note due 2015”). The loan matures in October 2015.
	Marketable Securities
	On August 20, 2014, Diversicare redeemed the shares of its Series C non-convertible, redeemable preferred stock held by Omega, which had a liquidation preference of approximately $4.9 million and a dividend rate of 7% per annum.  We received approximately $5.0 million in net proceeds from the redemption of our Diversicare preferred shares.  The preferred shares were originally issued to Omega in 2006 in connection with the restructuring of preferred stock and master lease agreements between Diversicare and Omega.  We recorded a gain of $0.6 million in other investment income.

CONCENTRATION_OF_RISK

CONCENTRATION OF RISK	12 Months Ended
	Dec. 31, 2014
Risks and Uncertainties [Abstract]
CONCENTRATION OF RISK	NOTE 8 - CONCENTRATION OF RISK
	As of December 31, 2014, our portfolio of real estate investments consisted of 568 healthcare facilities, located in 38 states and operated by 50 third‑party operators.  Our gross investment in these facilities, net of impairments and before reserve for uncollectible loans, totaled approximately $4.4 billion at December 31, 2014, with approximately 99% of our real estate investments related to long-term care facilities.  Our portfolio is made up of 474 SNFs, 23 ALFs, 11 specialty facilities, fixed rate mortgages on 53 SNFs and two ALFs, and five SNFs that are closed/held-for-sale.  At December 31, 2014, we also held miscellaneous investments of approximately $49.0 million, consisting primarily of secured loans to third-party operators of our facilities.
	At December 31, 2014, we had investments with one operator and/or manager that exceeded 10% of our total investments: New Ark (13%).  The three states in which we had our highest concentration of investments were Florida (14%), Michigan (10%) and Ohio (9%) at December 31, 2014.
	For the year ended December 31, 2014, our revenues from operations totaled $504.8 million, of which approximately $58.6 million was from New Ark (12%) and $55.2 million was from Genesis (11%).  No other operator generated more than 9% of our revenues from operations for the year ended December 31, 2014.

LEASE_AND_MORTGAGE_DEPOSITS

LEASE AND MORTGAGE DEPOSITS	12 Months Ended
	Dec. 31, 2014
Security Deposits and Letters Of Credit [Abstract]
LEASE AND MORTGAGE DEPOSITS	NOTE 9 - LEASE AND MORTGAGE DEPOSITS
	We obtain liquidity deposits and letters of credit from most operators pursuant to our lease and mortgage contracts with the operators.  These generally represent the rental and mortgage interest for periods ranging from three to six months with respect to certain of our investments.  At December 31, 2014, we held $5.8 million in such liquidity deposits and $60.2 million in letters of credit.  The liquidity deposits and the letters of credit may be used in the event of lease and/or loan defaults, subject to applicable limitations under bankruptcy law with respect to operators filing under Chapter 11 of the United States Bankruptcy Code.  Liquidity deposits are recorded as restricted cash on our consolidated balance sheets with the offset recorded as a liability.  Additional security for rental and mortgage interest revenue from operators is provided by covenants regarding minimum working capital and net worth, liens on accounts receivable and other operating assets of the operators, provisions for cross default, provisions for cross‑collateralization and by corporate/personal guarantees.

BORROWING_ARRANGEMENTS

BORROWING ARRANGEMENTS	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
BORROWING ARRANGEMENTS	NOTE 10 - BORROWING ARRANGEMENTS
	The following is a summary of our long-term borrowings:
					Current			December 31,
			Maturity		Rate			2014			2013
								(in thousands)
	Secured borrowings:
	HUD mortgages assumed June 2010 (1)			2040 - 2045		4.85	%	$	126,319		$	128,641
	HUD mortgages assumed October 2011 (1)			2036		4.91	%		26,658			31,145
	HUD mortgages assumed December 2011(1) (2)			2044		3.06	%		57,416			58,592
	HUD mortgages assumed December 2012(1)			2040 - 2045		4.64	%		41,061			80,153
	Total secured borrowings								251,454			298,531
	Unsecured borrowings:
	Revolving line of credit			2018		1.72	%		85,000			326,000
	Term loan			2019		1.67	%		200,000			200,000
									285,000			526,000
	2020 notes			2020		7.5	%		200,000			200,000
	2022 notes			2022		6.75	%		575,000			575,000
	2024 notes			2024		5.875	%		400,000			400,000
	2024 notes			2024		4.95	%		400,000			—
	2025 notes			2025		4.5	%		250,000			—
	Subordinated debt			2021		9	%		20,747			20,892
									1,845,747			1,195,892
	(Discount) premium - net								(3,698	)		3,995
	Total unsecured borrowings								2,127,049			1,725,887
	Totals – net							$	2,378,503		$	2,024,418
		-1	Reflects the weighted average interest rate on the mortgages.
		-2	The debt was refinanced in March 2013.
	Secured Borrowings
	HUD Mortgages Loans Payoff
	On October 31, 2014, we paid approximately $3.6 million to retire one HUD mortgage that was assumed as part of an October 2011 acquisition.  The payoff resulted in a $27 thousand gain on the extinguishment of the debt due to the write-off of the $0.2 million unamortized premium offset by a prepayment fee of approximately $0.2 million.
	On September 30, 2014, we paid approximately $36.1 million to retire four HUD mortgages that were assumed as part of a December 2012 acquisition.  The payoff resulted in a $1.6 million gain on the extinguishment of the debt due to the write-off of the $3.3 million unamortized premium offset by a prepayment fee of approximately $1.7 million.
	HUD Mortgage Debt assumed June 2010 (Paid-off)
	On May 31, 2013, we paid approximately $51.0 million to retire 11 HUD mortgages that were assumed in connection with our acquisition of certain subsidiaries of CapitalSource in June 2010.  The retirement of the 11 HUD mortgages resulted in a net gain of approximately $11.1 million.  The net gain included the write-off of approximately $11.3 million related to the unamortized premium offset by a prepayment fee of approximately $0.2 million.
	HUD Mortgage Debt assumed June 2010
	In connection with the second quarter 2010 acquisitions of 29 facilities from Capital Source, we assumed $128.8 million of HUD indebtedness with maturity dates ranging from January 2040 to January 2045.  On the date of the assumption, we estimated the fair value of the assumed debt to be approximately $7.3 million more than the face value of the debt assumed.  We are amortizing the premium utilizing the effective interest method from the date of assumption.  As of December 31, 2014 and 2013, the unamortized premium was $5.7 million and $6.0 million, respectively.  We estimate the amortization of premium will be approximately $0.3 million per annum over the next five years.  In 2014, 2013 and 2012, the amortization of the premium was $0.4 million in each year.
	HUD Debt assumed October 2011
	In connection with the October 31, 2011 acquisition of four SNFs, we assumed $29.9 million of HUD indebtedness with maturity dates ranging from March 2036 to September 2040.  On the date of the assumption, we estimated the fair value of the assumed debt to be approximately $3.0 million more than the face value of the debt assumed.  We are amortizing the premium utilizing the effective interest method from the date of assumption.  On October 31, 2014, we retired one mortgage for approximately $3.6 million (see above “HUD Mortgage Loans Payoff”).  As of December 31, 2014 and 2013, the unamortized premium was $2.2 million and $2.6 million, respectively.  We estimate the amortization of the premium will be between $0.1 million and $0.2 million per annum over the next five years.  In 2014, 2013 and 2012, the amortization of the premium was $0.2 million in each year.
	HUD Mortgage Debt assumed December 2011 Refinanced March 2013
	On March 26, 2013, we refinanced existing HUD mortgage debt on 12 properties in Arkansas for approximately $59.4 million including approximately $0.7 million of closing costs that were added to the outstanding balance and amortized over the term of the mortgage debt.  The annual interest rate for the refinanced debt decreased from 5.55% to approximately 3.06%, with the term of the refinanced mortgages remaining unchanged.
	HUD Mortgages assumed December 2012
	In connection with the fourth quarter 2012 acquisitions, we assumed $71.8 million of HUD indebtedness with maturity dates ranging from April 2031 to February 2045.  On the date of the assumption, we estimated the fair value of the assumed debt to be approximately $10.1 million more than the face value of the debt assumed.  We are amortizing the premium utilizing the effective interest method from the date of assumption.  On September 30, 2014, we retired four mortgages for approximately $36.1 million (see above “HUD Mortgages Loans Payoff”).  As of December 31, 2014 and 2013, the unamortized premium was $5.7 million and $9.5 million, respectively.  We estimate the amortization of the premium will be approximately $0.3 million per annum over the next five years.  In 2014, 2013 and 2012, the amortization of the premium was $0.5 million, $0.6 million and $0.1 million, respectively.
	Unsecured Borrowings
	$1.2 Billion Unsecured Credit Facility - 2014
	On June 27, 2014, we entered into a new $1.2 billion unsecured credit facility, comprised of a $1 billion senior unsecured revolving credit facility (the “Revolving Credit Facility”) and a $200 million senior unsecured term loan facility (the “Term Loan Facility” and, collectively, the “2014 Credit Facilities”).
	The 2014 Credit Facilities replace our previous $700 million senior unsecured credit facility (the “2012 Credit Facilities”).  The 2014 Credit Facilities include an “accordion feature” that permits us to expand our borrowing capacity by $550 million, for maximum aggregate commitments of up to $1.75 billion.
	The Revolving Credit Facility is priced at LIBOR plus an applicable percentage (beginning at 130 basis points, with a range of 92.5 to 170 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings, plus a facility fee based on the same ratings (initially 25 basis points, with a range of 12.5 to 30 basis points).  The Revolving Credit Facility is used for acquisitions and general corporate purposes.  At December 31, 2014, we had $85.0 million in borrowings outstanding under the Revolving Credit Facility. The Revolving Credit Facility matures on June 27, 2018, subject to a one-time option by us to extend such maturity date by one year.
	The Term Loan Facility is also priced at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 195 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings.  At December 31, 2014, we had $200 million in borrowings outstanding under the Term Loan Facility.  The Term Loan Facility matures on June 27, 2019.
	Termination of $700 Million Unsecured Credit Facility
	On June 27, 2014, we terminated our 2012 Credit Facilities that we entered into on December 6, 2012 and recorded a non-cash charge of approximately $2.6 million relating to the write-off of unamortized deferred financing costs associated with the termination of the 2012 Credit Facilities.
	Repayment of $200 Million Term Loan
	On December 27, 2013, we entered into a new $200 million senior unsecured, deferred draw, term loan facility (the “2013 Term Loan Facility”) that was scheduled to mature on February 29, 2016.
	The 2013 Term Loan Facility was priced at LIBOR plus an applicable percentage (beginning at 175 basis points, with a range of 110 to 230 basis points) based on the Company’s ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings.
	In January 2014, we drew all $200 million under the 2013 Term Loan Facility and used the proceeds to (i) fund a new mortgage investment and (ii) repay outstanding borrowings under the 2012 Credit Facility.  In March 2014, we paid off and terminated the 2013 Term Loan Facility with proceeds from the sale of our 4.95% Senior Notes due 2024 (see below).  In addition, we recorded a non-cash charge of approximately $2.0 million relating to the write-off of deferred financing costs associated with the termination of the 2013 Term Loan Facility.
	$200 Million 7.5% Senior Notes due 2020 and Exchange Offer
	On February 9, 2010, we issued and sold $200 million aggregate principal amount of 7.5% Senior Notes due 2020 (the “2020 Notes”).  The 2020 Notes mature on February 15, 2020 and pay interest semi-annually on August 15th and February 15th.
	We may redeem the 2020 Notes, in whole at any time or in part from time to time, at redemption prices of 103.75%, 102.5% and 101.25% of the principal amount thereof if the redemption occurs during the 12-month periods beginning on February 15 of the years 2015, 2016 and 2017, respectively, and at a redemption price of 100% of the principal amount thereof on and after February 15, 2018, in each case, plus any accrued and unpaid interest to the redemption date.  In addition, until February 15, 2013 we may redeem up to 35% of the 2020 Notes with the net proceeds of one or more public equity offerings at a redemption price of 107.5% of the principal amount of the 2020 Notes to be so redeemed, plus any accrued and unpaid interest to the redemption date.  If we undergo a change of control, we may be required to offer to purchase the notes from holders at a purchase price equal to 101% of the principal amount plus accrued interest.
	On October 20, 2010, we commenced an offer to exchange $200 million of our registered 7.5% Senior Notes due 2020 for all of the initial 2020 Notes. All $200 million outstanding aggregate principal amount of the initial notes were validity tendered and not withdrawn prior to the expiration of the exchange offer, and were exchanged for exchange notes as of November 22, 2010. The terms of the exchange notes are substantially identical to the terms of the initial notes, except that provisions of the initial notes relating to transfer restrictions, registration rights and additional interest do not apply to exchange notes.
	In February 2015, we notified the trustee of our intent to redeem and retire the 2020 Notes.  We anticipate the redemption will occur in the late first quarter or early second quarter of 2015.
	$575 Million 6.75% Senior Notes due 2022 and Exchange Offer
	On October 4, 2010, we issued and sold $225 million aggregate principal amount of our 6.75% Senior Notes due 2022 (the “Initial 2022 Notes”).  The Initial 2022 Notes mature on October 15, 2022 and pay interest semi-annually on April 15th and October 15th.  On November 23, 2010, we issued and sold $350 million aggregate principal amount of our 6.75% Senior Notes due 2022 (the “Additional 2022 Notes”). The Additional 2022 Notes are of the same series as, and thus have the same terms, as our Initial 2022 Notes.  The Initial 2022 Notes together with the Additional 2022 Notes, are collectively the “2022 Notes”.
	The Initial 2022 Notes were sold at an issue price of 98.984% of the principal amount, resulting in gross proceeds of approximately $223 million.  We used the net proceeds from the sale of the Initial 2022 Notes, after discounts and expenses, to (i) pay off borrowings under a previously terminated credit facility and (ii) for general corporate purposes.  The Additional 2022 Notes were sold at an issue price of 103% of their face value, before initial purchasers’ discount, plus accrued interest from October 4, 2010, resulting in gross proceeds to us of approximately $364 million. We used the net proceeds from the sale of the Additional 2020 Notes (i) to fund our tender offer for our outstanding $310 million aggregate principal amount of 7% Senior Notes due 2014, and (ii) for working capital and general corporate purposes.
	We may redeem the 2022 Notes, in whole at any time or in part from time to time, at redemption prices of 103.375%, 102.25% and 101.125% of the principal amount thereof if the redemption occurs during the 12-month periods beginning on October 15 of the years 2015, 2016 and 2017, respectively, and at a redemption price of 100% of the principal amount thereof on and after October 15, 2018, in each case, plus any accrued and unpaid interest to the redemption date.  In addition, until October 15, 2013 we may redeem up to 35% of the 2022 Notes with the net proceeds of one or more public equity offerings at a redemption price of 106.75% of the principal amount of the 2022 Notes to be so redeemed, plus any accrued and unpaid interest to the redemption date.  If we undergo a change of control, we may be required to offer to purchase the notes from holders at a purchase price equal to 101% of the principal amount plus accrued interest.
	On June 2, 2011, we commenced an offer to exchange $575 million of our 6.75% Senior Notes due 2022 for all of the 2022 Notes. All $575 million outstanding aggregate principal amount of the notes were validly tendered and not withdrawn prior to the expiration of the exchange offer, and were exchanged for exchange notes as of July 14, 2011, pursuant to the terms of the exchange offer. The exchange notes are identical in all material respects to the notes, except that the issuance of the exchange notes was registered under the Securities Act of 1933 and the provisions of the notes relating to transfer restrictions, registration rights and additional interest relating to registrations delays do not apply to the exchange notes.
	As of December 31, 2014, our subsidiaries that are not guarantors of the 2022 Notes accounted for approximately $377.4 million of our total assets.
$400 Million 5.875% Senior Notes due 2024 and Exchange Offer
On March 19, 2012, we issued $400 million aggregate principal amount of our 5.875% Senior Notes due 2024, or the 2024 Notes.  The 2024 Notes mature on March 15, 2024 and pay interest semi-annually on March 15 and September 15 of each year, commencing on September 15, 2012.
We may redeem the 2024 Notes, in whole at any time or in part from time to time, at redemption prices of 102.938%, 101.958% and 100.979% of the principal amount thereof if the redemption occurs during the 12-month periods beginning on March 15 of the years 2017, 2018 and 2019, respectively, and at a redemption price of 100% of the principal amount thereof on and after March 15, 2020, in each case, plus any accrued and unpaid interest to the redemption date.  In addition, until March 15, 2015 we may redeem up to 35% of the 2024 Notes with the net cash proceeds of one or more public equity offerings at a redemption price of 105.875% of the principal amount of the 2024 Notes to be so redeemed, plus any accrued and unpaid interest to the redemption date.  If we undergo a change of control, we may be required to offer to purchase the notes from holders at a purchase price equal to 101% of the principal amount plus accrued interest.
On August 15, 2012, we commenced an offer to exchange $400 million of our 5.875% Senior Notes due 2024 for all of the 2024 Notes. All $400 million outstanding aggregate principal amount of the initial notes were validly tendered and not withdrawn prior to the expiration of the exchange offer, and were exchanged for exchange notes as of September 20, 2012, pursuant to the terms of the exchange offer. The Exchange Notes are identical in all material respects to the Initial Notes, except that the Exchange Notes were registered under the Securities Act of 1933 and the provisions of the Initial Notes relating to transfer restrictions, registration rights and additional interest will not apply to the Exchange Notes.
As of December 31, 2014, our subsidiaries that are not guarantors of the 2024 Notes accounted for approximately $377.4 million of our total assets.
$400 Million 4.95% Senior Notes due 2024 and Exchange Offer
On March 11, 2014, we sold $400 million aggregate principal amount of our 4.95% Senior Notes due 2024.  These notes were sold at an issue price of 98.58% of the principal amount of the notes, before the initial purchasers’ discount resulting in gross proceeds of approximately $394.3 million.  We used the net proceeds of the offering to repay in full our $200 million 2013 Term Loan Facility defined above, and a portion of our indebtedness outstanding under our Revolving Credit Facility.
On August 26, 2014, we commenced an offer to exchange $400 million of our 4.95% Senior Notes due 2024 that have been registered under the Securities Act of 1933 (“exchange notes”) for the $400 million of our 4.95% Senior Notes due 2024 privately placed in March 2014 (“initial notes”).  Approximately 99.875% of the $400 million aggregate principal amount of the initial notes were validly tendered and not withdrawn prior to the expiration of the exchange offer, and were exchanged for exchange notes as of October 17, 2014, pursuant to the terms of the exchange offer.  The exchange notes are identical in all material respects to the initial notes, except that the exchange notes were registered under the Securities Act of 1933 and the provisions of the initial notes relating to transfer restrictions, registration rights and additional interest will not apply to the exchange notes.
We may redeem some or all of the notes prior to the date that is 90 days prior to the scheduled maturity of the notes at a price equal to 100% of the principal amount thereof plus a “make-whole” premium.  The notes will be redeemable at any time on or after the date that is 90 days prior to the final maturity date of the notes at a redemption price equal to 100% of the principal amount thereof plus accrued and unpaid interest, if any, to, but not including, the applicable redemption date.
As of December 31, 2014, our subsidiaries that are not guarantors of our 4.95% Senior Notes due 2024 accounted for approximately $377.4 million of our total assets.
$250 Million 4.5 % Senior Notes due 2025
On September 11, 2014, we sold $250 million aggregate principal amount of our 4.50% Senior Notes due 2025, or the 2025 Notes. The 2025 Notes were sold at an issue price of 99.131% of their face value before the initial purchasers’ discount resulting in gross proceeds of approximately $247.8 million. We used the net proceeds of the offering to repay a portion of our indebtedness outstanding under our Revolving Credit Facility.
The 2025 Notes were issued pursuant to an indenture dated as of September 11, 2014 among Omega, certain of its subsidiaries, as guarantors, and U.S. Bank National Association, as trustee. The 2025 Notes mature on January 15, 2025. The 2025 Notes bear an interest rate of 4.50% per annum, payable semi-annually in arrears on January 15 and July 15 of each year, commencing on July 15, 2015. The notes are fully and unconditionally guaranteed, jointly and severally, by our existing and future subsidiaries that guarantee indebtedness for money borrowed of Omega in a principal amount at least equal to $50 million (including as of the date hereof our existing senior notes and the facilities under our revolving credit agreement). We may redeem some or all of the notes prior to October 15, 2024 at a price equal to 100% of the principal amount thereof plus a “make-whole” premium, and accrued and unpaid interest, if any, to, but not including, the applicable redemption date. The notes are redeemable on or after October 15, 2024 at a redemption price equal to 100% of the principal amount thereof plus accrued and unpaid interest, if any, to, but not including, the applicable redemption date.
We may redeem some or all of the notes prior to October 15, 2024 at a price equal to 100% of the principal amount thereof plus a “make-whole” premium, and accrued and unpaid interest, if any, to, but not including, the applicable redemption date. The notes will be redeemable at any time on or after October 15, 2024 at a redemption price equal to 100% of the principal amount thereof plus accrued and unpaid interest, if any, to, but not including, the applicable redemption date.
As of December 31, 2014, our subsidiaries that are not guarantors of the 2025 Notes accounted for approximately $377.4 million of our total assets.
General
Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants.  As of December 31, 2013 and 2014, we were in compliance with all affirmative and negative covenants, including financial covenants, for our secured and unsecured borrowings.
The required principal payments, excluding the premium/discount on the 2025, 2024, 2022 and 2020 Notes, for each of the five years following December 31, 2014 and the aggregate due thereafter are set forth below:
		(in thousands)
2015		$	4,565
2016			4,768
2017			4,981
2018			90,202
2019			205,435
Thereafter			2,057,930
Totals		$	2,367,881
The following summarizes the refinancing related costs:
		Year Ended December 31,
		2014		2013			2012
		(in thousands)
Write off of deferred financing cost and unamortized premiums due to refinancing (1) (2)(3)		$	1,180	$	(11,278	)	$	3,024
Prepayment and other costs associated with refinancing (4)			1,861		166			4,896
Total debt extinguishment costs (gain)		$	3,041	$	(11,112	)	$	7,920
	-1	In 2014, we recorded: (a) $2.6 million write-off of deferred financing costs associated with the termination of the 2012 Credit Facilities, (b) $2.0 million write-off of deferred financing costs associated with the termination of our 2013 Term Loan Facility offset by (c) $3.5 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in September and December 2014.
	-2	In 2013, we recorded an $11.3 million interest refinancing gain associated with the write-off of the unamortized premium for debt assumed on 11 HUD mortgage loans that we paid off in May 2013.
	-3	In 2012, we wrote-off: (a) $2.2 million deferred financing costs associated with the tender offer and redemption of our $175 million 7% 2016 Notes; and (b) $2.5 million deferred financing costs associated with the termination of our $475 million 2011 Credit Facility.  These costs were offset by a $1.7 million gain resulting from the write-off of the unamortized premium on the four HUD loans that were paid off in the second quarter of 2012.
	-4	In 2014, we made prepayment penalties of $1.9 million associated with five HUD mortgage loans that we paid off in September and October 2014.  In 2013, we made prepayment penalties of $0.2 million associated with 11 HUD mortgage loans that we paid off in May 2013.  In 2012, we incurred $4.9 million of prepayment penalties and other costs associated with the tender offer and redemption of our $175 million 7% 2016 Notes.

FINANCIAL_INSTRUMENTS

FINANCIAL INSTRUMENTS	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
FINANCIAL INSTRUMENTS	NOTE 11 - FINANCIAL INSTRUMENTS
	At December 31, 2014 and 2013, the carrying amounts and fair values of our financial instruments were as follows:
			2014				2013
			Carrying		Fair		Carrying		Fair
			Amount		Value		Amount		Value
	Assets:		(in thousands)
	Cash and cash equivalents		$	4,489	$	4,489	$	2,616	$	2,616
	Restricted cash			29,076		29,076		31,759		31,759
	Investment in direct financing leases			539,232		539,232		529,445		529,445
	Mortgage notes receivable – net			648,079		642,626		241,515		240,482
	Other investments – net			48,952		49,513		53,054		50,124
	Totals		$	1,269,828	$	1,264,936	$	858,389	$	854,426
	Liabilities:
	Revolving line of credit		$	85,000	$	85,000	$	326,000	$	326,000
	Term loan			200,000		200,000		200,000		200,000
	7.50% notes due 2020 – net			198,235		264,269		197,890		256,852
	6.75% notes due 2022 – net			580,410		677,851		581,105		735,687
	5.875% notes due 2024 – net			400,000		449,242		400,000		411,266
	4.95% notes due 2024 – net			394,768		410,358		—		—
	4.50% notes due 2025 – net			247,889		244,053		—		—
	HUD debt			251,454		266,434		298,531		287,718
	Subordinated debt			20,747		26,434		20,892		28,849
	Totals		$	2,378,503	$	2,623,641	$	2,024,418	$	2,246,372
	Fair value estimates are subjective in nature and are dependent on a number of important assumptions, including estimates of future cash flows, risks, discount rates and relevant comparable market information associated with each financial instrument (see Note 2 – Summary of Significant Accounting Policies).  The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts.
	The following methods and assumptions were used in estimating fair value disclosures for financial instruments.
		●	Cash and cash equivalents and restricted cash:  The carrying amount of cash and cash equivalents and restricted cash reported in the balance sheet approximates fair value because of the short maturity of these instruments (i.e., less than 90 days) (Level 1).
		●	Mortgage notes receivable:  The fair values of the mortgage notes receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).
		●	Direct financing leases:  The fair values of the direct financing receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).
		●	Other investments:  Other investments are primarily comprised of: (i) notes receivable and (ii) an investment in redeemable non-convertible preferred security of an unconsolidated business accounted for using the cost method of accounting.  The fair values of notes receivable are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).  The fair value of the investment in the unconsolidated business is estimated using quoted market value and considers the terms of the underlying arrangement (Level 3).
		●	Revolving lines of credit and term loan:  The fair value of our borrowings under variable rate agreements are estimated using an expected present value technique based on expected cash flows discounted using the current market rates (Level 3).
		●	Senior notes and other long-term borrowings:  The fair value of our borrowings under fixed rate agreements are estimated based on open market trading activity provided by a third party (Level 2).
		●	HUD debt: The fair value of our borrowings under HUD debt agreements are estimated based on quotes obtained by HUD debt brokers (Level 2).

TAXES

TAXES	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
TAXES	NOTE 12 – TAXES
	We were organized, have operated, and intend to continue to operate in a manner that enables us to qualify for taxation as a REIT under Sections 856 through 860 of the Code.  On a quarterly and annual basis we perform several analyses to test our compliance within the REIT taxation rules.  In order to qualify as a REIT, in addition to other requirements, we must: (i) distribute dividends (other than capital gain dividends) to our stockholders in an amount at least equal to (A) the sum of (a) 90% of our “REIT taxable income” (computed without regard to the dividends paid deduction and our net capital gain), and (b) 90% of the net income (after tax), if any, from foreclosure property, minus (B) the sum of certain items of non-cash income on an annual basis, (ii) ensure that at least 75% and 95%, respectively of our gross income is generated from qualifying sources that are described in the REIT tax law, (iii) ensure that at least 75% of our assets consist of qualifying assets, such as real property, mortgages, and other qualifying assets described in the REIT tax law, (iv) ensure that we do not own greater than 10% in voting power or value of securities of any one issuer, (v) ensure that we do not own either debt or equity securities of another company that are in excess of 5% of our total assets and (vi) ensure that no more than 25% of our assets are invested in one or more taxable REIT subsidiaries. In addition to the above requirements, the REIT rules require that no less than 100 stockholders own shares or an interest in the REIT and that five or fewer individuals do not own (directly or indirectly) more than 50% of the shares or proportionate interest in the REIT.  If we fail to meet the above or any other requirements for qualification as a REIT in any tax year, we will be subject to federal income tax on our taxable income at regular corporate rates and may not be able to qualify as a REIT for the four subsequent years, unless we qualify for certain relief provisions that are available in the event we fail to satisfy any of these requirements.
	We are also subject to federal taxation of 100% of the derived net income if we sell or dispose of property, other than foreclosure property, that we held primarily for sale to customers in the ordinary course of a trade or business.  We believe that we do not hold assets for sale to customers in the ordinary course of business and that none of the assets currently held for sale or that have been sold would be considered a prohibited transaction within the REIT taxation rules.
	So long as we qualify as a REIT, we generally will not be subject to Federal income taxes on the REIT taxable income that we distribute to stockholders, subject to certain exceptions.  In 2014, we paid common dividend payments of approximately $258.6 million, which satisfies the 2014 REIT requirements relating to the distribution of our REIT taxable income.  On a quarterly and annual basis we tested our compliance within the REIT taxation rules described above to ensure that we were in compliance with the rules.
	Since the year 2000, the definition of foreclosure property has included any “qualified health care property,” as defined in Code Section 856(e)(6) acquired by us as the result of the termination or expiration of a lease of such property.  We have from time to time operated qualified healthcare facilities acquired in this manner for up to two years (or longer if an extension was granted).  Properties that we had taken back in a foreclosure or bankruptcy and operated for our own account were treated as foreclosure properties for income tax purposes, pursuant to Code Section 856(e).  Gross income from foreclosure properties was classified as “good income” for purposes of the annual REIT income tests upon making the election on the tax return.  Once made, the income was classified as “good” for a period of three years, or until the properties were no longer operated for our own account.  In all cases of foreclosure property, we utilized an independent contractor to conduct day-to-day operations to maintain REIT status.  In certain cases, we operated these facilities through a taxable REIT subsidiary.  For those properties operated through the taxable REIT subsidiary, we formed a new entity (TC Healthcare) on our behalf through the use of an eligible independent contractor to conduct day-to-day operations to maintain REIT status.  As a result of the foregoing, we do not believe that our participation in the operation of nursing homes increased the risk that we would fail to qualify as a REIT.  Through our 2014 taxable year, we had not paid any tax on our foreclosure property because those properties had been producing losses.
	Subject to the limitation described above under the REIT asset test rules, we are permitted to own up to 100% of the stock of one or more TRSs.  Currently, we have one TRS that is taxable as a corporation and that pays federal, state and local income tax on its net income at the applicable corporate rates.  As of December 31, 2014 and 2013, the TRS had a net operating loss carry-forward of $1.0 million.  The net operating loss carry-forward expires in 2024.  The loss carry-forward was fully reserved at December 31, 2014 and 2013 with a valuation allowance due to uncertainties regarding realization.

RETIREMENT_ARRANGEMENTS

RETIREMENT ARRANGEMENTS	12 Months Ended
	Dec. 31, 2014
Compensation Related Costs [Abstract]
RETIREMENT ARRANGEMENTS	NOTE 13 - RETIREMENT ARRANGEMENTS
	Our Company has a 401(k) Profit Sharing Plan covering all eligible employees.  Under this plan, employees are eligible to make contributions, and we, at our discretion, may match contributions and make a profit sharing contribution. Amounts charged to operations with respect to these retirement arrangements totaled approximately $0.3 million, $0.2 million, $0.2 million in 2014, 2013 and 2012, respectively.
	In addition, we have a deferred compensation plan that allows employees and directors the ability to defer receipt of stock awards. The deferred stock awards (units) participate in future dividends as well as the change in the value of the Company’s common stock. As of December 31, 2014 and 2013, the Company had 398,373 and 40,566 deferred stock units outstanding.

STOCKHOLDERS_EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2014
Equity [Abstract]
STOCKHOLDERS' EQUITY	NOTE 14 – STOCKHOLDERS’ EQUITY
	Stockholders’ Equity
	2.875 Million Shares of Common Stock Offering
	On October 7, 2013, we sold 2,875,000 shares of common stock in an underwritten public offering at a price of $29.48 per share, after underwriting discounts but before expenses.  Our total net proceeds from the offering, after underwriting discounts and expenses were approximately $84.6 million.
	$250 Million Equity Shelf Program
	On March 18, 2013, we entered into separate Equity Distribution Agreements (collectively, the “2013 Equity Shelf Agreements”) to sell shares of our common stock having an aggregate gross sales price of up to $250 million (the “2013 Equity Shelf Program”) with several financial institutions, each as a sales agent and/or principal (collectively, the “Managers”).  Under the terms of the 2013 Equity Shelf Agreements, we may sell shares of our common stock, from time to time, through or to the Managers having an aggregate gross sales price of up to $250 million.  Sales of the shares will be made by means of ordinary brokers’ transactions on the New York Stock Exchange at market prices, or as otherwise agreed with the applicable Manager.  We will pay each Manager compensation for sales of the shares equal to 2% of the gross sales price per share of shares sold through such Manager under the applicable 2013 Agreement.  We are not obligated to sell and the Managers are not obligated to buy or sell any shares under the 2013 Equity Shelf Agreements.  No assurance can be given that we will sell any shares under the 2013 Equity Shelf Agreements, or, if we do, as to the price or amount of shares that we sell, or the dates when such sales will take place.
	For the year ended December 31, 2014, we issued approximately 1.8 million shares under the 2013 Equity Shelf Program, at an average price of $34.33 per share, generating gross proceeds of approximately $63.5 million, before $1.5 million of commissions and expenses.
	Since inception of the 2013 Equity Shelf Program, we sold a total of 7.4 million shares of common stock generating total gross proceeds of $233.8 million under the program, before $4.7 million of commissions.  We have approximately $16.2 million available to under the 2013 Equity Shelf Program.
	Termination of $245 Million Equity Shelf Program
	Also on March 18, 2013, we terminated our previous $245 million Equity Shelf Program (the “2012 Equity Shelf Program”) that we entered into with several financial institutions on June 19, 2012.  For the year ended December 31, 2013, we issued approximately 1.0 million shares under the 2012 Equity Shelf Program at an average price of $28.29 per share, generating gross proceeds of approximately $27.8 million, before $0.6 million of commissions.
	For the year ended December 31, 2012, we issued 2.6 million shares under the 2012 Equity Shelf Program, at an average price of $24.10 per share, generating gross proceeds of approximately $63.6 million, before $1.3 million of commissions.
	Since inception of the 2012 Equity Shelf Program, we sold a total of 3.6 million shares of common stock generating total gross proceeds of $91.4 million under the program, before $1.9 million of commissions.  As a result of the termination of the 2012 Equity Shelf Program, no additional shares were issued under the 2012 Equity Shelf Program.
	Termination of $140 Million Equity Shelf Program
	Also on June 19, 2012, we terminated our $140 million Equity Shelf Program (“2010 Equity Shelf Program”) that we entered into with several financial intuitions on June 25, 2010.  For the year ended December 31, 2012, we issued approximately 759,000 shares of our common stock under the 2010 Equity Shelf Program at an average price per share of $21.27, generating gross proceeds of approximately $16.1 million, before $0.3 million of commissions.
	Dividend Reinvestment and Common Stock Purchase Plan
	We have a Dividend Reinvestment and Common Stock Purchase Plan (the “DRSPP”) that allows for the reinvestment of dividends and the optional purchase of our common stock.  For the year ended December 31, 2014, we issued 2.1 million shares of common stock for approximately $71.5 million in net proceeds.  For the year ended December 31, 2013, we issued 1.9 million shares of common stock for approximately $55.8 million in net proceeds.  For the year ended December 31, 2012, we issued 5.1 million shares of common stock for approximately $111.9 million in net proceeds.

STOCKBASED_COMPENSATION

STOCK-BASED COMPENSATION	12 Months Ended
	Dec. 31, 2014
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]
STOCK-BASED COMPENSATION	NOTE 15 –STOCK-BASED COMPENSATION
	Restricted stock and restricted stock units (“RSUs”) are subject to forfeiture if the holder’s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.  Prior to vesting, ownership of the shares/units cannot be transferred.  The restricted stock has the same dividend and voting rights as our common stock.  RSUs accrue dividend equivalents but have no voting rights.  Restricted stock and RSUs are valued at the price of our common stock on the date of grant.  We expense the cost of these awards ratably over their vesting period.
	In January 2011, we granted 428,503 shares of restricted stock to six employees.  The 428,503 shares of restricted stock vested as of December 31, 2013 and were distributed to all six employees.
	On December 31, 2013, we granted 213,741 RSUs to six employees.  The RSUs vest ratably over the three year period ending December 31, 2016, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	On January 1, 2014, we granted 122,137 RSUs to six employees.  The RSUs vest on December 31, 2016, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	In addition, we grant restricted stock to directors each year as part of director compensation.  These shares vest ratably over a three year period, subject to exceptions for death, disability, mandatory retirement or a change in control of the Company.
	The following table summarizes the activity in restricted stock and RSUs for the years ended December 31, 2012, 2013 and 2014:
			Number of Shares/Units				Weighted - Average Grant-Date Fair Value per Share			Compensation Cost (1)
										(in millions)
	Non-vested at December 31, 2011			458,302			$	22.31
	Granted during 2012			15,500				20.29		$	0.3
	Vested during 2012			(14,300	)			19.56
	Non-vested at December 31, 2012			459,502			$	22.33
	Granted during 2013			241,699				29.87		$	7.2
	Vested during 2013			(444,003	)			22.38
	Non-vested at December 31, 2013			257,198			$	29.32
	Granted during 2014			143,637				30.7		$	4.4
	Vested during 2014			(90,901	)			28.87
	Non-vested at December 31, 2014			309,934			$	30.08
	(1)  Total compensation cost to be recognized on the awards based on grant date fair value, which is based on the market price of the Company’s common stock on the date of grant.
	Performance Restricted Stock Units
	Performance restricted stock units (“PRSUs”) are subject to forfeiture if the performance requirements are not achieved or if the holder’s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.  The PRSUs awarded in January 2011, January 2013, December 2013 and January 2014 have varying degrees of performance requirements to achieve vesting, and each PRSU award represents the right to a variable number of shares of common stock based on performance and related dividend equivalents based on dividends paid to stockholders during the applicable performance period.  The vesting requirements are based on either the (i) total shareholders return (“TSR”) of Omega or (ii) Omega’s TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index.  We expense the cost of these awards ratably over their service period.
	Prior to vesting and distribution of shares, ownership of the PRSUs cannot be transferred.  The dividends on the PRSUs accumulate and if vested are paid when the shares are distributed to the employee.
	PRSUs (for Performance Periods 2011 through 2013)
	In January 2011, we awarded three types of PRSUs to six employees: (i) 124,244 annual TSR PRSUs for the year ended December 31, 2011 (“2011 Annual TSR PRSUs”); (ii) 279,552 multi-year absolute TSR PRSUs and (iii) 93,183 multi-year relative TSR PRSUs.  On January 1, 2012, we awarded to the six employees 124,244 annual TSR PRSUs for the year ended December 31, 2012 (“2012 Annual TSR PRSUs”).  On January 1, 2013, we awarded to the six employees 124,244 annual TSR PRSUs for the year ended December 31, 2013 (“2013 Annual TSR PRSUs”).
	Annual TSR PRSUs (for Performance Periods 2011 through 2013)
	The number of shares earned under the annual TSR PRSUs depended generally on the level of achievement of TSR for the applicable year.  The annual TSR PRSUs vest on December 31 of the year, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	The 2011 Annual TSR PRSUs were forfeited because the required TSR for 2011 was not achieved.  The TSR goal was achieved at “high” for the 2012 Annual TSR PRSUs and 124,244 shares vested and were distributed to the employees in January 2013.  The TSR goal was achieved at “high” for the 2013 Annual TSR PRSUs and 124,244 shares vested and were distributed to the employees in January 2014.
	Multi-year TSR PRSUs (for the 2011- 2013 Performance Period)
	The number of shares earned under the multi-year TSR PRSUs depended generally on the level of achievement of TSR for the three years ending December 31, 2013.  In January 2014, the board of directors reviewed the performance and determined the performance targets were met at the “high” level.  The multi-year TSR PRSUs vested 25% on the last day of each calendar quarter in 2014, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.  As of December 31, 2014, all of these shares have been distributed to the employees.
	Multi-year Relative TSR PRSUs (for the 2011- 2013 Performance Period)
	The number of shares earned under the multi-year relative TSR PRSUs depended generally on the level of achievement of TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index for the three-years ending December 31, 2013.  In January 2014, the board of directors reviewed the performance and determined the performance targets were met at the “high” level.  The multi-year relative TSR PRSUs vested 25% on the last day of each calendar quarter in 2014, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.  As of December 31, 2014, all of these shares have been distributed to the employees.
	PRSUs (for 2013- 2016 Performance Periods)
	In December 2013, we awarded six types of PRSUs to six employees: (i) 77,371 PRSUs that vest based on TSR for the one year period starting December 31, 2013 and ending December 31, 2014 (“2014 Transition TSR PRSUs”), (ii) 77,369 PRSUs that vest based on the TSR for the two year period starting December 31, 2013 and ending December 31, 2015 (“2015 Transition TSR PRSUs”), (iii) 115,785 PRSUs that vest based on TSR for the three year period starting December 31, 2013 and ending December 31, 2016 (“2016 Transition TSR PRSUs”), (iv) 77,371 PRSUs that vest based on relative TSR for the one year period starting December 31, 2013 and ending December 31, 2014 (“2014 Transition Relative TSR PRSUs”), (v) 77,368 Transition PRSUs that vest based on relative TSR for the two year period starting December 31, 2013 and ending December 31, 2015 (“2015 Transition Relative TSR PRSUs”), and (vi) 115,781 PRSUs that vest based on relative TSR for the three year period starting December 31, 2013 and ending December 31, 2016 (“2016 Transition Relative TSR PRSUs”).
	2014 Transition TSR PRSUs
	The number of shares earned under the 2014 Transition TSR PRSUs depends generally on the level of achievement of Omega’s TSR for the period beginning December 31, 2013 and ending December 31, 2014.  The 2014 Transition TSR PRSUs vested on December 31, 2014, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.  In January 2015, the board of directors reviewed the performance and determined the performance targets were met at the “high” level and the shares were distributed in January 2015.
	2015 Transition TSR PRSUs
	The number of shares earned under the 2015 Transition TSR PRSUs depends generally on the level of achievement of Omega’s TSR for the period beginning December 31, 2013 and ending December 31, 2015.  The 2015 Transition TSR PRSUs vest on December 31, 2015, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	2016 Transition TSR PRSUs
	The number of shares earned under the 2016 Transition TSR PRSUs depends generally on the level of achievement of Omega’s TSR for the period beginning December 31, 2013 and ending December 31, 2016.  The 2016 Transition TSR PRSUs vest on December 31, 2016, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	2014 Transition Relative TSR PRSUs
	The number of shares earned under the 2014 Transition Relative TSR PRSUs depends generally on the level of achievement of TSR relative to the MSCI U.S. REIT Index for the period beginning December 31, 2013 and ending December 31, 2014. The 2014 Transition Relative TSR PRSUs vested on December 31, 2014, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company. In January 2015, the board of directors reviewed the performance and determined that 61,769 shares were earned. The shares were distributed in January 2015.
	2015 Transition Relative TSR PRSUs
	The number of shares earned under the 2015 Transition Relative TSR PRSUs depends generally on the level of achievement of TSR relative to MSCI U.S. REIT Index for the period beginning December 31, 2013 and ending December 31, 2015.  The 2015 Transition Relative TSR PRSUs vest on December 31, 2015, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	2016 Transition Relative TSR PRSUs
	The number of shares earned under the 2016 Transition Relative TSR PRSUs depends generally on the level of achievement of TSR relative to MSCI U.S. REIT Index for the period beginning December 31, 2013 and ending December 31, 2016.  The 2016 Transition Relative TSR PRSUs vest on December 31, 2016, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	PRSUs (for 2014- 2016 Performance Periods)
	In January 2014, we awarded two types of PRSUs to six employees: (i) 154,584 PRSUs that vest based on TSR for the three year period starting January 1, 2014 and ending December 31, 2016 (“2016 TSR PRSUs”), and (ii) 154,584 PRSUs that vest based on relative TSR for the three year period starting January 1, 2014 and ending December 31, 2016 (“2016 Relative TSR PRSUs”).
	2016 TSR PRSUs
	The number of shares earned under the 2016 TSR PRSUs depends generally on the level of achievement of Omega’s TSR for the period beginning January 1, 2014 and ending December 31, 2016.  The 2016 TSR PRSUs vest quarterly in 2017 in equal increments, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	2016 Relative TSR PRSUs
	The number of shares earned under the 2016 Relative TSR PRSUs depends generally on the level of achievement of Omega’s TSR relative to MSCI U.S. REIT Index for the period beginning January 1, 2014 and ending December 31, 2016.  The 2016 Relative TSR PRSUs vest quarterly in 2017 in equal increments, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	We used a Monte Carlo model to estimate the fair value and the derived service periods for the PRSUs granted to the employees.  The following are the significant assumptions used in estimating the value of the awards for grants made on the following dates:
			1-Jan-12		1-Jan-13		31-Dec-13
							and January 1, 2014
	Closing Price on date of grant	$	19.35	$	23.85	$	29.8
	Dividend Yield		8.27%		4.24%		6.44%
	Risk Free interest rate at time of grant		0.03% to 0.35%		0.05% to 0.43%		0.04% to 0.86%
	Expected volatility		35.64% to 38.53%		15.56% to 23.83%		24.16% to 25.86%
	The following table summarizes the activity in PRSUs for the years ended December 31, 2012, 2013 and 2014:
			Number of Shares				Weighted-Average Grant-Date Fair Value per Share
										Compensation Cost (1)
										(in millions)
	Non-vested at December 31, 2011			372,735			$	11.36
Granted during 2012			124,244				9.61		$	1.2
Vested during 2012			(124,244	)			9.61
Non-vested at December 31, 2012			372,735			$	11.36
Granted during 2013			665,289				10.36		$	6.9
Vested during 2013 (2)			-				-
Non-vested at December 31, 2013			1,038,024			$	10.72
Granted during 2014			309,168				11.46		$	3.5
Vested during 2014 (3)			(496,979	)			10.75
Non-vested at December 31, 2014			850,213			$	10.97
	-1	Total compensation cost to be recognized on the awards was based on grant date fair value or the modification date fair value.
	-2	Subsequent to December 31, 2013, the board of directors reviewed the performance measure for the 372,735 PRSUs granted in January 2011 and outstanding at December 31, 2012 as well as the 124,244 shares granted in January 2013 and determined the PRSUs were earned.
	-3	In January 2014, the 124,244 PRSUs granted in January 2013 vested and were issued to the employees.  The 372,735 PRSUs granted in 2011 vested 25% on March 31, June 30, September 30 and December 31, 2014.
The following table summarizes our total unrecognized compensation cost as of December 31, 2014 associated with outstanding restricted stock, restricted stock units and PRSU awards to employees:
	Grant		Shares/				Grant Date			Total		Weighted		Unrecognized Compensation
	Year		Units				Average Fair			Compensation		Average		Cost
							Value Per			Cost		Period of		(in millions)
							Unit/ Share			(in millions)		Expense
												Recognition
												(in months)
Restricted stock units	2013			213,741				29.8			6.4		36		4.2
2015 Transition TSR PRSUs	2013			77,369				7.48			0.6		24		0.3
2016 Transition TSR PRSUs	2013			115,785				8.67			1		36		0.7
2015 Transition Relative TSR PRSUs	2013
				77,368				13.06			1		24		0.5
2016 Transition Relative TSR PRSUs	2013
				115,781				14.25			1.7		36		1.1
Restricted stock units	2014			122,137				29.8			3.6		36		2.4
2016 TSR PRSUs	2014			154,584				8.67			1.3		48		1
2016 Relative TSR PRSUs	2014			154,584				14.25			2.2		48		1.7
Total				1,031,349			$	17.25		$	17.8			$	11.9
Tax Withholding
Stock withheld to pay minimum statutory tax withholdings for equity instruments granted under stock-based payment arrangements for the years ended December 31, 2014, 2013 and 2012, was $3.6 million, $5.8 million and $1.2 million, respectively.
Shares Available for Issuance for Compensation Purposes
On June 6, 2013, at our Company’s Annual Meeting, our stockholders approved the 2013 Stock Incentive Plan (the “2013 Plan”), which amended and restated the Company’s 2004 Stock Incentive Plan.  The 2013 Plan is a comprehensive incentive compensation plan that allows for various types of equity-based compensation, including restricted stock units (including performance-based restricted stock units), stock awards, deferred restricted stock units, incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights and certain cash-based awards (including performance-based cash awards).  The 2013 Plan increased the number of shares reserved for issuance for compensation purposes by 3,000,000.
As of December 31, 2014, 2,646,977 shares of common stock were reserved for issuance to our employees, directors and consultants under our stock incentive plans.  Awards under our stock incentive plans may be in the form of stock, stock options, restricted stock, and performance restricted stock units.

DIVIDENDS

DIVIDENDS	12 Months Ended
	Dec. 31, 2014
Dividends [Abstract]
DIVIDENDS	NOTE 16 - DIVIDENDS
	Common Dividends
	On January 14, 2015, the Board of Directors declared a common stock dividend of $0.53 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, which was paid February 16, 2015 to common stockholders of record on February 2, 2015.
	On October 16, 2014, the Board of Directors declared a common stock dividend of $0.52 per share, increasing the quarterly common dividend by $0.01 per share over the previous quarter, which was paid November 17, 2014 to common stockholders of record on October 31, 2014.
	On July 15, 2014, the Board of Directors declared a common stock dividend of $0.51 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, which was paid August 15, 2014 to common stockholders of record on July 31, 2014.
	On April 18, 2014, the Board of Directors declared a common stock dividend of $0.50 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, which was paid May 15, 2014 to common stockholders of record on April 30, 2014.
	On January 15, 2014, the Board of Directors declared a common stock dividend of $0.49 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, which was paid February 17, 2014 to common stockholders of record on January 31, 2014.
	Per Share Distributions
	Per share distributions by our Company were characterized in the following manner for income tax purposes (unaudited):
		Year Ended December 31,
		2014		2013		2012
	Common
	Ordinary income	$	1.834	$	1.536	$	0.884
	Return of capital		0.186		0.324		0.806
	Total dividends paid	$	2.02	$	1.86	$	1.69
	For additional information regarding dividends, see Note 10 – Borrowing Arrangements and Note 12 – Taxes.

LITIGATION

LITIGATION	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
LITIGATION	NOTE 17 - LITIGATION
	We are subject to various legal proceedings, claims and other actions arising out of the normal course of business. While any legal proceeding or claim has an element of uncertainty, management believes that the outcome of each lawsuit, claim or legal proceeding that is pending or threatened, or all of them combined, will not have a material adverse effect on our consolidated financial position or results of operations.
	Four putative class actions have been filed by purported stockholders of Aviv against Aviv, its directors, the Company and Merger Sub challenging the Merger. The lawsuits seek injunctive relief preventing the parties from consummating the Merger, rescission of the transactions contemplated by the Merger Agreement, imposition of a constructive trust in favor of the class upon any benefits improperly received by the defendants, compensatory damages, and litigation costs including attorneys’ fees. The four cases have been transferred to the Business and Technology Case Management Program of the Circuit Court, Baltimore City, Maryland. The plaintiffs in each case amended their complaints to add allegations that the disclosures in the Form S-4 filed with the Securities and Exchange Commission on January 5, 2015 in connection with the Merger, are inadequate to allow Aviv shareholders to make an informed decision whether to approve the Merger. On January 28, 2015, the court entered a stipulated consolidation order consolidating the four lawsuits into a single proceeding styled In re Aviv REIT Inc. Stockholder Litigation, Case No. 24-C-14-006352. On February 6, 2015, the parties filed a stipulation providing that the Second Amended Complaint filed by plaintiff Andrew Wolf shall serve as the operative consolidated complaint. On the same date, (1) Aviv, the Aviv Partnership and the Aviv directors filed a motion to dismiss the consolidated complaint and (2) the Company, Merger Sub and the Omega Operating Partnership separately moved to dismiss the consolidated complaint as to them. The plaintiffs have moved to expedite the discovery period. A hearing to consider the motions to dismiss and the plaintiffs’ request to expedite discovery has been scheduled for February 27, 2015.
	The Company believes that these actions have no merit and intend to defend vigorously against them.

SUMMARY_OF_QUARTERLY_RESULTS_U

SUMMARY OF QUARTERLY RESULTS (UNAUDITED)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
SUMMARY OF QUARTERLY RESULTS (UNAUDITED)	NOTE 18 - SUMMARY OF QUARTERLY RESULTS (UNAUDITED)
	The following summarizes quarterly results of operations for the years ended December 31, 2014 and 2013.
		31-Mar		30-Jun		30-Sep		31-Dec
		(in thousands, except per share amounts)
	2014
	Revenues	$	121,001	$	121,800	$	130,665	$	131,321
	Net income		55,829		46,817		61,713		56,990
	Net income available to common stockholders		55,829		46,817		61,713		56,990
	Net income available to common per share:
	Basic	$	0.45	$	0.37	$	0.48	$	0.45
	Diluted	$	0.45	$	0.37	$	0.48	$	0.44
	Cash dividends paid on common stock	$	0.49	$	0.5	$	0.51	$	0.52
	2013
	Revenues	$	101,761	$	102,515	$	103,301	$	111,137
	Net income		38,120		49,058		38,137		47,206
	Net income available to common stockholders		38,120		49,058		38,137		47,206
	Net income available to common per share:
	Basic	$	0.34	$	0.42	$	0.32	$	0.39
	Diluted	$	0.34	$	0.42	$	0.32	$	0.38
	Cash dividends paid on common stock	$	0.45	$	0.46	$	0.47	$	0.48

EARNINGS_PER_SHARE

EARNINGS PER SHARE	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
EARNINGS PER SHARE	NOTE 19 - EARNINGS PER SHARE
	The computation of basic EPS is computed by dividing net income available to common stockholders by the weighted-average number of shares of common stock outstanding during the relevant period.  Diluted EPS is computed using the treasury stock method, which is net income available to common stockholders divided by the total weighted-average number of common outstanding shares plus the effect of dilutive common equivalent shares during the respective period.  Dilutive common shares reflect the assumed issuance of additional common shares pursuant to certain of our share-based compensation plans, including restricted stock and performance restricted stock units.
	The following tables set forth the computation of basic and diluted earnings per share:
		Year Ended December 31,
		2014		2013		2012
		(in thousands, except per share amounts)
	Numerator:
	Net income	$	221,349	$	172,521	$	120,698
	Numerator for net income available to common per share - basic and diluted	$	221,349	$	172,521	$	120,698
	Denominator:
	Denominator for basic earnings per share		126,550		117,257		107,591
	Effect of dilutive securities:
	Common stock equivalents		744		843		420
	Denominator for diluted earnings per share		127,294		118,100		108,011
	Earnings per share - basic:
	Net income - basic	$	1.75	$	1.47	$	1.12
	Earnings per share - diluted:
	Net income - diluted	$	1.74	$	1.46	$	1.12

CONSOLIDATING_FINANCIAL_STATEM

CONSOLIDATING FINANCIAL STATEMENTS	12 Months Ended
	Dec. 31, 2014
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]
CONSOLIDATING FINANCIAL STATEMENTS	NOTE 20– CONSOLIDATING FINANCIAL STATEMENTS
	As of December 31, 2014, we had outstanding: (i) $200 million 7.5% Senior Notes due 2020, (ii) $575 million 6.75% Senior Notes due 2022, (iii) $400 million 5.875% Senior Notes due 2024, (iv) $400 million 4.95% Senior Notes due 2024 and (v) $250 million 4.5% Senior Notes due 2025, which we collectively refer to as the Senior Notes.  The Senior Notes are fully and unconditionally guaranteed, jointly and severally, by each of our subsidiaries that guarantee other indebtedness of Omega or any of the Subsidiary Guarantors.  All of our subsidiaries that guarantee the Senior Notes also guarantee the 2014 Credit Facilities.  Any subsidiary that we properly designate as an “unrestricted subsidiary” under the indentures governing the Senior Notes will not provide guarantees of the Senior Notes or the 2014 Credit Facilities.
	As of and prior to March 31, 2010, the non-guarantor subsidiaries were minor and insignificant.  On June 29, 2010, we designated as “unrestricted subsidiaries” the 39 subsidiaries subject to HUD indebtedness, of which 12 subsidiaries were re-designated as “restricted subsidiaries” and Subsidiary Guarantors in July 2013 due to the retirement of the HUD related debt on 11 facilities.  During the fourth quarter of 2011, we designated as “unrestricted subsidiaries” 20 subsidiaries we acquired subject to HUD indebtedness, of which five subsidiaries were re-designated as “restricted subsidiaries” and Subsidiary Guarantors in July 2012 due to the retirement of the HUD related mortgages on five facilities.  During the fourth quarter of 2012, we designated as “unrestricted subsidiaries” eight subsidiaries we acquired subject to HUD indebtedness, of which four subsidiaries were re-designated as “restricted subsidiaries and Subsidiary Guarantors” due to the retirement of the HUD related debt on four facilities in September 2014.  In October 2014, we retired HUD debt on one facility and one subsidiary was re-designated as a restricted subsidiary.  The following summarized condensed consolidating financial information reflects these changes.
	For the years ended December 31, 2014 and 2013, the operating cash flow of the non-guarantor subsidiaries approximated net income of the non-guarantor subsidiaries, adjusted for depreciation and amortization expense and rent recorded on a straight-line basis.  On March 26, 2013, the non-guarantor subsidiaries refinanced existing HUD mortgage debt on 12 properties in Arkansas for approximately $59.4 million. The refinanced amount included $58.7 million related to retiring the old HUD debt and $0.7 million of closing costs that were added to the new (refinanced) HUD debt.  On September 30, 2014, we retired four HUD mortgages, $34.3 million related to the outstanding principal of the four HUD mortgages, $3.3 million related to the noncash write off of unamortized premium recorded at the time of acquisition offset by a prepayment fee of approximately $1.7 million.  On October 31, 2014, we retired one HUD mortgage, $3.4 million related to the outstanding principal of the mortgage, $0.2 million related to noncash of unamortized premium offset by a prepayment fee of approximately $0.2 million.
	For the years ended December 31, 2014, 2013 and 2012, the non-guarantor subsidiaries did not engage in investing or financing activities other than the principal payment of $4.4 million, $4.0 million and $3.1 million, respectively for the HUD mortgages on the facilities owned by the non-guarantor subsidiaries.  All of the Subsidiary Guarantors of our outstanding Senior Notes and 2014 Credit Facilities, and all of our non-guarantor subsidiaries, are 100% owned by Omega.
	The following summarized condensed consolidating financial information segregates the financial information of the non-guarantor subsidiaries from the financial information of Omega Healthcare Investors, Inc. and the Subsidiary Guarantors under the Senior Notes.  The results and financial position of acquired entities are included from the dates of their respective acquisitions.
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING BALANCE SHEET
	(in thousands, except per share amounts)
		31-Dec-14
		Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries			Elimination Company			Consolidated
	ASSETS
	Real estate properties
	Land and buildings	$	2,834,498		$	389,287		$	—		$	3,223,785
	Less accumulated depreciation		(754,517	)		(67,195	)		—			(821,712	)
	Real estate properties – net		2,079,981			322,092			—			2,402,073
	Investment in direct financing leases		539,232			—			—			539,232
	Mortgage notes receivable – net		648,079			—			—			648,079
			3,267,292			322,092			—			3,589,384
	Other investments – net		48,952			—			—			48,952
			3,316,244			322,092			—			3,638,336
	Assets held for sale – net		12,792			—			—			12,792
	Total investments		3,329,036			322,092			—			3,651,128
	Cash and cash equivalents		4,489			—			—			4,489
	Restricted cash		7,016			22,060			—			29,076
	Accounts receivable – net		160,789			7,387			—			168,176
	Investment in affiliates		73,622			—			(73,622	)		—
	Other assets		42,876			25,900			—			68,776
	Total assets	$	3,617,828		$	377,439		$	(73,622	)	$	3,921,645
	LIABILITIES AND STOCKHOLDERS’ EQUITY
	Revolving line of credit	$	85,000		$	—		$	—		$	85,000
	Term loan		200,000			—			—			200,000
	Secured borrowings		—			251,454			—			251,454
	Unsecured borrowings – net		1,821,302			20,747			—			1,842,049
	Accrued expenses and other liabilities		110,199			31,616			—			141,815
	Intercompany payable		—			40,309			(40,309	)		—
	Total liabilities		2,216,501			344,126			(40,309	)		2,520,318
	Stockholders’ equity:
	Common stock		12,761			—			—			12,761
	Common stock – additional paid-in-capital		2,136,234			—			—			2,136,234
	Cumulative net earnings		1,147,998			33,313			(33,313	)		1,147,998
	Cumulative dividends paid		(1,895,666	)		—			—			(1,895,666	)
	Total stockholders’ equity		1,401,327			33,313			(33,313	)		1,401,327
	Total liabilities and stockholders’ equity	$	3,617,828		$	377,439		$	(73,622	)	$	3,921,645
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING BALANCE SHEET
	(in thousands, except per share amounts)
		31-Dec-13
		Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries			Elimination Company			Consolidated
	ASSETS
	Real estate properties
	Land and buildings	$	2,712,652		$	386,895		$	—		$	3,099,547
	Less accumulated depreciation		(656,988	)		(50,422	)		—			(707,410	)
	Real estate properties – net		2,055,664			336,473			—			2,392,137
	Investment in direct financing leases		529,445			—			—			529,445
	Mortgage notes receivable – net		241,515			—			—			241,515
			2,826,624			336,473			—			3,163,097
	Other investments – net		53,054			—			—			53,054
			2,879,678			336,473			—			3,216,151
	Assets held for sale – net		1,356			—			—			1,356
	Total investments		2,881,034			336,473			—			3,217,507
	Cash and cash equivalents		2,616			—			—			2,616
	Restricted cash		8,812			22,947			—			31,759
	Accounts receivable – net		141,704			5,800			—			147,504
Investment in affiliates		78,075			—			(78,075	)		—
Other assets		39,997			22,833			—			62,830
Total assets	$	3,152,238		$	388,053		$	(78,075	)	$	3,462,216
LIABILITIES AND STOCKHOLDERS’ EQUITY
Revolving line of credit	$	326,000		$	—		$	—		$	326,000
Term loan		200,000			—			—			200,000
Secured borrowings		41,876			256,655			—			298,531
Unsecured borrowings – net		1,178,995			20,892			—			1,199,887
Accrued expenses and other liabilities		105,264			32,431			—			137,695
Intercompany payable		—			56,994			(56,994	)		—
Total liabilities		1,852,135			366,972			(56,994	)		2,162,113
Stockholders’ equity:
Common stock		12,353			—			—			12,353
Common stock – additional paid-in-capital		1,998,169			—			—			1,998,169
Cumulative net earnings		926,649			21,081			(21,081	)		926,649
Cumulative dividends paid		(1,637,068	)		—			—			(1,637,068	)
Total stockholders’ equity		1,300,103			21,081			(21,081	)		1,300,103
Total liabilities and stockholders’ equity	$	3,152,238		$	388,053		$	(78,075	)	$	3,462,216
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATING STATEMENT OF OPERATIONS
(in thousands, except per share amounts)
Year Ended December 31, 2014
Issuer &		Non – Guarantor
Subsidiary		Subsidiaries		Elimination
Guarantors				Company		Consolidated
Revenue
Rental income	$	346,479		$	41,964		$	-		$	388,443
Income from direct financing leases		56,719									56,719
Mortgage interest income		53,007			-			-			53,007
Other investment income – net		6,618			-			-			6,618
Total operating revenues		462,823			41,964			-			504,787
Expenses
Depreciation and amortization		106,484			16,773			-			123,257
General and administrative		25,546			342			-			25,888
Acquisition costs		3,948			-			-			3,948
Impairment loss on real estate properties		3,660			-			-			3,660
Provisions for uncollectible mortgages, notes and accounts receivable		2,723			-			-			2,723
Total operating expenses		142,361			17,115			-			159,476
Income before other income and expense		320,462			24,849			-			345,311
Other income (expense):
Interest income		19			25			-			44
Interest expense		(106,748	)		(12,621	)		-			(119,369	)
Interest – amortization of deferred financing costs		(4,438	)		(21	)		-			(4,459	)
Interest – refinancing costs		(3,041	)		-			-			(3,041	)
Equity in earnings		12,232			-			(12,232	)		-
Total other expense		(101,976	)		(12,617	)		(12,232	)		(126,825	)
Income before gain on assets sold		218,486			12,232			(12,232	)		218,486
Loss on assets sold - net		2,863			-			-			2,863
Net income available to common stockholders	$	221,349		$	12,232		$	(12,232	)	$	221,349
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATING STATEMENT OF OPERATIONS
(in thousands, except per share amounts)
Year Ended December 31, 2013
Issuer &		Non –
Subsidiary		Guarantor		Elimination
Guarantors		Subsidiaries		Company		Consolidated
Revenue
Rental income	$	333,015		$	42,120		$	-		$	375,135
Income from direct financing leases		5,203									5,203
Mortgage interest income		29,351			-			-			29,351
Other investment income – net		9,025			-			-			9,025
Total operating revenues		376,594			42,120			-			418,714
Expenses
Depreciation and amortization		110,535			18,111			-			128,646
General and administrative		21,263			325			-			21,588
Acquisition costs		245			-			-			245
Impairment loss on real estate properties		415			-			-			415
Provisions for uncollectible mortgages, notes and accounts receivable		2,141			-			-			2,141
Total operating expenses		134,599			18,436			-			153,035
Income before other income and expense		241,995			23,684			-			265,679
Other income (expense):
Interest income		17			24			-			41
Interest expense		(87,240	)		(13,141	)		-			(100,381	)
Interest – amortization of deferred financing costs		(2,763	)		(16	)		-			(2,779	)
Interest – refinancing gain		11,112			-			-			11,112
Equity in earnings		10,551			-			(10,551	)		-
Total other expense		(68,323	)		(13,133	)		(10,551	)		(92,007	)
Income before gain on assets sold		173,672			10,551			(10,551	)		173,672
Loss on assets sold - net		(1,151	)		-			-			(1,151	)
Net income available to common stockholders	$	172,521		$	10,551		$	(10,551	)	$	172,521
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATING STATEMENT OF OPERATIONS
(in thousands, except per share amounts)
Year Ended December 31, 2012
Issuer &		Non –
Subsidiary		Guarantor		Elimination
Guarantors		Subsidiaries		Company		Consolidated
Revenue
Rental income	$	279,458		$	35,134		$	-		$	314,592
Mortgage interest income		30,446			-			-			30,446
Other investment income – net		5,422			-			-			5,422
Total operating revenues		315,326			35,134			-			350,460
Expenses
Depreciation and amortization		97,057			15,926			-			112,983
General and administrative		21,025			305			-			21,330
Acquisition costs		909			-			-			909
Impairment loss on real estate properties		272			-			-			272
Total operating expenses		119,263			16,231			-			135,494
Income before other income and expense		196,063			18,903			-			214,966
Other income (expense):
Interest income		7			22			-			29
Interest expense		(82,691	)		(12,836	)		-			(95,527	)
Interest – amortization of deferred financing costs		(2,649	)		-			-			(2,649	)
Interest – refinancing costs		(7,920	)		-			-			(7,920	)
Equity in earnings		6,089			-			(6,089	)		-
Total other expense		(87,164	)		(12,814	)		(6,089	)		(106,067	)
Income before gain on assets sold		108,899			6,089			(6,089	)		108,899
Gain on assets sold - net		11,799			-			-			11,799
Net income available to common stockholders	$	120,698		$	6,089		$	(6,089	)	$	120,698

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 21– SUBSEQUENT EVENTS
	$1.2 Billion Unsecured Credit Facility Proposed Amendments
	In January 2015, we entered into an engagement letter with respect to various proposed amendments to our existing 2014 Credit Facilities. Among other modifications to the 2014 Credit Facilities, the proposed amendments would increase the amount of the 2014 Credit Facilities to $1.75 billion, consisting of a $1.25 billion senior unsecured revolving credit facility, a $200 million senior unsecured term loan facility, and a $300 million senior unsecured incremental term loan facility. The amended 2014 Credit Facilities is also expected to include an accordion feature permitting us to increase the amount of the 2014 Credit Facilities to $2.0 billion and to allocate the $250 million increase to the existing revolving or term loan facilities or additional tranches thereunder as we may elect, subject to various conditions set forth in our existing 2014 Credit Facilites. The amended 2014 Credit Facilities is expected to include maturity dates of June 27, 2017, 2018 and 2019 for the incremental term loan facility, revolving credit facility and term loan facility, respectively, subject to our ability to extend the maturity date of the revolving credit facility and the incremental term loan facility to June 27, 2019 subject to various conditions. We have received commitment letters from lenders for increased amounts that would be available under the facility in accordance with the proposed amendments, subject to our completion of the Merger. Our ability to complete the proposed amendments to our existing senior unsecured credit facility is subject to a number of conditions, and the completion of definitive loan documentation. Although we expect that the amendments to our senior unsecured credit facility will be completed, we can offer no assurances that the conditions to the proposed amendments will be satisfied.
	Issuance of 10.925 Million Shares of Common Stock
	On February 9, 2015, we issued 10.925 million shares of our common stock in an underwritten public offering at a public offering price of $42.00 per share, before underwriting discounts and offering expenses. We intend to use the $439 million in net proceeds of the offering to redeem our outstanding $200 million aggregate principal amount 7.50% senior notes due 2020 (callable February 2015), repay outstanding borrowings under our revolving credit facility, and for general corporate purposes.

SCHEDULE_III_REAL_ESTATE_AND_A

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION	12 Months Ended
	Dec. 31, 2014
Real Estate and Accumulated Depreciation Disclosure [Abstract]
REAL ESTATE AND ACCUMULATED DEPRECIATION	SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION
	OMEGA HEALTHCARE INVESTORS, INC.
	31-Dec-14
																	-3
																	Gross Amount at
																	Which Carried at
					Initial Cost to			Cost Capitalized									Close of Period								Life on Which
					Company			Subsequent to									Buildings								Depreciation
					Buildings			Acquisition									and Land		-4						in Latest
					and Land												Improvements		Accumulated		Date of		Date		Income Statements
	Description (1)		Encumbrances		Improvements			Improvements			Impairment			Other			Total		Depreciation		Construction		Acquired		is Computed
	Genesis HealthCare:
	Alabama (LTC)					23,584,956			6,523,220			-			-			30,108,176		14,821,233		1964-1974		1997	33 years
	California (LTC)					15,618,263			26,652			-			-			15,644,915		7,729,889		1927-1972		1997	33 years
	Colorado (LTC, ILF)					38,341,877			5,444,311			-			-			43,786,188		10,871,806		1963-1975		2006	39 years
	Idaho (LTC)					15,511,569			974,011			-			-			16,485,580		4,975,092		1920-1987		1997-2006	33 years to 39 years
	Massachusetts (LTC)					57,139,658			2,660,093			(8,257,521	)		-			51,542,230		19,343,167		1964-1993		1997-2010	20 years to 39 years
	New Hampshire (LTC, AL)					21,619,503			1,462,797			-			-			23,082,300		7,194,705		1963-1999		1998-2006	33 years to 39 years
	North Carolina (LTC)					22,652,488			3,550,986			-			-			26,203,474		15,217,007		1964-1986		1994-1997	30 years to 33 years
	Ohio (LTC)					11,653,451			20,246			-			-			11,673,697		5,874,319		1968-1983		1997	33 years
	Rhode Island (LTC)					38,740,812			4,792,882			-			-			43,533,694		13,106,970		1965-1981		2006	25 years to 39 years
	Tennessee (LTC)					7,905,139			2,537,508			-			-			10,442,647		5,769,691		1984-1985		1994	30 years
	Vermont (LTC)					6,322,888			602,296			-			-			6,925,184		2,054,957		1971		2004	39 years
	Washington (LTC)					10,000,000			1,798,844			-			-			11,798,844		10,538,065		1965		1995	20 years
	West Virginia (LTC)					44,277,206			6,528,560			-			-			50,805,766		20,923,934		1961-1986		1997-2008	25 years to 33 years
	Total Genesis HealthCare					313,367,810			36,922,406			(8,257,521	)		-			342,032,695		138,420,835
	Health and Hospital Corporation:
	Indiana (LTC, AL, ILF)					306,144,765			394,818			(1,820,624	)		-			304,718,959		36,832,728		1942-2001		1992-2013	20 years to 40 years
	Total Health and Hospital Corporation					306,144,765			394,818			(1,820,624	)		-			304,718,959		36,832,728
	CommuniCare Health Services, Inc:
	Ohio (LTC, AL, SH)					218,726,757			27,693,288			-			-			246,420,045		69,849,801		1927-2008		1998-2008	20 years to 39 years
	Pennsylvania (LTC)					20,286,067			11,281,116			-			-			31,567,183		7,051,118		1950-1964		2005	39 years
	Total CommuniCare Health Services, Inc.					239,012,824			38,974,404			-			-			277,987,228		76,900,919
	Airamid Health Management
	Florida (LTC, AL)		-2			240,352,759			-			-			-			240,352,759		57,122,266		1951-1999		2009-2010	20 years to 37 years
	Pennsylvania (LTC)					14,771,868			-			-			-			14,771,868		3,419,396		1969		2009	26 years
	Total Airamid Health Management					255,124,627			-			-			-			255,124,627		60,541,662
	Signature Holdings II, LLC.:
	Florida (LTC)					119,332,120			9,474,286			-			-			128,806,406		37,781,526		1940-1991		1996-2010	20 years to 39 years
	Georgia (LTC)					14,679,314			3,950,028			-			-			18,629,342		6,900,424		1964-1970		2007	20 years
	Kentucky (LTC)					44,737,440			4,174,496			-			-			48,911,936		14,884,149		1964-1978		1999-2010	20 years to 33 years
	Maryland (LTC)					28,629,686			1,787,838			-			-			30,417,524		7,125,335		1959-1985		2010	26 years to 30 years
	Tennessee (LTC, AL)					11,230,702			819,991			-						12,050,693		4,163,014		1982-2014		2007-2014	20 years
	Total Signature Holdings II, LLC					218,609,262			20,206,639			-			-			238,815,901		70,854,448
	S&F Management Company, LLC:
	Arizona (LTC, AL)		-2			69,342,862			-			-			-			69,342,862		4,115,975		1949-1999		2012-2014	35 years to 40 years
	California (LTC)		-2			147,729,886			-			-			-			147,729,886		10,837,508		1939-1970		2012	20 years to 35 years
	Total S&F Management Company, LLC					217,072,748			-			-			-			217,072,748		14,953,483
	Affiliates of Capital Funding Group, Inc.
	Arkansas (LTC, AL)		-2			114,174,172			2,391,661			-			-			116,565,833		11,716,057		1960-2000		2011-2014	20 years to 40 years
	Colorado (LTC)					5,482,855			-			-			-			5,482,855		918,618		1961		2011	20 years
	Florida (LTC)					14,636,992			-			-			-			14,636,992		1,302,106		1985		2011	40 years
	Michigan (LTC)					16,500,317			-			-			-			16,500,317		2,247,027		1964-1973		2011	25 years
	Oregon (AL)					13,949,716			-			-			-			13,949,716		43,789		2004		2014	40 years
	Pennsylvania (AL)					37,133,751			-			-			-			37,133,751		109,767		1965-2012		2014	40 years
	Wisconsin (LTC)					12,008,620			-			-			-			12,008,620		1,711,651		1964		2011	20 years
	Total Affiliates of Capital Funding Group, Inc.					213,886,423			2,391,661			-			-			216,278,084		18,049,015
	Other:
	Alabama (LTC)					17,939,710			6,392,567			-			-			24,332,277		13,870,762		1960-1986		1992-2010	20 years to 31.5 years
	Arizona (LTC)					34,318,094			5,712,049			(6,603,745	)		-			33,426,398		13,004,473		1983-1985		1998-2010	29 years to 33 years
	Arkansas (LTC)					36,023,409			8,856,328			(36,350	)		-			44,843,387		29,105,302		1967-1988		1992	31.5 years
	California (LTC)					21,879,146			1,778,353			-			-			23,657,499		9,392,234		1950-1990		1997-2010	20 years to 33 years
	Colorado (LTC)					28,044,216			2,346,167			-			-			30,390,383		10,862,485		1958-1973		1998-2010	20 years to 33 years
	Florida (LTC, AL)					215,032,053			7,414,141			(970,000	)		-			221,476,194		57,375,253		1933-2007		1992-2013	20 years to 40 years
Georgia (LTC)					17,617,507			-			-			-			17,617,507		2,997,315		1967-1971		1998-2014	30 years to 37.5 years
Idaho (LTC)					6,193,698			100,000			-			-			6,293,698		2,829,241		1988		1999	20 years
Illinois (LTC)					13,961,501			444,484			-			-			14,405,985		7,313,022		1926-1990		1996-1999	30 years to 33 years
Indiana (LTC, AL)					37,220,697			1,897,203			(1,580,474	)		(1,956,998	)		35,580,428		9,191,091		1923-1996		1992-2012	20 years to 38 years
Iowa (LTC)					19,116,936			2,084,807			-			-			21,201,743		7,872,936		1965-1983		1997-2010	23 years to 33 years
Kansas (LTC)					3,210,020			-			-			-			3,210,020		863,861		1985		2010	20 years
Kentucky (LTC)					15,151,027			4,148,392			-			-			19,299,419		10,980,212		1948-1995		1994-1995	33 years
Louisiana (LTC)					55,046,915			1,748,900			-			-			56,795,815		14,938,189		1957-1983		1997-2006	33 years to 39 years
Maryland (LTC)		-2			48,731,498			-			-			-			48,731,498		6,605,884		1921-1969		2011	25 years to 30 years
Massachusetts (LTC)					5,804,554			-			-			-			5,804,554		1,724,429		1964		2009	20 years
Michigan (AL)					20,000,000			-			-			-			20,000,000		1,518,996		1974		2012	30 years
Mississippi (LTC)					52,416,905			826,654			-			-			53,243,559		10,715,897		1962-1988		2009-2010	20 years to 40 years
Missouri (LTC)					12,301,560			-			(149,386	)		-			12,152,174		5,586,269		1965-1989		1999	33 years
Nevada (LTC, SH)					20,926,778			3,034,207			-			-			23,960,985		5,014,282		1972-1978		2009	26 years to 27 years
New Mexico (LTC)					7,097,600			130,323			-			-			7,227,923		2,547,285		1972-1989		2008-2010	20 years
North Carolina (LTC)					33,092,980			-			-			-			33,092,980		6,919,451		1969-1987		2010	25 years to 36 years
Ohio (LTC)					102,938,384			6,260,958			-			-			109,199,342		32,553,336		1962-1998		1994-2010	20 years to 39 years
Oklahoma (LTC)					24,136,703			-			-			-			24,136,703		4,610,313		1965-2013		2010-2012	20 years to 25 years
Pennsylvania (LTC, AL, ILF)					138,881,687			-			-			-			138,881,687		42,133,904		1942-2001		1998-2009	20 years to 39 years
South Carolina (LTC)					26,982,493			-			-			-			26,982,493		629,844		1959-1961		2014	20 years to 25 years
Tennessee (LTC)					94,531,371			2,359,950			-			-			96,891,321		31,396,301		1958-1983		1992-2010	20 years to 31.5 years
Texas (LTC)					157,784,829			15,763,105			(2,079,893	)		(1,819,856	)		169,648,185		48,827,817		1952-2010		1997-2014	20 years to 40 years
Washington (AL)					5,673,693			54,253			-			-			5,727,946		2,544,879		1999		1999	33 years
West Virginia (LTC)					24,641,423			348,641			-			-			24,990,064		5,930,519		1961-1996		1994-2011	33 years to 39 years
Wisconsin (LTC)					18,552,886			-			-			-			18,552,886		5,303,119		1964-1972		2009-2010	20 years
Total Other					1,315,250,273			71,701,482			(11,419,848	)		(3,776,854	)		1,371,755,053		405,158,901
Total					3,078,468,732			170,591,410			(21,497,993	)		(3,776,854	)		3,223,785,295		821,711,991
-1	The real estate included in this schedule is being used in either the operation of long-term care facilities (LTC), assisted living facilities (AL), independent living facilities (ILF) or specialty hospitals (SH) located in the states indicated.
-2	Certain of the real estate indicated are security for the HUD loan borrowings totaling $251,454,346, including FMV of $13,573,496, at December 31, 2014.
			Year Ended December 31,
-3			2012			2013			2014
	Balance at beginning of period		$	2,537,038,892		$	3,038,552,898		$	3,099,547,182
	Acquisitions			491,207,838			35,529,419			131,689,483
	Impairment						(414,687	)		(3,660,381	)
	Improvements			29,436,456			31,346,919			17,916,855
	Disposals/other			(19,130,288	)		(5,467,367	)		(21,707,844	)
	Balance at close of period		$	3,038,552,898		$	3,099,547,182		$	3,223,785,295
-4				2012			2013			2014
	Balance at beginning of period		$	470,420,023		$	580,373,211		$	707,409,888
	Provisions for depreciation			112,871,408			128,523,788			123,141,880
	Dispositions/other			(2,918,220	)		(1,487,111	)		(8,839,777	)
	Balance at close of period		$	580,373,211		$	707,409,888		$	821,711,991
-5	The reported amount of our real estate at December 31, 2014 is greater than the tax basis of the real estate by approximately $57.9 million.

SCHEDULE_IV_MORTGAGE_LOANS_ON_

SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE	12 Months Ended
	Dec. 31, 2014
Mortgage Loans On Real Estate [Abstract]
MORTGAGE LOANS ON REAL ESTATE	SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE
	OMEGA HEALTHCARE INVESTORS, INC.
	31-Dec-14
	Grouping	Description (1)	Interest Rate			Final Maturity			Periodic Payment	Prior Liens	Face Amount of Mortgages		Carrying Amount		Principal Amount
						Date			Terms				of Mortgages (2)		of Loans Subject
													-3		to Delinquent
															Principal or
															Interest
	1	Florida (3 LTC facilities)		10.82%			2030		Interest payable monthly	None		15,900,000		15,880,156
	2	Maryland (7 LTC facilities)		11.00%			2023		Interest payable monthly	None		74,927,751		69,927,759
	3	Maryland (1 LTC facility)		12.00%			2046		Interest payable monthly	None		10,000,000		10,000,000
	4	Maryland (1 LTC facility)		12.00%			2046		Interest payable monthly	None		9,500,000		9,500,000
	5	Maryland (1 LTC facility)		12.00%			2046		Interest payable monthly	None		5,500,000		5,500,000
	6	Michigan (31 LTC facilities)		9.00%			2029		Interest plus $90,000 of principal payable monthly	None		415,000,000		414,550,050
	7	Michigan (1 LTC facility)		10.25%			2021		Interest payable monthly	None		1,325,921		1,325,921
	8	Michigan (1 LTC facility)		12.00%			2046		Interest payable monthly	None		1,500,000		1,500,000
	9	Ohio (2 LTC facilities) and Pennsylvania (5 LTC and 2 AL facilities)		9.50%			2024		Interest payable monthly	None		112,500,000		112,500,000
	10	Ohio (1 LTC facility)		12.00%			2022		Interest plus $2,100 of principal payable monthly	None		6,112,406		6,052,075
				12.00%			2022		Interest payable monthly	None		345,011		345,011
				12.00%			2022		Interest payable monthly	None		796,397		796,397
				12.00%			2022		Interest payable monthly	None		112,100		112,100
				12.00%			2022		Interest payable monthly	None		89,081		89,081
											$	653,608,667	$	648,078,550
		(1) Mortgage loans included in this schedule represent first mortgages on facilities used in the delivery of long-term healthcare of which such facilities are located in the states indicated.
		(2) The aggregate cost for federal income tax purposes is equal to the carrying amount.
			Year Ended December 31,
		(3)		2012			2013		2014
		Balance at beginning of period	$	238,674,601		$	238,621,161		$             241,514,812
		Additions during period - Placements		11,967,892			3,378,357		529,547,836
		Deductions during period - collection of principal/other		(12,021,332	)		(484,706	)	(122,984,098)
		Balance at close of period	$	238,621,161		$	241,514,812		$             648,078,550

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2014
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
Accounting Estimates	Accounting Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
Fair Value Measurement	Fair Value Measurement
	The Company measures and discloses the fair value of nonfinancial and financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace.  Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions.  This hierarchy requires the use of observable market data when available.  These inputs have created the following fair value hierarchy:
		●	Level 1 - quoted prices for identical instruments in active markets;
		●	Level 2 - quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and
		●	Level 3 - fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	The Company measures fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at fair value.  When available, the Company utilizes quoted market prices from an independent third party source to determine fair value and classifies such items in Level 1.  In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, the Company consistently applies the dealer (market maker) pricing estimate and classifies the asset or liability in Level 2.
	If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads and/or market capitalization rates.  Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement.  As a result, the asset or liability could be classified in either Level 2 or Level 3 even though there may be some significant inputs that are readily observable.  Internal fair value models and techniques used by the Company include discounted cash flow and Monte-Carlo valuation models.
Purchase Accounting/Real Estate Investments and Depreciation	Purchase Accounting/Real Estate Investments and Depreciation
	We record the purchase of properties to net tangible and identified intangible assets acquired and liabilities assumed at their fair value. In making estimates of fair value for purposes of recording the purchase, we utilize a number of sources, including independent appraisals that may be obtained in connection with the acquisition or financing of the respective property and other market data. We also consider information obtained about each property as a result of our pre-acquisition due diligence, marketing and leasing activities as well as other critical valuation metrics such as capitalization rates and discount rates used to estimate the fair value of the tangible and intangible assets acquired (Level 3). When liabilities are assumed as part of a transaction, we consider information obtained about the liabilities and use similar valuation metrics (Level 3). In some instances when debt is assumed and an identifiable active market for similar debt is present, we use market interest rates for similar debt to estimate the fair value of the debt assumed (Level 2). The Company determines fair value as follows:
		●	Land is determined based on third party appraisals.
		●	Buildings and site improvements acquired are valued using a combination of discounted cash flow projections that assume certain future revenue and costs and consider capitalization and discount rates using current market conditions as well as replacement cost analysis.
		●	Furniture and fixture is determined based on third party appraisals.
		●	Intangible assets acquired are valued using a combination of discounted cash flow projections as well as other valuation techniques based on current market conditions for the intangible asset being acquired. For additional information regarding above and below market leases assumed as part of an acquisition see “In-Place Leases” below.
		●	Other assets acquired and liabilities assumed are typically valued at stated amounts, which approximate fair value on the date of the acquisition.
		●	Assumed debt balances are valued by discounting the contractual cash flows using a current market rate of interest rate, with the computed discount/premium amortized over the remaining term of the obligation assumed.
	The costs of significant improvements, renovations and replacements are capitalized. In addition, we capitalize leasehold improvements when certain criteria are met, including when we supervise construction and will own the improvement. Expenditures for maintenance and repairs are charged to operations as they are incurred.
	Depreciation is computed on a straight-line basis over the estimated useful lives ranging from 20 to 40 years for buildings and improvements and three to 10 years for furniture, fixtures and equipment. Leasehold interests are amortized over the shorter of the estimated useful life or term of the lease.
	As of December 31, 2014 and 2013, we had identified conditional asset retirement obligations primarily related to the future removal and disposal of asbestos that is contained within certain of our real estate investment properties. The asbestos is appropriately contained, and we believe we are compliant with current environmental regulations. If these properties undergo major renovations or are demolished, certain environmental regulations are in place, which specify the manner in which asbestos must be handled and disposed. We are required to record the fair value of these conditional liabilities if they can be reasonably estimated. As of December 31, 2014 and 2013, sufficient information was not available to estimate our liability for conditional asset retirement obligations as the obligations to remove the asbestos from these properties have indeterminable settlement dates. As such, no liability for conditional asset retirement obligations was recorded on our accompanying consolidated balance sheets as of December 31, 2014 and 2013.
Lease Accounting	Lease Accounting
	At the inception of the lease and during the amendment process, we evaluate each lease to determine if the lease should be considered an operating lease, sales-type lease, or direct financing lease. We have determined that all of our leases except for the four New Ark Investment, Inc. (“New Ark”) leases entered into in 2013 should be accounted for as operating leases. The four New Ark leases are accounted for as direct financing leases.
	For leases accounted for as operating leases, we retain ownership of the asset and record depreciation expense, see “Purchase Accounting/Real Estate Investments and Depreciation” above for additional information regarding our investment in real estate leased under operating lease agreements. We also record lease revenue based on the contractual terms of the operating lease agreement which often includes annual rent escalators, see “Revenue Recognition” below for further discussion regarding the recordation of revenue on our operating leases.
	For leases accounted for as direct financing leases, we record the present value of the future minimum lease payments (utilizing a constant interest rate over the term of the lease agreement) as a receivable and record interest income based on the contractual terms of the lease agreement. The New Ark lease agreements include annual rent escalators; see “Revenue Recognition” below for further discussion regarding the recording of interest income on our direct financing leases. As of December 31, 2014, $3.4 million of unamortized direct costs related to originating the direct financing leases have been deferred and recorded as “other assets” in our consolidated balance sheets.
In-Place Leases	In-Place Leases
	In-place lease assets and liabilities result when we assume a lease as part of a facility purchase. The fair value of in-place leases consists of the following components as applicable (1) the estimated cost to replace the leases, and (2) the above/below market cash flow of the leases, determined by comparing the projected cash flows of the leases in place at the time of acquisition to projected cash flows of comparable market-rate leases (referred to as Lease Intangibles). Lease Intangible assets and liabilities are classified as lease contracts above and below market value, respectively in “other assets” and “accrued expenses and other liabilities,” and amortized on a straight-line basis as decreases and increases, respectively, to rental revenue over the remaining term of the underlying leases. Should a tenant terminate its lease, the unamortized portion of the Lease Intangible is written off.
	As of December 31, 2014 and 2013, we had $20.4 million and $26.5 million, respectively, of below market leases and $2.4 million and $3.5 million, respectively, of above market leases recorded on our consolidated balance sheets. We expect net amortization of the in-place leases to increase rental income by:
			(in millions)
	2015		$	4.3
	2016			3.1
	2017			2
	2018			1.7
	2019			1.5
	Thereafter			5.4
	Total		$	18
	For the years ended December 31, 2014, 2013 and 2012, we have amortized $5.0 million, $5.0 million and $5.3 million, respectively as a net increase to rental revenue.
Asset Impairment	Asset Impairment
	Management periodically, but not less than annually, evaluates our real estate investments for impairment indicators, including the evaluation of our assets’ useful lives.  The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance and legal structure.  If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities.  Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets.  An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value.  The fair value of the real estate investment is determined by market research, which includes valuing the property as a nursing home as well as other alternative uses.  All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset.
	If we decide to sell real estate properties or land holdings, we evaluate the recoverability of the carrying amounts of the assets.  If the evaluation indicates that the carrying value is not recoverable from estimated net sales proceeds, the property is written down to estimated fair value less costs to sell.  Our estimates of cash flows and fair values of the properties are based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers.
	For the years ended December 31, 2014, 2013 and 2012, we recognized impairment losses of $3.7 million, $0.4 million and $0.3 million, respectively.  The impairments are primarily the result of closing facilities or updating the estimated proceeds we expect to receive for the sale of closed facilities.  For additional information, see Note 3 – Properties and Note 4 – Assets Held For Sale.
Loan and Direct Financing Lease Impairment	Loan and Direct Financing Lease Impairment
	Management evaluates our outstanding mortgage notes, direct financing leases and other notes receivable.  When management identifies potential loan or direct financing lease impairment indicators, such as non-payment under the loan documents, impairment of the underlying collateral, financial difficulty of the operator or other circumstances that may impair full execution of the loan documents or direct financing leases, and management believes it is probable that all amounts will not be collected under the contractual terms of the loan or direct financing lease, the loan or direct financing lease is written down to the present value of the expected future cash flows.  In cases where expected future cash flows are not readily determinable, the loan or direct financing lease is written down to the fair value of the collateral.  The fair value of the loan or direct financing lease is determined by market research, which includes valuing the property as a nursing home as well as other alternative uses.
	We currently account for impaired loans and direct financing leases using (a) the cost-recovery method, and/or (b) the cash basis method.  We generally utilize the cost-recovery method for impaired loans or direct financing leases for which impairment reserves were recorded.  We utilize the cash basis method for impaired loans or direct financing leases for which no impairment reserves were recorded because the net present value of the discounted cash flows expected under the loan or direct financing lease and/or the underlying collateral supporting the loan or direct financing lease were equal to or exceeded the book value of the loans or direct financing leases.  Under the cost-recovery method, we apply cash received against the outstanding loan balance or direct financing lease prior to recording interest income.  Under the cash basis method, we apply cash received to principal or interest income based on the terms of the agreement.  As of December 31, 2014 and 2013, we had loan loss reserves totaling $0 and $2.0 million, respectively.  As of December 31, 2014 and 2013, we had no reserves for direct financing leases.  In 2014 and 2013, we received recovery on previously written-off loans relating to an existing operator’s note from the receivership of approximately $46 thousand and $0.2 million, respectively.  In 2012, we did not record provisions for loan losses or charge-offs related to our mortgage or note receivable portfolios.
	For additional information, see Note 5 – Direct Financing Leases, Note 6 – Mortgage Notes Receivable and Note 7 – Other Investments.
Cash and Cash Equivalents	Cash and Cash Equivalents
	Cash and cash equivalents consist of cash on hand and highly liquid investments with a maturity date of three months or less when purchased.  These investments are stated at cost, which approximates fair value.  The majority of our cash and cash equivalents are held at major commercial banks.
Restricted Cash	Restricted Cash
	Restricted cash consists primarily of funds escrowed for tenants’ security deposits required by us pursuant to certain contractual terms (see Note 9 – Lease and Mortgage Deposits).
Accounts Receivable	Accounts Receivable
	Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts.  Contractual receivables relate to the amounts currently owed to us under the terms of the lease agreement.  Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement.  Straight-line receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts due to us contractually.  Lease inducements result from value provided by us to the lessee at the inception or renewal of the lease and amortized as a reduction of rental revenue over the non cancellable lease term.
	On a quarterly basis, we review our accounts receivable to determine their collectability. The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement. If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance. In the case of a lease recognized on a straight-line basis or existence of lease inducements, we generally provide an allowance for straight-line accounts receivable and/or the lease inducements when certain conditions or indicators of adverse collectability are present.
	A summary of our net receivables by type is as follows:
		December 31,
		2014				2013
		(in thousands)
	Contractual receivables		$	4,799			$	2,941
	Effective yield interest receivables			6,232				5,333
	Straight-line receivables			143,652				123,486
	Lease inducements			13,571				16,228
	Allowance			(78	)			(484	)
	Accounts receivable – net		$	168,176			$	147,504
	In 2014, we wrote-off (i) $0.8 million of straight-line rent receivables associated with a lease amendment to an existing operator for two facilities that were transitioned to a new operator and (ii) $2.0 million of effective yield interest receivables associated with the termination of a mortgage note that was due November 2021.  See Note 6 – Mortgage Notes Receivable for additional information related to the early termination of the November 2021 mortgage note.
	We continuously evaluate the payment history and financial strength of our operators and have historically established allowance reserves for straight-line rent adjustments for operators that do not meet our requirements.  We consider factors such as payment history, the operator’s financial condition as well as current and future anticipated operating trends when evaluating whether to establish allowance reserves.
Deferred Financing Costs	Deferred Financing Costs
	External costs incurred from placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method.  The deferred financing costs are included in “other assets” in our consolidated balance sheets.  Amortization of financing costs totaling $4.5 million, $2.8 million and $2.6 million in 2014, 2013 and 2012, respectively, is classified as “interest - amortization of deferred financing costs” in our consolidated statements of operations.  When financings are terminated, unamortized deferred financing costs, as well as charges incurred for the termination, are expensed at the time the termination is made.  Gains and losses from the extinguishment of debt are presented within income from continuing operations in the accompanying consolidated financial statements.
Revenue Recognition	Revenue Recognition
	We have various different investments that generate revenue, including leased and mortgaged properties, as well as other investments, including working capital loans. We recognize rental income and other investment income as earned over the terms of the related master leases and notes, respectively. Interest income is recorded on an accrual basis to the extent that such amounts are expected to be collected using the effective interest method. In applying the effective interest method, the effective yield on a loan is determined based on its contractual payment terms, adjusted for prepayment terms.
	Substantially all of our operating leases contain provisions for specified annual increases over the rents of the prior year and are generally computed in one of three methods depending on specific provisions of each lease as follows: (i) a specific annual increase over the prior year’s rent, generally between 2.0% and 3.0%; (ii) an increase based on the change in pre-determined formulas from year to year (e.g. increases in the Consumer Price Index); or (iii) specific dollar increases over prior years. Revenue under lease arrangements with minimum fixed and determinable increases is recognized over the non-cancellable term of the lease on a straight-line basis. The authoritative guidance does not provide for the recognition of contingent revenue until all possible contingencies have been eliminated. We consider the operating history of the lessee, the payment history, the general condition of the industry and various other factors when evaluating whether all possible contingencies have been eliminated. We do not recognize contingent rents as income until the contingencies have been resolved.
	In the case of rental revenue recognized on a straight-line basis, we generally record reserves against earned revenues from leases when collection becomes questionable or when negotiations for restructurings of troubled operators result in significant uncertainty regarding ultimate collection. The amount of the reserve is estimated based on what management believes will likely be collected. We continually evaluate the collectability of our straight-line rent assets. If it appears that we will not collect future rent due under our leases, we will record a provision for loss related to the straight-line rent asset.
	We record direct financing lease income on a constant interest rate basis over the term of the lease. The costs related to originating the direct financing leases have been deferred and are being amortized on a straight-line basis as a reduction to income from direct financing leases over the term of the direct financing leases.
	Gains on sales of real estate assets are recognized in accordance with the authoritative guidance for sales of real estate. The specific timing of the recognition of the sale and the related gain is measured against the various criteria in the guidance related to the terms of the transactions and any continuing involvement associated with the assets sold. To the extent the sales criteria are not met, we defer gain recognition until the sales criteria are met.
Assets Held for Sale and Discontinued Operations	Assets Held for Sale and Discontinued Operations
	Assets that qualify as held for sale may also be considered as a discontinued operation if they meet the new criteria set by the Financial Accounting Standards Board (“FASB”) (see “Recent Accounting Pronouncements” below).  For assets that qualify as discontinued operations, we reclassify the operations of those assets to discontinued operations in the consolidated statements of operations for all periods presented and assets held for sale in the consolidated balance sheets for all periods presented.  We had three facilities and one parcel of land classified as held for sale as of December 31, 2014 with a net book value of $12.8 million.  We had three facilities and one parcel of land classified as held for sale as of December 31, 2013 with a net book value of $1.4 million.  The held for sale assets do not meet the FASB criteria to be classified as discontinued operations.
Earnings Per Share	Earnings Per Share
	Basic earnings per common share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of shares of common stock outstanding during the year.  All outstanding unvested share-based payment awards that contain rights to non-forfeitable dividends or dividend equivalents that participate in undistributed earnings with common stockholders are considered participating securities that shall be included in the two-class method of computing basic EPS.  Diluted EPS reflects the potential dilution that could occur from shares issuable through stock-based compensation, including stock options and restricted stock.  For additional information, see Note 19 – Earnings Per Share.
Income Taxes	Income Taxes
	We were organized to qualify for taxation as a REIT under Section 856 through 860 of the Code.  As long as we qualify as a REIT; we will not be subject to Federal income taxes on the REIT taxable income that we distributed to stockholders, subject to certain exceptions.  In 2014, we paid common dividend payments of $258.6 million which satisfies the 2014 REIT requirements relating to qualifying income. We are permitted to own up to 100% of a taxable REIT subsidiary (“TRS”).  Currently, we have one TRS that is taxable as a corporation and that pays federal, state and local income tax on its net income at the applicable corporate rates.  The loss carry forward of $1.0 million was fully reserved with a valuation allowance due to uncertainties regarding realization.  We record interest and penalty charges associated with tax matters as income tax.  For additional information on income taxes, see Note 12 – Taxes.  As of December 31, 2014 and 2013, we did not have any unrecognized tax benefits.  We do not believe that there will be any material changes in our unrecognized tax positions over the next 12 months.  We are subject to examination by the respective taxing authorities for the tax years 2007 through 2014.
Stock-Based Compensation	Stock-Based Compensation
	Stock-based compensation expense is adjusted for estimated forfeitures and is recognized on a straight-line basis over the requisite service period of the awards, see Note 15 – Stock-Based Compensation for additional details.
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	Discontinued Operations
	In April 2014, we adopted the FASB Accounting Standards Update No 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (ASU 2014-08).  ASU 2014-08 changes the criteria for determining which disposals can be presented as discontinued operations and modified related disclosure requirements.  Under the new guidance, a discontinued operation is defined as: (i) a disposal of a component or group of components that is disposed of or is classified as held for sale that represents a strategic shift that has or will have a major effect on an entity’s operations and financial results or (ii) an acquired business or nonprofit activity that is classified as held for sale on the date of acquisition.  The standard states that a strategic shift could include a disposal of (i) a major geographical area of operations, (ii) a major line of business, (iii) a major equity method investment, or (iv) other major parts of an entity.
	The standard expands the disclosures for discontinued operations and requires new disclosures related to individually material disposals that do not meet the definition of a discontinued operation, an entity’s continuing involvement with a discontinued operation following the disposal date and retained equity method investments in a discontinued operation.  The guidance is effective for annual periods beginning on or after December 15, 2014 and interim periods within that year.  Early adoption is permitted, and calendar year-end companies may early adopt the guidance in the first quarter of 2014, but only for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued or available for issue.  We have chosen to adopt the guidance effective January 1, 2014 and determined that the adoption had no impact on our consolidated financial statements.
	Revenue Recognition
	In May 2014, the FASB issued a comprehensive new revenue recognition standard that will supersede nearly all existing revenue recognition guidance under GAAP. The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. We will be required to apply the new standard in the first quarter of 2017 and are assessing whether the new standard will have a material effect on our financial position or results of operations.
Risks and Uncertainties	Risks and Uncertainties
	Our company is subject to certain risks and uncertainties affecting the healthcare industry as a result of healthcare legislation and growing regulation by federal, state and local governments. Additionally, we are subject to risks and uncertainties as a result of changes affecting operators of nursing home facilities due to the actions of governmental agencies and insurers to limit the growth in cost of healthcare services (see Note 8 – Concentration of Risk).

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Schedule of below and above market lease, future amortization income	We expect net amortization of the in-place leases to increase rental income by:
			(in millions)
	2015		$	4.3
	2016			3.1
	2017			2
	2018			1.7
	2019			1.5
	Thereafter			5.4
	Total		$	18
Schedule of summary of net receivables	A summary of our net receivables by type is as follows:
		December 31,
		2014				2013
		(in thousands)
	Contractual receivables		$	4,799			$	2,941
	Effective yield interest receivables			6,232				5,333
	Straight-line receivables			143,652				123,486
	Lease inducements			13,571				16,228
	Allowance			(78	)			(484	)
	Accounts receivable – net		$	168,176			$	147,504

PROPERTIES_Tables

PROPERTIES (Tables)	12 Months Ended
	Dec. 31, 2014
Real Estate [Abstract]
Schedule of investment in leased real estate properties	A summary of our investment in leased real estate properties is as follows:
		December 31,
		2014			2013
		(in thousands)
	Buildings	$	2,745,872		$	2,631,774
	Site improvement and equipment		227,411			222,394
	Land		250,502			245,379
			3,223,785			3,099,547
	Less accumulated depreciation		(821,712	)		(707,410	)
	Total	$	2,402,073		$	2,392,137
Schedule of future minimum estimated contractual rents due for the remainder of the initial terms of the leases	The future minimum estimated contractual rents due for the remainder of the initial terms of the leases are as follows at December 31, 2014:
		(in thousands)
	2015	$	380,157
	2016		387,580
	2017		395,079
	2018		381,697
	2019		364,405
	Thereafter		1,823,132
	Total	$	3,732,050
Schedule of pro forma information not indicative of future operations	The following pro forma information is not indicative of future operations.
		Pro Forma
		Year Ended December 31,
		2014			2013
		(in thousands, except per share
		amounts, unaudited)
	Revenues	$	512,370		$	432,031
	Net income available to common stockholders		224,183			177,589
	Earnings per share – diluted:
	Net income available to common stockholders – as reported	$	1.74		$	1.46
	Net income available to common stockholders – pro forma	$	1.76		$	1.5

ASSETS_HELD_FOR_SALE_Tables

ASSETS HELD FOR SALE (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
Schedule of properties held-for-sale
			Properties Held-For-Sale
			Number of			Net Book Value
			Properties			(in thousands)
	December 31, 2012 (1)			3		$	1,020
	Properties sold			-			-
	Properties added			1			336
	December 31, 2013 (2)			4			1,356
	Properties sold (3)			(3	)		(686	)
	Properties added			3			12,122
	December 31, 2014 (2)			4		$	12,792
		-1	Includes one parcel of land and two facilities.
		-2	Includes one parcel of land and three facilities.
		-3	In 2014, we sold these facilities for approximately $2.8 million in net proceeds recognizing a gain on sale of approximately $2.0 million.

DIRECT_FINANCING_LEASES_Tables

DIRECT FINANCING LEASES (Tables)	12 Months Ended
	Dec. 31, 2014
Leases, Capital [Abstract]
Schedule of components of investment in direct financing leases	The components of investment in direct financing leases consist of the following:
			December 31,
			2014			2013
			(in thousands)
	Minimum lease payments receivable		$	4,244,067		$	4,291,067
	Estimated residual values			—			—
	Less unearned income			(3,704,835	)		(3,761,622	)
	Net investment in direct financing leases		$	539,232		$	529,445
	Properties subject to direct financing leases			56			56
Schedule of minimum rents due under direct financing leases	As of December 31, 2014, the following minimum rents are due under our direct financing leases for the next five years (in thousands):
	Year 1	Year 2	Year 3	Year 4	Year 5
	$47,000	$47,032	$47,482	$48,669	$49,886

MORTGAGE_NOTES_RECEIVABLE_Tabl

MORTGAGE NOTES RECEIVABLE (Tables)	12 Months Ended
	Dec. 31, 2014
Mortgage Notes Receivable Investments [Abstract]
Schedule of mortgage notes receivable, net of allowances	The outstanding principal amounts of mortgage notes receivable, net of allowances, were as follows:
			December 31,
			2014		2013
			(in thousands)
	Mortgage note due 2014; interest at 11.00%		$	-	$	5,000
	Mortgage note due 2021; interest at 12.50%			-		5,574
	Mortgage note due 2021; interest at 11.00%			-		91,123
	Mortgage note due 2021; interest at 10.00%			-		913
	Mortgage note due 2021; interest at 10.25%			1,326		-
	Mortgage note due 2022; interest at 12.50%			-		5,310
	Four Mortgage notes due 2022; interest at 12.00%			7,395		7,313
	Mortgage note due 2023; interest at 11.00%			69,928		69,928
	Mortgage note due 2023; interest at 12.50%			-		7,782
	Mortgage note due 2023; interest at 12.50%			-		6,175
	Mortgage note due 2024; interest at 9.50%			112,500		-
	Mortgage note due 2029; monthly payment of $90,000, including interest at 9.00%			414,550		-
	Mortgage note due 2030; interest at 10.82%			15,880		15,897
	Four Mortgage notes due 2046; interest at 12.00%			26,500		26,500
	Total mortgages — net (1)		$	648,079	$	241,515
		-1	As of December 31, 2013 and 2014 we have no allowance for loan loss for any of our mortgages.

OTHER_INVESTMENTS_Tables

OTHER INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2014
Receivables [Abstract]
Schedule of other investments	A summary of our other investments is as follows:
			December 31,
			2014		2013
			(in thousands)
	Other investment notes due 2015		$	141	$	2,318
	Other investment notes due 2021 - 2023			16,182		13,427
	Other investment note due 2014			-		62
	$31.5 million other investment note due 2017			23,500		23,750
	$2.5 million other investment note due 2014			1,640		546
	$6.0 million other investment note due 2015			5,439		5,439
	$1.3 million other investment note due 2017			1,300		1,300
	$1.5 million other investment note due 2014			-		1,456
	$0.9 million other investment note due 2015			750		-
	Notes receivable, gross(1)			48,952		48,298
	Allowance for loss on notes receivable			-		(1,977	)
	Notes receivable, net			48,952		46,321
	Other			-		2,400
	Marketable securities			-		4,333
	Total other investments		$	48,952	$	53,054
		-1	These notes bear interest at a weighted average rate of approximately 10% annually as of December 31, 2014.

BORROWING_ARRANGEMENTS_Tables

BORROWING ARRANGEMENTS (Tables)	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Schedule of long-term borrowings	The following is a summary of our long-term borrowings:
					Current			December 31,
			Maturity		Rate			2014			2013
								(in thousands)
	Secured borrowings:
	HUD mortgages assumed June 2010 (1)			2040 - 2045		4.85	%	$	126,319		$	128,641
	HUD mortgages assumed October 2011 (1)			2036		4.91	%		26,658			31,145
	HUD mortgages assumed December 2011(1) (2)			2044		3.06	%		57,416			58,592
	HUD mortgages assumed December 2012(1)			2040 - 2045		4.64	%		41,061			80,153
	Total secured borrowings								251,454			298,531
	Unsecured borrowings:
	Revolving line of credit			2018		1.72	%		85,000			326,000
	Term loan			2019		1.67	%		200,000			200,000
									285,000			526,000
	2020 notes			2020		7.5	%		200,000			200,000
	2022 notes			2022		6.75	%		575,000			575,000
	2024 notes			2024		5.875	%		400,000			400,000
	2024 notes			2024		4.95	%		400,000			—
	2025 notes			2025		4.5	%		250,000			—
	Subordinated debt			2021		9	%		20,747			20,892
									1,845,747			1,195,892
	(Discount) premium - net								(3,698	)		3,995
	Total unsecured borrowings								2,127,049			1,725,887
	Totals – net							$	2,378,503		$	2,024,418
		-1	Reflects the weighted average interest rate on the mortgages.
		-2	The debt was refinanced in March 2013.
Schedule of principal payments, excluding the premium/discount and the aggregate due thereafter	The required principal payments, excluding the premium/discount on the 2025, 2024, 2022 and 2020 Notes, for each of the five years following December 31, 2014 and the aggregate due thereafter are set forth below:
			(in thousands)
	2015		$	4,565
	2016			4,768
	2017			4,981
	2018			90,202
	2019			205,435
	Thereafter			2,057,930
	Totals		$	2,367,881
Schedule of refinancing related costs	The following summarizes the refinancing related costs:
			Year Ended December 31,
			2014		2013			2012
			(in thousands)
	Write off of deferred financing cost and unamortized premiums due to refinancing (1) (2)(3)		$	1,180	$	(11,278	)	$	3,024
	Prepayment and other costs associated with refinancing (4)			1,861		166			4,896
	Total debt extinguishment costs (gain)		$	3,041	$	(11,112	)	$	7,920
		-1	In 2014, we recorded: (a) $2.6 million write-off of deferred financing costs associated with the termination of the 2012 Credit Facilities, (b) $2.0 million write-off of deferred financing costs associated with the termination of our 2013 Term Loan Facility offset by (c) $3.5 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in September and December 2014.
		-2	In 2013, we recorded an $11.3 million interest refinancing gain associated with the write-off of the unamortized premium for debt assumed on 11 HUD mortgage loans that we paid off in May 2013.
		-3	In 2012, we wrote-off: (a) $2.2 million deferred financing costs associated with the tender offer and redemption of our $175 million 7% 2016 Notes; and (b) $2.5 million deferred financing costs associated with the termination of our $475 million 2011 Credit Facility.  These costs were offset by a $1.7 million gain resulting from the write-off of the unamortized premium on the four HUD loans that were paid off in the second quarter of 2012.
		-4	In 2014, we made prepayment penalties of $1.9 million associated with five HUD mortgage loans that we paid off in September and October 2014.  In 2013, we made prepayment penalties of $0.2 million associated with 11 HUD mortgage loans that we paid off in May 2013.  In 2012, we incurred $4.9 million of prepayment penalties and other costs associated with the tender offer and redemption of our $175 million 7% 2016 Notes.

FINANCIAL_INSTRUMENTS_Tables

FINANCIAL INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Schedule of the carrying amounts and fair values of financial instruments	At December 31, 2014 and 2013, the carrying amounts and fair values of our financial instruments were as follows:
		2014				2013
		Carrying		Fair		Carrying		Fair
		Amount		Value		Amount		Value
	Assets:	(in thousands)
	Cash and cash equivalents	$	4,489	$	4,489	$	2,616	$	2,616
	Restricted cash		29,076		29,076		31,759		31,759
	Investment in direct financing leases		539,232		539,232		529,445		529,445
	Mortgage notes receivable – net		648,079		642,626		241,515		240,482
	Other investments – net		48,952		49,513		53,054		50,124
	Totals	$	1,269,828	$	1,264,936	$	858,389	$	854,426
	Liabilities:
	Revolving line of credit	$	85,000	$	85,000	$	326,000	$	326,000
	Term loan		200,000		200,000		200,000		200,000
	7.50% notes due 2020 – net		198,235		264,269		197,890		256,852
	6.75% notes due 2022 – net		580,410		677,851		581,105		735,687
	5.875% notes due 2024 – net		400,000		449,242		400,000		411,266
	4.95% notes due 2024 – net		394,768		410,358		—		—
	4.50% notes due 2025 – net		247,889		244,053		—		—
	HUD debt		251,454		266,434		298,531		287,718
	Subordinated debt		20,747		26,434		20,892		28,849
	Totals	$	2,378,503	$	2,623,641	$	2,024,418	$	2,246,372

STOCKBASED_COMPENSATION_Tables

STOCK-BASED COMPENSATION (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]
Schedule of activity in restricted stock and RSUs	The following table summarizes the activity in restricted stock and RSUs for the years ended December 31, 2012, 2013 and 2014:
			Number of Shares/Units				Weighted - Average Grant-Date Fair Value per Share			Compensation Cost (1)
										(in millions)
	Non-vested at December 31, 2011			458,302			$	22.31
	Granted during 2012			15,500				20.29		$	0.3
	Vested during 2012			(14,300	)			19.56
	Non-vested at December 31, 2012			459,502			$	22.33
	Granted during 2013			241,699				29.87		$	7.2
	Vested during 2013			(444,003	)			22.38
	Non-vested at December 31, 2013			257,198			$	29.32
	Granted during 2014			143,637				30.7		$	4.4
	Vested during 2014			(90,901	)			28.87
	Non-vested at December 31, 2014			309,934			$	30.08
	(1)  Total compensation cost to be recognized on the awards based on grant date fair value, which is based on the market price of the Company’s common stock on the date of grant.
Schedule of assumptions used for estimating fair value of stock awards using Monte-Carlo model	The following are the significant assumptions used in estimating the value of the awards for grants made on the following dates:
			1-Jan-12		1-Jan-13		31-Dec-13
							and January 1, 2014
	Closing Price on date of grant	$	19.35	$	23.85	$	29.8
	Dividend Yield		8.27%		4.24%		6.44%
	Risk Free interest rate at time of grant		0.03% to 0.35%		0.05% to 0.43%		0.04% to 0.86%
	Expected volatility		35.64% to 38.53%		15.56% to 23.83%		24.16% to 25.86%
Schedule of activity in PRSU	The following table summarizes the activity in PRSUs for the years ended December 31, 2012, 2013 and 2014:
			Number of Shares				Weighted-Average Grant-Date Fair Value per Share
										Compensation Cost (1)
										(in millions)
	Non-vested at December 31, 2011			372,735			$	11.36
	Granted during 2012			124,244				9.61		$	1.2
	Vested during 2012			(124,244	)			9.61
	Non-vested at December 31, 2012			372,735			$	11.36
	Granted during 2013			665,289				10.36		$	6.9
	Vested during 2013 (2)			-				-
	Non-vested at December 31, 2013			1,038,024			$	10.72
	Granted during 2014			309,168				11.46		$	3.5
	Vested during 2014 (3)			(496,979	)			10.75
	Non-vested at December 31, 2014			850,213			$	10.97
		-1	Total compensation cost to be recognized on the awards was based on grant date fair value or the modification date fair value.
		-2	Subsequent to December 31, 2013, the board of directors reviewed the performance measure for the 372,735 PRSUs granted in January 2011 and outstanding at December 31, 2012 as well as the 124,244 shares granted in January 2013 and determined the PRSUs were earned.
		-3	In January 2014, the 124,244 PRSUs granted in January 2013 vested and were issued to the employees.  The 372,735 PRSUs granted in 2011 vested 25% on March 31, June 30, September 30 and December 31, 2014.
Schedule of total unrecognized compensation cost associated with outstanding restricted stock, restricted stock units and PRSU awards to employees	The following table summarizes our total unrecognized compensation cost as of December 31, 2014 associated with outstanding restricted stock, restricted stock units and PRSU awards to employees:
		Grant		Shares/				Grant Date			Total		Weighted		Unrecognized Compensation
		Year		Units				Average Fair			Compensation		Average		Cost
								Value Per			Cost		Period of		(in millions)
								Unit/ Share			(in millions)		Expense
													Recognition
													(in months)
	Restricted stock units	2013			213,741				29.8			6.4		36		4.2
	2015 Transition TSR PRSUs	2013			77,369				7.48			0.6		24		0.3
	2016 Transition TSR PRSUs	2013			115,785				8.67			1		36		0.7
	2015 Transition Relative TSR PRSUs	2013
					77,368				13.06			1		24		0.5
	2016 Transition Relative TSR PRSUs	2013
					115,781				14.25			1.7		36		1.1
	Restricted stock units	2014			122,137				29.8			3.6		36		2.4
	2016 TSR PRSUs	2014			154,584				8.67			1.3		48		1
	2016 Relative TSR PRSUs	2014			154,584				14.25			2.2		48		1.7
	Total				1,031,349			$	17.25		$	17.8			$	11.9

DIVIDEND_Tables

DIVIDEND (Tables)	12 Months Ended
	Dec. 31, 2014
Dividends [Abstract]
Schedule of per share distribution for income tax purpose	Per share distributions by our Company were characterized in the following manner for income tax purposes (unaudited):
		Year Ended December 31,
		2014		2013		2012
	Common
	Ordinary income	$	1.834	$	1.536	$	0.884
	Return of capital		0.186		0.324		0.806
	Total dividends paid	$	2.02	$	1.86	$	1.69

SUMMARY_OF_QUARTERLY_RESULTS_U1

SUMMARY OF QUARTERLY RESULTS (UNAUDITED) (Tables)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Schedule of quarterly financial information	The following summarizes quarterly results of operations for the years ended December 31, 2014 and 2013.
		31-Mar		30-Jun		30-Sep		31-Dec
		(in thousands, except per share amounts)
	2014
	Revenues	$	121,001	$	121,800	$	130,665	$	131,321
	Net income		55,829		46,817		61,713		56,990
	Net income available to common stockholders		55,829		46,817		61,713		56,990
	Net income available to common per share:
	Basic	$	0.45	$	0.37	$	0.48	$	0.45
	Diluted	$	0.45	$	0.37	$	0.48	$	0.44
	Cash dividends paid on common stock	$	0.49	$	0.5	$	0.51	$	0.52
	2013
	Revenues	$	101,761	$	102,515	$	103,301	$	111,137
	Net income		38,120		49,058		38,137		47,206
	Net income available to common stockholders		38,120		49,058		38,137		47,206
	Net income available to common per share:
	Basic	$	0.34	$	0.42	$	0.32	$	0.39
	Diluted	$	0.34	$	0.42	$	0.32	$	0.38
	Cash dividends paid on common stock	$	0.45	$	0.46	$	0.47	$	0.48

EARNINGS_PER_SHARE_Tables

EARNINGS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
Schedule of computation of basic and diluted earnings per share	The following tables set forth the computation of basic and diluted earnings per share:
		Year Ended December 31,
		2014		2013		2012
		(in thousands, except per share amounts)
	Numerator:
	Net income	$	221,349	$	172,521	$	120,698
	Numerator for net income available to common per share - basic and diluted	$	221,349	$	172,521	$	120,698
	Denominator:
	Denominator for basic earnings per share		126,550		117,257		107,591
	Effect of dilutive securities:
	Common stock equivalents		744		843		420
	Denominator for diluted earnings per share		127,294		118,100		108,011
	Earnings per share - basic:
	Net income - basic	$	1.75	$	1.47	$	1.12
	Earnings per share - diluted:
	Net income - diluted	$	1.74	$	1.46	$	1.12

CONSOLIDATING_FINANCIAL_STATEM1

CONSOLIDATING FINANCIAL STATEMENTS (Tables)	12 Months Ended
	Dec. 31, 2014
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]
Schedule of consolidating balance sheets
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING BALANCE SHEET
	(in thousands, except per share amounts)
		31-Dec-14
		Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries			Elimination Company			Consolidated
	ASSETS
	Real estate properties
	Land and buildings	$	2,834,498		$	389,287		$	—		$	3,223,785
	Less accumulated depreciation		(754,517	)		(67,195	)		—			(821,712	)
	Real estate properties – net		2,079,981			322,092			—			2,402,073
	Investment in direct financing leases		539,232			—			—			539,232
	Mortgage notes receivable – net		648,079			—			—			648,079
			3,267,292			322,092			—			3,589,384
	Other investments – net		48,952			—			—			48,952
			3,316,244			322,092			—			3,638,336
	Assets held for sale – net		12,792			—			—			12,792
	Total investments		3,329,036			322,092			—			3,651,128
	Cash and cash equivalents		4,489			—			—			4,489
	Restricted cash		7,016			22,060			—			29,076
	Accounts receivable – net		160,789			7,387			—			168,176
	Investment in affiliates		73,622			—			(73,622	)		—
	Other assets		42,876			25,900			—			68,776
	Total assets	$	3,617,828		$	377,439		$	(73,622	)	$	3,921,645
	LIABILITIES AND STOCKHOLDERS’ EQUITY
	Revolving line of credit	$	85,000		$	—		$	—		$	85,000
	Term loan		200,000			—			—			200,000
	Secured borrowings		—			251,454			—			251,454
	Unsecured borrowings – net		1,821,302			20,747			—			1,842,049
	Accrued expenses and other liabilities		110,199			31,616			—			141,815
	Intercompany payable		—			40,309			(40,309	)		—
	Total liabilities		2,216,501			344,126			(40,309	)		2,520,318
	Stockholders’ equity:
	Common stock		12,761			—			—			12,761
	Common stock – additional paid-in-capital		2,136,234			—			—			2,136,234
	Cumulative net earnings		1,147,998			33,313			(33,313	)		1,147,998
	Cumulative dividends paid		(1,895,666	)		—			—			(1,895,666	)
	Total stockholders’ equity		1,401,327			33,313			(33,313	)		1,401,327
	Total liabilities and stockholders’ equity	$	3,617,828		$	377,439		$	(73,622	)	$	3,921,645
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING BALANCE SHEET
	(in thousands, except per share amounts)
		31-Dec-13
		Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries			Elimination Company			Consolidated
	ASSETS
	Real estate properties
	Land and buildings	$	2,712,652		$	386,895		$	—		$	3,099,547
	Less accumulated depreciation		(656,988	)		(50,422	)		—			(707,410	)
	Real estate properties – net		2,055,664			336,473			—			2,392,137
	Investment in direct financing leases		529,445			—			—			529,445
	Mortgage notes receivable – net		241,515			—			—			241,515
			2,826,624			336,473			—			3,163,097
	Other investments – net		53,054			—			—			53,054
			2,879,678			336,473			—			3,216,151
	Assets held for sale – net		1,356			—			—			1,356
	Total investments		2,881,034			336,473			—			3,217,507
	Cash and cash equivalents		2,616			—			—			2,616
	Restricted cash		8,812			22,947			—			31,759
	Accounts receivable – net		141,704			5,800			—			147,504
	Investment in affiliates		78,075			—			(78,075	)		—
	Other assets		39,997			22,833			—			62,830
	Total assets	$	3,152,238		$	388,053		$	(78,075	)	$	3,462,216
	LIABILITIES AND STOCKHOLDERS’ EQUITY
	Revolving line of credit	$	326,000		$	—		$	—		$	326,000
Term loan		200,000			—			—			200,000
Secured borrowings		41,876			256,655			—			298,531
Unsecured borrowings – net		1,178,995			20,892			—			1,199,887
Accrued expenses and other liabilities		105,264			32,431			—			137,695
Intercompany payable		—			56,994			(56,994	)		—
Total liabilities		1,852,135			366,972			(56,994	)		2,162,113
Stockholders’ equity:
Common stock		12,353			—			—			12,353
Common stock – additional paid-in-capital		1,998,169			—			—			1,998,169
Cumulative net earnings		926,649			21,081			(21,081	)		926,649
Cumulative dividends paid		(1,637,068	)		—			—			(1,637,068	)
Total stockholders’ equity		1,300,103			21,081			(21,081	)		1,300,103
Total liabilities and stockholders’ equity	$	3,152,238		$	388,053		$	(78,075	)	$	3,462,216
Schedule of consolidating statement of operations	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING STATEMENT OF OPERATIONS
	(in thousands, except per share amounts)
	Year Ended December 31, 2014
	Issuer &		Non – Guarantor
	Subsidiary		Subsidiaries		Elimination
	Guarantors				Company		Consolidated
	Revenue
	Rental income	$	346,479		$	41,964		$	-		$	388,443
	Income from direct financing leases		56,719									56,719
	Mortgage interest income		53,007			-			-			53,007
	Other investment income – net		6,618			-			-			6,618
	Total operating revenues		462,823			41,964			-			504,787
	Expenses
	Depreciation and amortization		106,484			16,773			-			123,257
	General and administrative		25,546			342			-			25,888
	Acquisition costs		3,948			-			-			3,948
	Impairment loss on real estate properties		3,660			-			-			3,660
	Provisions for uncollectible mortgages, notes and accounts receivable		2,723			-			-			2,723
	Total operating expenses		142,361			17,115			-			159,476
	Income before other income and expense		320,462			24,849			-			345,311
	Other income (expense):
	Interest income		19			25			-			44
	Interest expense		(106,748	)		(12,621	)		-			(119,369	)
	Interest – amortization of deferred financing costs		(4,438	)		(21	)		-			(4,459	)
	Interest – refinancing costs		(3,041	)		-			-			(3,041	)
	Equity in earnings		12,232			-			(12,232	)		-
	Total other expense		(101,976	)		(12,617	)		(12,232	)		(126,825	)
	Income before gain on assets sold		218,486			12,232			(12,232	)		218,486
	Loss on assets sold - net		2,863			-			-			2,863
	Net income available to common stockholders	$	221,349		$	12,232		$	(12,232	)	$	221,349
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING STATEMENT OF OPERATIONS
	(in thousands, except per share amounts)
	Year Ended December 31, 2013
	Issuer &		Non –
	Subsidiary		Guarantor		Elimination
	Guarantors		Subsidiaries		Company		Consolidated
	Revenue
	Rental income	$	333,015		$	42,120		$	-		$	375,135
	Income from direct financing leases		5,203									5,203
	Mortgage interest income		29,351			-			-			29,351
	Other investment income – net		9,025			-			-			9,025
	Total operating revenues		376,594			42,120			-			418,714
	Expenses
	Depreciation and amortization		110,535			18,111			-			128,646
	General and administrative		21,263			325			-			21,588
	Acquisition costs		245			-			-			245
	Impairment loss on real estate properties		415			-			-			415
	Provisions for uncollectible mortgages, notes and accounts receivable		2,141			-			-			2,141
	Total operating expenses		134,599			18,436			-			153,035
	Income before other income and expense		241,995			23,684			-			265,679
	Other income (expense):
	Interest income		17			24			-			41
	Interest expense		(87,240	)		(13,141	)		-			(100,381	)
	Interest – amortization of deferred financing costs		(2,763	)		(16	)		-			(2,779	)
	Interest – refinancing gain		11,112			-			-			11,112
	Equity in earnings		10,551			-			(10,551	)		-
	Total other expense		(68,323	)		(13,133	)		(10,551	)		(92,007	)
	Income before gain on assets sold		173,672			10,551			(10,551	)		173,672
	Loss on assets sold - net		(1,151	)		-			-			(1,151	)
	Net income available to common stockholders	$	172,521		$	10,551		$	(10,551	)	$	172,521
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING STATEMENT OF OPERATIONS
(in thousands, except per share amounts)
Year Ended December 31, 2012
Issuer &		Non –
Subsidiary		Guarantor		Elimination
Guarantors		Subsidiaries		Company		Consolidated
Revenue
Rental income	$	279,458		$	35,134		$	-		$	314,592
Mortgage interest income		30,446			-			-			30,446
Other investment income – net		5,422			-			-			5,422
Total operating revenues		315,326			35,134			-			350,460
Expenses
Depreciation and amortization		97,057			15,926			-			112,983
General and administrative		21,025			305			-			21,330
Acquisition costs		909			-			-			909
Impairment loss on real estate properties		272			-			-			272
Total operating expenses		119,263			16,231			-			135,494
Income before other income and expense		196,063			18,903			-			214,966
Other income (expense):
Interest income		7			22			-			29
Interest expense		(82,691	)		(12,836	)		-			(95,527	)
Interest – amortization of deferred financing costs		(2,649	)		-			-			(2,649	)
Interest – refinancing costs		(7,920	)		-			-			(7,920	)
Equity in earnings		6,089			-			(6,089	)		-
Total other expense		(87,164	)		(12,814	)		(6,089	)		(106,067	)
Income before gain on assets sold		108,899			6,089			(6,089	)		108,899
Gain on assets sold - net		11,799			-			-			11,799
Net income available to common stockholders	$	120,698		$	6,089		$	(6,089	)	$	120,698

ORGANIZATION_AND_BASIS_OF_PRES1

ORGANIZATION AND BASIS OF PRESENTATION (Narrative) (Detail)	12 Months Ended	3 Months Ended	1 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Jun. 30, 2015	Oct. 30, 2014	Dec. 31, 2013
	Segment			Facility
	Facility
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Number of reportable segments	1
Number of facilities owned	568
Number of available for sale facilities	5			3
Aviv Operating Partnership | Subsequent event | Omega common stock
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Number of shares and units issued		45.5
Aviv Operating Partnership | Subsequent event | Operating Partnership units
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Number of shares and units issued		10.3
Merger Entity | Aviv Operating Partnership
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Number of common stock right to received for each common stock			0.9

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail) (USD $)	Dec. 31, 2014
In Millions, unless otherwise specified
Accounting Policies [Abstract]
2015	$4.30
2016	3.1
2017	2
2018	1.7
2019	1.5
Thereafter	5.4
Total	$18

SUMMARY_OF_SIGNIFICANT_ACCOUNT4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Accounting Policies [Abstract]
Contractual receivables	$4,799	$2,941
Effective yield interest receivables	6,232	5,333
Straight-line receivables	143,652	123,486
Lease inducements	13,571	16,228
Allowance	-78	-484
Accounts receivable - net	$168,176	$147,504

SUMMARY_OF_SIGNIFICANT_ACCOUNT5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail)	12 Months Ended
	Dec. 31, 2014
Buildings and improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	20 years
Buildings and improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	40 years
Furniture, fixtures and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Furniture, fixtures and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	10 years

SUMMARY_OF_SIGNIFICANT_ACCOUNT6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
	Parcel	Parcel	Parcel
	Subsidiary	Facility	Facility
	Facility
Accounting Policies [Line Items]
Below market leases	$20,400,000	$26,500,000
Above market leases	2,400,000	3,500,000
Amortization of above and below market leases	5,000,000	5,000,000	5,300,000
Recognized impairment losses	3,660,000	415,000	272,000
Loan loss reserves	0	2,000,000
Recovery on previously written-off loans	46,000	200,000
Number of facilities transitioned	2
Straight line rent receivables wrote off	800,000
Effective yield interest receivables wrote off	2,000,000
Amortization of financing costs	4,459,000	2,779,000	2,649,000
Annual percentage increases over the rents of the prior year, minimum	2.00%
Annual percentage increases over the rents of the prior year, maximum	3.00%
Number of facilities held for sale	3	3	2
Number of parcel of land held-for-sale	1	1	1
Assets held for sale - net	12,792,000	1,356,000
Dividend paid	258,501,000	218,116,000	182,190,000
Permitted ownership of a taxable REIT subsidiary ("TRS"), maximum percentage	100.00%
Loss carried forward	1,000,000
Number of taxable REIT subsidiaries	1
Unamortized direct costs related to origination of direct financing leases	$3,400,000

PROPERTIES_Detail

PROPERTIES (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Real Estate [Abstract]
Buildings	$2,745,872	$2,631,774
Site improvement and equipment	227,411	222,394
Land	250,502	245,379
Property, plant and equipment, gross	3,223,785	3,099,547
Less accumulated depreciation	-821,712	-707,410
Total	$2,402,073	$2,392,137

PROPERTIES_Detail_1

PROPERTIES (Detail 1) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Real Estate [Abstract]
2015	$380,157
2016	387,580
2017	395,079
2018	381,697
2019	364,405
Thereafter	1,823,132
Total	$3,732,050

PROPERTIES_Detail_2

PROPERTIES (Detail 2) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Earnings per share - diluted:
Net income available to common stockholders - as reported	$0.44	$0.48	$0.37	$0.45	$0.38	$0.32	$0.42	$0.34	$1.74	$1.46	$1.12
Pro forma
Proforma Information [Line Items]
Revenues									$512,370	$432,031
Net income available to common stockholders									$224,183	$177,589
Earnings per share - diluted:
Net income available to common stockholders - as reported									$1.74	$1.46
Net income available to common stockholders - pro forma									$1.76	$1.50

PROPERTIES_Leased_Property_Nar

PROPERTIES - Leased Property (Narrative) (Detail)	12 Months Ended
	Dec. 31, 2014	Nov. 20, 2014
		Facility
Real Estate Properties [Line Items]
Number of leased real estate properties	568
Property available for operating lease | Minimum
Real Estate Properties [Line Items]
Lease term	5 years
Property available for operating lease | Maximum
Real Estate Properties [Line Items]
Lease term	15 years
SNF's
Real Estate Properties [Line Items]
Number of leased real estate properties	474
SNF's | Purchase leaseback transactions
Real Estate Properties [Line Items]
Number of leased real estate properties	421
ALFs
Real Estate Properties [Line Items]
Number of leased real estate properties	23
ALFs | Purchase leaseback transactions
Real Estate Properties [Line Items]
Number of leased real estate properties	22	4
Specialty facilities
Real Estate Properties [Line Items]
Number of leased real estate properties	11

PROPERTIES_2014_Acquisition_Na

PROPERTIES - 2014 Acquisition (Narrative) (Detail 1) (USD $)	12 Months Ended	1 Months Ended			0 Months Ended	1 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Nov. 20, 2014	Jan. 30, 2014	Aug. 30, 2013	Jul. 01, 2014	Jun. 27, 2014	Sep. 30, 2014
	Facility	Facility	Facility	Facility	Facility	Facility	Facility
		Bed	Bed	Bed	Bed	Bed	Bed
Real Estate Properties [Line Items]
Number of Real Estate Properties	568
Acquisition related expenses	$3.90
Number of facilities transitioned	2
Revenue attributable to the acquired assets	3.2
Net income attributable to the acquired assets	1.2
ALFs
Real Estate Properties [Line Items]
Number of Real Estate Properties	23
ALFs | Purchase leaseback transactions
Real Estate Properties [Line Items]
Number of Real Estate Properties	22	4
Number of beds		371
Cash paid for acquisition		84.2
Number of facility to be added to the master lease		4
Percentage annual cash yield		6.00%
ALFs | Purchase leaseback transactions | Land
Real Estate Properties [Line Items]
Purchase price allocated	5.1
ALFs | Purchase leaseback transactions | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price allocated	76.7
ALFs | Purchase leaseback transactions | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price allocated	2.4
ALFs | Pennsylvania | Purchase leaseback transactions
Real Estate Properties [Line Items]
Number of Real Estate Properties		2
ALFs | Oregon | Purchase leaseback transactions
Real Estate Properties [Line Items]
Number of Real Estate Properties		1
ALFs | Arkansas | Purchase leaseback transactions
Real Estate Properties [Line Items]
Number of Real Estate Properties		1
ALFs | ARIZONA
Real Estate Properties [Line Items]
Number of Real Estate Properties			1
Number of beds			90
Cash paid for acquisition			4.7
ALFs | ARIZONA | Land
Real Estate Properties [Line Items]
Cash paid for acquisition			0.4
ALFs | ARIZONA | Buildings and site improvements
Real Estate Properties [Line Items]
Cash paid for acquisition			3.9
ALFs | ARIZONA | Furniture and fixtures
Real Estate Properties [Line Items]
Cash paid for acquisition			0.4
SNF's
Real Estate Properties [Line Items]
Number of Real Estate Properties	474
SNF's | Purchase leaseback transactions
Real Estate Properties [Line Items]
Number of Real Estate Properties	421
SNF's | Arkansas
Real Estate Properties [Line Items]
Number of beds				1,084
Number of facilities transitioned				11
Provision for uncollectible straight-line rent receivable				2.3
SNF's | Texas
Real Estate Properties [Line Items]
Number of Real Estate Properties					1
Number of beds					125
Cash paid for acquisition					8.2
Percentage annual cash yield					9.75%
SNF's | Texas | Land
Real Estate Properties [Line Items]
Cash paid for acquisition					0.4
SNF's | Texas | Buildings and site improvements
Real Estate Properties [Line Items]
Cash paid for acquisition					7.4
SNF's | Texas | Furniture and fixtures
Real Estate Properties [Line Items]
Cash paid for acquisition					0.4
SNF's | Georgia And South Carolina
Real Estate Properties [Line Items]
Number of Real Estate Properties						2
Number of beds						213
Cash paid for acquisition						17.3
Percentage annual cash yield						9.50%
Period of master lease agreement						12 years
SNF's | South Carolina
Real Estate Properties [Line Items]
Number of Real Estate Properties							1
Number of beds							132
Cash paid for acquisition							34.6
SNF's | South Carolina | Land
Real Estate Properties [Line Items]
Cash paid for acquisition							0.9
SNF's | South Carolina | Buildings and site improvements
Real Estate Properties [Line Items]
Cash paid for acquisition							32.1
SNF's | South Carolina | Furniture and fixtures
Real Estate Properties [Line Items]
Cash paid for acquisition							1.6
SNFs West Virginia Facility Bed
Real Estate Properties [Line Items]
Number of beds					150
Number of facilities transitioned					2
Provision for uncollectible straight-line rent receivable	$0.80
Period of master lease agreement	12 years

PROPERTIES_2013_Acquisition_Na

PROPERTIES - 2013 Acquisition (Narrative) (Detail 2) (USD $)	0 Months Ended	12 Months Ended	1 Months Ended
In Millions, unless otherwise specified	Oct. 02, 2013	Dec. 31, 2013	Oct. 31, 2013	Aug. 30, 2013	Dec. 31, 2014
	Bed		Bed	Bed	Facility
			Facility	Facility
Real Estate Properties [Line Items]
Number of facilities owned					568
Acquisition related expenses					$3.90
Number of facilities transitioned					2
ALFs
Real Estate Properties [Line Items]
Number of facilities owned					23
ALFs | Florida
Real Estate Properties [Line Items]
Number of beds	97
Purchase price of beds acquired paid in cash	10.3
ALFs | Florida | Land
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash		0.6
ALFs | Florida | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash		9
ALFs | Florida | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash		0.7
SNF's
Real Estate Properties [Line Items]
Number of facilities owned					474
SNF's | Indiana
Real Estate Properties [Line Items]
Number of facilities owned			4
Number of beds			384
Purchase price of beds acquired paid in cash			22.2
Purchase price allocated below market lease			3
Total purchase price			25.2
Acquisition related expenses		0.2
SNF's | Indiana | Land
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash		0.7
SNF's | Indiana | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash		21.8
SNF's | Indiana | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash		2.7
SNF's | Arkansas
Real Estate Properties [Line Items]
Number of beds				1,084
Number of facilities transitioned				11
Provision for uncollectible straight-line rent receivable				$2.30

PROPERTIES_2012_Acquisitions_G

PROPERTIES - 2012 Acquisitions - Genesis Healthcare (Narrative) (Detail 3)	Dec. 31, 2014	Dec. 31, 2013	Dec. 01, 2012	Nov. 30, 2012
	Facility	Facility	Facility	State
	State			Facility
Real Estate Properties [Line Items]
Number of facilities owned	568
Number of states	38
Number of facilities transitioned	2
Master lease
Real Estate Properties [Line Items]
Number of facilities owned		52
Number of facilities transitioned		1
Genesis Healthcare | Master lease
Real Estate Properties [Line Items]
Number of facilities owned			53	13
Number of states				5
Sun Healthcare
Real Estate Properties [Line Items]
Number of facilities owned				40
Number of states				10

PROPERTIES_2012_Acquisitions_A

PROPERTIES - 2012 Acquisitions - Arizona and California Acquisitions (Narrative) (Detail 4) (USD $)	1 Months Ended	12 Months Ended	1 Months Ended
In Millions, unless otherwise specified	Jan. 30, 2014	Dec. 31, 2012	Nov. 30, 2012	Dec. 31, 2014
	Facility	Loan	Facility	Facility
	Bed			Loan
Real Estate Properties [Line Items]
Number of facilities owned				568
Number of mortgage loans				13
SNF's
Real Estate Properties [Line Items]
Number of facilities owned				474
ALFs
Real Estate Properties [Line Items]
Number of facilities owned				23
ALFs | ARIZONA
Real Estate Properties [Line Items]
Number of facilities owned	1
Cash paid for acquisition	$4.70
Number of beds	90
ALFs | ARIZONA | Land
Real Estate Properties [Line Items]
Cash paid for acquisition	0.4
ALFs | ARIZONA | Buildings and site improvements
Real Estate Properties [Line Items]
Cash paid for acquisition	3.9
ALFs | ARIZONA | Furniture and fixtures
Real Estate Properties [Line Items]
Cash paid for acquisition	0.4
Arizona and California Acquisitions
Real Estate Properties [Line Items]
Total purchase price		203.4
Number of facilities owned		14
Number of beds		1,830
Arizona and California Acquisitions | California
Real Estate Properties [Line Items]
Number of facilities owned		10
Arizona and California Acquisitions | ARIZONA
Real Estate Properties [Line Items]
Number of facilities owned		4
Arizona and California Acquisitions | Housing and Urban Development
Real Estate Properties [Line Items]
Assumption of debt indebtedness for acquisition		71.9
Cash paid for acquisition		131.5
Number of mortgage loans		8
Interest rate of assumed debt		5.50%
Lease expiration period		April 2031 and February 2045
Arizona and California Acquisitions | SNF's
Real Estate Properties [Line Items]
Number of facilities owned		12
Arizona and California Acquisitions | ALFs
Real Estate Properties [Line Items]
Number of facilities owned		1
Arizona and California Acquisitions | SNF's and ALF's
Real Estate Properties [Line Items]
Number of facilities owned		1
Arizona and California Acquisitions | First Closing
Real Estate Properties [Line Items]
Total purchase price			60
Number of facilities owned			4
Cash paid for acquisition			32.4
Number of facilities leased			4
Period of master lease agreement			12 years
Purchase price allocated				64.6
Fair value adjustment related to debt assumed				4.6
Arizona and California Acquisitions | First Closing | Land
Real Estate Properties [Line Items]
Purchase price allocated				5.5
Arizona and California Acquisitions | First Closing | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price allocated				55.9
Arizona and California Acquisitions | First Closing | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price allocated				3.2
Arizona and California Acquisitions | First Closing | Housing and Urban Development
Real Estate Properties [Line Items]
Assumption of debt indebtedness for acquisition			27.6
Interest rate of assumed debt			4.73%
Arizona and California Acquisitions | First Closing | SNF's
Real Estate Properties [Line Items]
Number of facilities owned			2
Arizona and California Acquisitions | First Closing | ALFs
Real Estate Properties [Line Items]
Number of facilities owned			1
Arizona and California Acquisitions | First Closing | SNF's and ALF's
Real Estate Properties [Line Items]
Number of facilities owned			1
Arizona and California Acquisitions | Second Closing | SNF's
Real Estate Properties [Line Items]
Number of facilities leased			5
Period of master lease agreement			12 years
Purchase price allocated				70.2
Arizona and California Acquisitions | Second Closing | SNF's | Land
Real Estate Properties [Line Items]
Purchase price allocated				11.5
Arizona and California Acquisitions | Second Closing | SNF's | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price allocated				55.5
Arizona and California Acquisitions | Second Closing | SNF's | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price allocated				3.2
Arizona and California Acquisitions | Second Closing | SNF's | California
Real Estate Properties [Line Items]
Total purchase price			70.2
Number of facilities owned			10
Arizona and California Acquisitions | Third Closing
Real Estate Properties [Line Items]
Cash paid for acquisition		28.9
Purchase price allocated				77.5
Fair value adjustment related to debt assumed				5.4
Arizona and California Acquisitions | Third Closing | Land
Real Estate Properties [Line Items]
Purchase price allocated				13
Arizona and California Acquisitions | Third Closing | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price allocated				60.8
Arizona and California Acquisitions | Third Closing | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price allocated				3.7
Arizona and California Acquisitions | Third Closing | Housing and Urban Development
Real Estate Properties [Line Items]
Assumption of debt indebtedness for acquisition		44.3
Reduction price related to funds escrowed by the seller		1
Arizona and California Acquisitions | Third Closing | SNF's
Real Estate Properties [Line Items]
Number of facilities leased		5
Period of master lease agreement		12 years
Arizona and California Acquisitions | Third Closing | SNF's | California
Real Estate Properties [Line Items]
Total purchase price		$72.20
Arizona and California Acquisitions | Third Closing | SNF's | Housing and Urban Development | California
Real Estate Properties [Line Items]
Interest rate of assumed debt		5.97%

PROPERTIES_2012_Acquisitions_I

PROPERTIES - 2012 Acquisitions - Indiana Acquisitions (Narrative) (Detail 5) (USD $)	1 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Aug. 31, 2012	Dec. 31, 2014	Dec. 31, 2012	Jun. 29, 2012	Jun. 30, 2012
	Bed		Facility	Bed	Facility
	Facility		Operator
Real Estate Properties [Line Items]
Number of facilities owned		568
Number of operators		50
SNF's
Real Estate Properties [Line Items]
Number of facilities owned		474
ALFs
Real Estate Properties [Line Items]
Number of facilities owned		23
Indiana Acquisitions
Real Estate Properties [Line Items]
Number of facilities owned			34
Number of operators			2
Indiana Acquisitions | Transaction 1
Real Estate Properties [Line Items]
Number of beds				80
Total purchase price				$3.40
Purchase price allocated			3.4
Indiana Acquisitions | Transaction 1 | SNF's
Real Estate Properties [Line Items]
Number of facilities owned					1
Indiana Acquisitions | Transaction 1 | Land
Real Estate Properties [Line Items]
Purchase price allocated			0.2
Indiana Acquisitions | Transaction 1 | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price allocated			2.9
Indiana Acquisitions | Transaction 1 | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price allocated			0.3
Indiana Acquisitions | Transaction 2
Real Estate Properties [Line Items]
Number of facilities owned				4
Number of beds				383
Total purchase price				21.7
Purchase price allocated			21.7
Indiana Acquisitions | Transaction 2 | Land
Real Estate Properties [Line Items]
Purchase price allocated			1.9
Indiana Acquisitions | Transaction 2 | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price allocated			18.4
Indiana Acquisitions | Transaction 2 | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price allocated			1.4
Indiana Acquisitions | Transaction 3
Real Estate Properties [Line Items]
Number of facilities owned	27
Number of beds	2,892
Cash paid for acquisition	203	219.7
Business acquisition, purchase price allocation, liabilities assumed	13.9
Business acquisition, purchase price allocation, land	2.8
Indiana Acquisitions | Transaction 3 | SNF's
Real Estate Properties [Line Items]
Number of facilities owned	17
Indiana Acquisitions | Transaction 3 | ALFs
Real Estate Properties [Line Items]
Number of facilities owned	4
Indiana Acquisitions | Transaction 3 | Independent Living Facilities
Real Estate Properties [Line Items]
Number of facilities owned	6
Indiana Acquisitions | Transaction 3 | Land
Real Estate Properties [Line Items]
Cash paid for acquisition		16.1
Indiana Acquisitions | Transaction 3 | Buildings and site improvements
Real Estate Properties [Line Items]
Cash paid for acquisition		189.2
Indiana Acquisitions | Transaction 3 | Furniture and fixtures
Real Estate Properties [Line Items]
Cash paid for acquisition		14.4
Indiana Acquisitions | Transaction 4
Real Estate Properties [Line Items]
Number of beds			167
Total purchase price			9.5
Purchase price allocated		9.5
Indiana Acquisitions | Transaction 4 | SNF's
Real Estate Properties [Line Items]
Number of facilities owned			2
Indiana Acquisitions | Transaction 4 | Land
Real Estate Properties [Line Items]
Purchase price allocated		0.6
Indiana Acquisitions | Transaction 4 | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price allocated		8
Indiana Acquisitions | Transaction 4 | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price allocated		$0.90

PROPERTIES_2012_Acquisitions_M

PROPERTIES - 2012 Acquisitions - Michigan Acquisition (Narrative) (Detail 6) (USD $)	Dec. 31, 2014	Nov. 30, 2012
In Millions, unless otherwise specified	Facility	Facility
Real Estate Properties [Line Items]
Number of facilities owned	568
ALFs
Real Estate Properties [Line Items]
Number of facilities owned	23
Michigan Acquisition
Real Estate Properties [Line Items]
Purchase price allocated	20
Michigan Acquisition | ALFs
Real Estate Properties [Line Items]
Total purchase price		20
Number of facilities owned		1
Michigan Acquisition | ALFs | Michigan
Real Estate Properties [Line Items]
Number of beds		171
Michigan Acquisition | Land
Real Estate Properties [Line Items]
Purchase price allocated	0.4
Michigan Acquisition | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price allocated	18.9
Michigan Acquisition | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price allocated	0.7

PROPERTIES_2012_Acquisitions_T

PROPERTIES - 2012 Acquisitions - Texas Acquisition (Narrative) (Detail 7) (USD $)	Dec. 31, 2014	Dec. 31, 2012	Oct. 31, 2012
In Millions, unless otherwise specified	Facility		Bed
Real Estate Properties [Line Items]
Number of facilities owned	568
Acquisition related expenses	$3.90
Acquisition 2012
Real Estate Properties [Line Items]
Acquisition related expenses		0.9
SNF's
Real Estate Properties [Line Items]
Number of facilities owned	474
Texas Acquisition
Real Estate Properties [Line Items]
Number of beds			90
Total purchase price			2.7
Purchase price allocated	2.7
Texas Acquisition | SNF's
Real Estate Properties [Line Items]
Number of facilities owned			1
Texas Acquisition | Land
Real Estate Properties [Line Items]
Purchase price allocated	0.2
Texas Acquisition | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price allocated	2.2
Texas Acquisition | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price allocated	$0.30

PROPERTIES_Narrative_Detail_8

PROPERTIES (Narrative) (Detail 8) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
	Facility
Real Estate Properties [Line Items]
Number of properties closed	2
Provision for impairment on real estate properties	$3,660,000	$415,000	$272,000
SNF's
Real Estate Properties [Line Items]
Net book value	$1,200,000

ASSETS_HELD_FOR_SALE_Detail

ASSETS HELD FOR SALE (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013
	Facility		Facility
Number Of Properties
Beginning Balance	4	[1]	3	[2]
Properties sold	-3	[3]
Properties added	3		1
Ending balance	4	[1]	4	[1]
Net Book Value
Beginning Balance	$1,356	[1]	$1,020	[2]
Properties sold	-686	[3]
Properties added	12,122		336
Ending Balance	$12,792	[1]	$1,356	[1]
[1]	Includes one parcel of land and three facilities.
[2]	Includes one parcel of land and two facilities.
[3]	In 2014, we sold these facilities for approximately $2.8 million in net proceeds recognizing a gain on sale of approximately $2.0 million.

ASSETS_HELD_FOR_SALE_Detail_Te

ASSETS HELD FOR SALE (Detail Textuals) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
	Facility	Parcel	Parcel
	Parcel	Facility	Facility
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
Number of parcel of land held-for-sale	1	1	1
Number of facilities held for sale	3	3	2
Net proceeds from sale of facilities held for sale	$2.80
Gain from sale of facilities	$2

DIRECT_FINANCING_LEASES_Detail

DIRECT FINANCING LEASES (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Lease	Lease
Leases, Capital [Abstract]
Minimum lease payments receivable	$4,244,067	$4,291,067
Estimated residual values
Less unearned income	-3,704,835	-3,761,622
Net investment in direct financing leases	$539,232	$529,445
Properties subject to direct financing leases	56	56

DIRECT_FINANCING_LEASES_Detail1

DIRECT FINANCING LEASES (Details 1) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Leases, Capital [Abstract]
Year 1	$47,000
Year 2	47,032
Year 3	47,482
Year 4	48,669
Year 5	$49,886

DIRECT_FINANCING_LEASES_Narrat

DIRECT FINANCING LEASES (Narrative) (Detail) (USD $)	1 Months Ended
In Millions, unless otherwise specified	Nov. 27, 2013	Dec. 31, 2014
	Lease	Facility
	Bed	State
	Facility
	State
Capital Leased Assets [Line Items]
Number of facilities		568
Number of states		38
Ark Holding Company Inc
Capital Leased Assets [Line Items]
Cash paid for acquisition	$529
Number of lease	4
Lease term	50 years
Interest on lease per annum	10.60%
Number of facilities	56
Number of licensed beds	5,623
Number of states	12
Annual incremental rate beginning in year five through the term of the lease	2.50%
Ark Holding Company Inc | Southeast
Capital Leased Assets [Line Items]
Number of facilities	39
Ark Holding Company Inc | Northwest
Capital Leased Assets [Line Items]
Number of facilities	7
Ark Holding Company Inc | Texas
Capital Leased Assets [Line Items]
Number of facilities	9
Ark Holding Company Inc | Indiana
Capital Leased Assets [Line Items]
Number of facilities	1
SNF's | Ark Holding Company Inc | Direct financing leases
Capital Leased Assets [Line Items]
Number of facilities	55
ALFs | Ark Holding Company Inc
Capital Leased Assets [Line Items]
Number of facilities	1

MORTGAGE_NOTES_RECEIVABLE_Deta

MORTGAGE NOTES RECEIVABLE (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable	$648,079	[1]	$241,515	[1]
Number of mortgage loans	13
Mortgage note due 2014
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable			5,000
Mortgage loans on real estate, interest rate	11.00%
Mortgage note due 2021; interest at 12.50%
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable			5,574
Mortgage loans on real estate, interest rate	12.50%
Mortgage note due 2021; interest at 11.00%
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable			91,123
Mortgage loans on real estate, interest rate	11.00%
Mortgage note due 2021; interest at 10.00%
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable			913
Mortgage loans on real estate, interest rate	10.00%
Mortgage note due 2021: interest at 10.25%
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable	1,326
Mortgage loans on real estate, interest rate	10.25%
Mortgage note due 2022; interest at 12.50%
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable			5,310
Mortgage loans on real estate, interest rate	12.50%
Four Mortgage notes due 2022; interest at 12.00%
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable	7,395		7,313
Mortgage loans on real estate, interest rate	12.00%
Number of mortgage loans	4
Mortgage note due 2023; interest at 11.00%
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable	69,928		69,928
Mortgage loans on real estate, interest rate	11.00%
Mortgage note due 2023; interest at 12.50%
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable			7,782
Mortgage loans on real estate, interest rate	12.50%
Mortgage note due 2023; interest at 12.50%
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable			6,175
Mortgage loans on real estate, interest rate	12.50%
Mortgage note due 2024; interest at 9.50%
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable	112,500
Mortgage loans on real estate, interest rate	9.50%
Mortgage notes due 2029; interest at 9.00%
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable	414,550
Mortgage loans on real estate, interest rate	9.00%
Mortgage loans on real estate, monthly payment	90,000
Mortgage note due 2030; interest at 10.82%
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable	15,880		15,897
Mortgage loans on real estate, interest rate	10.82%
Four Mortgage notes due 2046; interest at 12.00%
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable	$26,500		$26,500
Mortgage loans on real estate, interest rate	12.00%
Number of mortgage loans	4
[1]	As of December 31, 2013 and 2014 we have no allowance for loan loss for any of our mortgages.

MORTGAGE_NOTES_RECEIVABLE_Narr

MORTGAGE NOTES RECEIVABLE (Narrative) (Detail) (USD $)

12 Months Ended

1 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2014

Dec. 31, 2010

Nov. 30, 2012

Jan. 17, 2014

Jul. 01, 2014

Oct. 02, 2013

Oct. 31, 2012

Entity

Bed

Bed

Bed

Facility

Bed

Facility

State

Facility

Bed

Facility

Loan

Mortgage Loans on Real Estate [Line Items]

Number of mortgage loans

13

Number of facilities under fixed rate mortgage loan

55

Number of states

38

Number of mortgage notes receivable independent operating companies

5

Mortgage notes receivable

$648,079,000

[1]

$241,515,000

[1]

Payment of mortgage loans

529,548,000

3,378,000

11,969,000

Collection of mortgage principal

122,984,098,000

484,706,000

12,021,332,000

Number of facilities owned

568

Placement of mortgage loans

529,547,836,000

3,378,357,000

11,967,892,000

Effective yield interest receivables

6,232,000

5,333,000

Effective yield interest receivables wrote off

2,000,000

Mortgage Loans

Mortgage Loans on Real Estate [Line Items]

Number of states

5

Effective yield interest receivables

2,000,000

Effective yield interest receivables wrote off

2,000,000

SNF's

Mortgage Loans on Real Estate [Line Items]

Number of facilities under fixed rate mortgage loan

53

Number of facilities owned

474

Retired Mortgage Loans Mortgage Facility

Mortgage Loans on Real Estate [Line Items]

Mortgage notes receivable

117,000,000

Number of facilities owned

17

ALFs

Mortgage Loans on Real Estate [Line Items]

Number of facilities under fixed rate mortgage loan

2

Number of facilities owned

23

Texas | SNF's

Mortgage Loans on Real Estate [Line Items]

Number of beds

125

Number of facilities owned

1

Michigan | Mortgage Loans

Mortgage Loans on Real Estate [Line Items]

Number of beds

3,430

Mortgage loans on real estate, interest rate

9.00%

Number of facilities owned

31

Number of additional facilities for mortgage financing

14

Annual incremental interest rate

0.23%

Placement of mortgage loans

415,000,000

Description of cash interest rate

The new loan bears an initial annual cash interest rate of 9.0% and increases by 0.225% per year (e.g., beginning in year 2 the interest rate will be 9.225%, in year 3 the rate will be 9.45%, etc.).

Florida | ALFs

Mortgage Loans on Real Estate [Line Items]

Number of beds

97

Pennsylvania | SNF's | Mortgage Loans

Mortgage Loans on Real Estate [Line Items]

Number of beds

7

Ohio | SNF's | Mortgage Loans

Mortgage Loans on Real Estate [Line Items]

Number of beds

2

Mortgage note due 2014 | Texas

Mortgage Loans on Real Estate [Line Items]

Payment of mortgage loans

5,000,000

Mortgage Note due 2021

Mortgage Loans on Real Estate [Line Items]

Mortgage notes receivable

1,300,000

3,500,000

Mortgage loans on real estate, interest rate

10.00%

Annual incremental interest rate

2.50%

Mortgage Note due 2021 | First Mortgage | Florida | SNF's

Mortgage Loans on Real Estate [Line Items]

Number of facilities owned

2

Mortgage note due 2022, interest rate 12%

Mortgage Loans on Real Estate [Line Items]

Mortgage notes receivable

7,400,000

Mortgage loans on real estate, interest rate

12.00%

Mortgage note due 2030 | First Mortgage | SNF's

Mortgage Loans on Real Estate [Line Items]

Number of facilities owned

3

Mortgage note due 2030 | First Mortgage | Florida

Mortgage Loans on Real Estate [Line Items]

Mortgage notes receivable

15,900,000

Number of beds

240

Mortgage loans on real estate, interest rate

10.00%

Annual incremental interest rate

2.00%

Mortgage Notes due 2046 | First Mortgage | Michigan

Mortgage Loans on Real Estate [Line Items]

Mortgage notes receivable

1,500,000

Mortgage loans on real estate, interest rate

12.00%

Mortgage loans on real estate, increase interest rate

13.50%

Mortgage Notes due 2046 | First Mortgage | Michigan | SNF's

Mortgage Loans on Real Estate [Line Items]

Number of beds

60

Mortgage Notes Due 2024 | Mortgage Loans

Mortgage Loans on Real Estate [Line Items]

Mortgage notes receivable

$112,500,000

Number of beds

798

Mortgage loans on real estate, interest rate

9.50%

Mortgage Notes Due 2024 | SNF's | Mortgage Loans

Mortgage Loans on Real Estate [Line Items]

Number of facilities owned

7

Mortgage Notes Due 2024 | ALFs | Mortgage Loans

Mortgage Loans on Real Estate [Line Items]

Number of facilities owned

2

[1]

As of December 31, 2013 and 2014 we have no allowance for loan loss for any of our mortgages.

MORTGAGE_NOTES_RECEIVABLE_Narr1

MORTGAGE NOTES RECEIVABLE (Narrative) (Detail 1) (USD $)	1 Months Ended
In Thousands, unless otherwise specified	Nov. 30, 2012	Dec. 31, 2014		Dec. 31, 2013		Oct. 31, 2011
		Facility
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable		$648,079	[1]	$241,515	[1]
Number of facilities owned		568
SNF's
Mortgage Loans on Real Estate [Line Items]
Number of facilities owned		474
Mortgage Notes due 2046 | First Mortgage | Michigan
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable	1,500
Mortgage loans on real estate, interest rate	12.00%
Mortgage Notes due 2046 | First Mortgage | Maryland
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable						25,000
Mortgage Notes due 2046 | First Mortgage | SNF's | Michigan
Mortgage Loans on Real Estate [Line Items]
Number of beds	60
Mortgage Notes due 2046 | First Mortgage | SNF's | Maryland
Mortgage Loans on Real Estate [Line Items]
Number of beds						352
Number of facilities owned						3
Mortgage note due 2023 | Maryland
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable		$69,900
Mortgage loans on real estate, interest rate		11.00%
Mortgage loans on real estate for seven year interest rate		13.75%
Number of facilities owned		7
[1]	As of December 31, 2013 and 2014 we have no allowance for loan loss for any of our mortgages.

OTHER_INVESTMENTS_Detail

OTHER INVESTMENTS (Detail) (USD $)	Dec. 31, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Schedule of Investments [Line Items]
Notes receivable, gross	$48,952	[1]	$48,298	[1]
Allowance for loss on notes receivable			-1,977
Notes receivable, net	48,952		46,321
Other			2,400
Marketable securities			4,333
Total other investments	48,952		53,054
Other investment note due 2015
Schedule of Investments [Line Items]
Notes receivable, gross	141		2,318
Other investment notes due 2021 - 2023
Schedule of Investments [Line Items]
Notes receivable, gross	16,182		13,427
Other investment note due 2014
Schedule of Investments [Line Items]
Notes receivable, gross			62
$31.5 million other investment note due 2017
Schedule of Investments [Line Items]
Notes receivable, gross	23,500		23,750
$2.5 million other investment note due 2014
Schedule of Investments [Line Items]
Notes receivable, gross	1,640		546
$6.0 million other investment note due 2015
Schedule of Investments [Line Items]
Notes receivable, gross	5,439		5,439
$1.3 million other investment note due 2017
Schedule of Investments [Line Items]
Notes receivable, gross	1,300		1,300
$1.5 million other investment note due 2014 - one year promissory note
Schedule of Investments [Line Items]
Notes receivable, gross			1,456
$0.9 million other investment note due 2015
Schedule of Investments [Line Items]
Notes receivable, gross	$750
[1]	These notes bear interest at a weighted average rate of approximately 10% annually as of December 31, 2014.

OTHER_INVESTMENTS_Narrative_De

OTHER INVESTMENTS (Narrative) (Detail) (USD $)	1 Months Ended	12 Months Ended		1 Months Ended
	Aug. 20, 2014	Dec. 31, 2014		Feb. 28, 2014	Nov. 30, 2013	Oct. 31, 2013	Dec. 31, 2013		Nov. 30, 2012
Schedule of Investments [Line Items]
Notes receivable, gross		$48,952,000	[1]				$48,298,000	[1]
Non-convertible redeemable preferred stock
Schedule of Investments [Line Items]
Liquidation preference	4,900,000
Dividend rate	7.00%
Proceeds from the redemption of preferred shares	5,000,000
Gain on other investment	600,000
Other investment note due 2015
Schedule of Investments [Line Items]
Write off loan amount		2,000,000
Notes receivable, gross		141,000					2,318,000
$31.5 million other investment note due 2017
Schedule of Investments [Line Items]
Percentage of interest rate received				10.00%
Additional loan drawn interest rate				10.50%
Amount of additional loan drawn				3,500,000
Notes receivable, gross		23,500,000					23,750,000
Notes receivable term				5 years
Other investment notes due 2021 - 2023
Schedule of Investments [Line Items]
Notes receivable, gross		16,182,000					13,427,000
Other investment notes due 2021 - 2023 | Capital renovation loans
Schedule of Investments [Line Items]
Number of loans		17
Percentage of interest rate received		10.00%					10.00%
Escalators rate of interest per year		2.50%
Maximum drawing capacity of loan		22,700,000
Other investment note due 2014
Schedule of Investments [Line Items]
Notes receivable, gross							62,000
$2.5 million other investment note due 2014
Schedule of Investments [Line Items]
Notes receivable, gross		1,640,000					546,000
$6.0 million other investment note due 2015
Schedule of Investments [Line Items]
Notes receivable, gross		5,439,000					5,439,000
$6.0 million other investment note due 2015 | Working capital note
Schedule of Investments [Line Items]
Percentage of interest rate received		10.00%							10.00%
Amount of additional loan drawn		6,000,000							4,000,000
$1.3 million other investment note due 2017
Schedule of Investments [Line Items]
Notes receivable, gross		1,300,000					1,300,000
$1.5 million other investment note due 2014 - one year promissory note
Schedule of Investments [Line Items]
Percentage of interest rate received					8.95%
Amount of additional loan drawn					1,500,000
Notes receivable, gross							1,456,000
Notes receivable term					1 year
Other Investment
Schedule of Investments [Line Items]
Percentage of interest rate received						9.50%
Amount of additional loan drawn						900,000
Proceeds from loan						1,500,000
Other Investment | Construction of New Facilities
Schedule of Investments [Line Items]
Amount of additional loan drawn						$2,400,000
[1]	These notes bear interest at a weighted average rate of approximately 10% annually as of December 31, 2014.

CONCENTRATION_OF_RISK_Narrativ

CONCENTRATION OF RISK (Narrative) (Detail) (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
	Facility				Facility				Facility	Facility
	State								State
	Operator								Operator
Concentration Risk [Line Items]
Number of facilities owned	568								568
Number of states	38								38
Number of operators	50								50
Gross investment in facilities, net of impairments and before reserve for uncollectible loans	$4,400,000,000								$4,400,000,000
Percentage share of real estate investments related to long-term care facilities	99.00%								99.00%
Number of available for sale facilities	5				3				5	3
Number of facilities under fixed rate mortgage loan	55								55
Miscellaneous investments, net	48,952,000				53,054,000				48,952,000	53,054,000
Concentration percent of operated facilities for separate disclosure	10.00%								10.00%
Concentration number of operated facilities	1								1
Revenues from operations	131,321,000	130,665,000	121,800,000	121,001,000	111,137,000	103,301,000	102,515,000	101,761,000	504,787,000	418,714,000	350,460,000
Revenues from operations, percentage									10.00%
Florida
Concentration Risk [Line Items]
Concentration percent by state	14.00%								14.00%
Ohio
Concentration Risk [Line Items]
Concentration percent by state	9.00%								9.00%
Michigan
Concentration Risk [Line Items]
Concentration percent by state	10.00%								10.00%
Genesis Healthcare
Concentration Risk [Line Items]
Revenues from operations									55,200,000
Revenues from operations, percentage									11.00%
New Ark Investment Inc
Concentration Risk [Line Items]
Revenues from operations									$58,600,000
Revenues from operations, percentage									12.00%
Operated, concentration percent	13.00%								13.00%
SNF's
Concentration Risk [Line Items]
Number of facilities owned	474								474
Number of facilities under fixed rate mortgage loan	53								53
ALFs
Concentration Risk [Line Items]
Number of facilities owned	23								23
Number of facilities under fixed rate mortgage loan	2								2
Specialty facilities
Concentration Risk [Line Items]
Number of facilities owned	11								11

LEASE_AND_MORTGAGE_DEPOSITS_Na

LEASE AND MORTGAGE DEPOSITS (Narrative) (Detail) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014
Security Deposits And Letters Of Credit [Line Items]
Liquidity deposits	5.8
Letters of credit outstanding	60.2
Minimum
Security Deposits And Letters Of Credit [Line Items]
Period specified for rental and mortgage interest	3 months
Maximum
Security Deposits And Letters Of Credit [Line Items]
Period specified for rental and mortgage interest	6 months

BORROWING_ARRANGEMENTS_Longter

BORROWING ARRANGEMENTS - Long-term borrowings (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Feb. 09, 2010	Mar. 11, 2014	Mar. 19, 2012	Mar. 31, 2014	Sep. 11, 2014
Secured borrowings:
HUD debt	$251,454		$298,531
Unsecured borrowings:
Revolving line of credit	85,000		326,000
Term loan	200,000		200,000
Revolving line of credit including term loan	285,000		526,000
Totals - net	2,378,503		2,024,418
2020 Notes
Unsecured borrowings:
Senior notes outstanding	200,000
2022 Notes
Unsecured borrowings:
Senior notes outstanding	575,000
2024 Notes
Unsecured borrowings:
Senior notes outstanding	400,000
2024 notes
Unsecured borrowings:
Senior notes outstanding	400,000
2025 notes
Unsecured borrowings:
Senior notes outstanding	250,000
Secured borrowings | HUD mortgages assumed June 2010
Debt Instrument [Line Items]
Maturity	2040 - 2045	[1]
Current Rate	4.85%	[1]
Secured borrowings:
Long-term borrowing amount	126,319	[1]	128,641	[1]
Secured borrowings | HUD mortgages assumed October 2011
Debt Instrument [Line Items]
Maturity	2036	[1]
Current Rate	4.91%	[1]
Secured borrowings:
Long-term borrowing amount	26,658	[1]	31,145	[1]
Secured borrowings | HUD mortgages assumed December 2011
Debt Instrument [Line Items]
Maturity	2044	[1],[2]
Current Rate	3.06%	[1],[2]
Secured borrowings:
Long-term borrowing amount	57,416	[1],[2]	58,592	[1],[2]
Secured borrowings | HUD mortgages assumed December 2012
Debt Instrument [Line Items]
Maturity	2040 - 2045	[1]
Current Rate	4.64%	[1]
Secured borrowings:
Long-term borrowing amount	41,061	[1]	80,153	[1]
Unsecured borrowings
Unsecured borrowings:
Unsecured borrowings	1,845,747		1,195,892
(Discount) premium - net	-3,698		3,995
Total unsecured borrowings	2,127,049		1,725,887
Unsecured borrowings | Revolving Credit Facility
Debt Instrument [Line Items]
Maturity	2018
Current Rate	1.72%
Unsecured borrowings:
Revolving line of credit	85,000		326,000
Unsecured borrowings | Term loan
Debt Instrument [Line Items]
Maturity	2019
Current Rate	1.67%
Unsecured borrowings:
Term loan	200,000		200,000
Unsecured borrowings | 2020 Notes
Debt Instrument [Line Items]
Maturity	2020
Current Rate	7.50%				7.50%
Unsecured borrowings:
Senior notes outstanding	200,000		200,000		200,000
Unsecured borrowings | 2022 Notes
Debt Instrument [Line Items]
Maturity	2022
Current Rate	6.75%
Unsecured borrowings:
Senior notes outstanding	575,000		575,000
Unsecured borrowings | 2024 Notes
Debt Instrument [Line Items]
Maturity	2024
Current Rate	5.88%					4.95%	5.88%
Unsecured borrowings:
Senior notes outstanding	400,000		400,000			400,000	400,000
Unsecured borrowings | 2024 notes
Debt Instrument [Line Items]
Maturity	2024
Current Rate	4.95%							4.95%
Unsecured borrowings:
Senior notes outstanding	400,000
Unsecured borrowings | 2025 notes
Debt Instrument [Line Items]
Maturity	2025
Current Rate	4.50%								4.50%
Unsecured borrowings:
Senior notes outstanding	250,000								250,000
Unsecured borrowings | Subordinated debt
Debt Instrument [Line Items]
Maturity	2021
Current Rate	9.00%
Unsecured borrowings:
Subordinated debt	$20,747		$20,892
[1]	Reflects the weighted average interest rate on the mortgages.
[2]	The debt was refinanced in March 2013.

BORROWING_ARRANGEMENTS_Princip

BORROWING ARRANGEMENTS - Principal payments (Detail 1) (Senior notes, USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Senior notes
Borrowing Arrangements [Line Items]
2015	$4,565
2016	4,768
2017	4,981
2018	90,202
2019	205,435
Thereafter	2,057,930
Totals	$2,367,881

BORROWING_ARRANGEMENTS_Refinan

BORROWING ARRANGEMENTS - Refinancing related costs (Detail 2) (USD $)	12 Months Ended						3 Months Ended
	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012		Jun. 30, 2012
							HUD
Financing Activities and Borrowing Arrangements [Line Items]
Write off of deferred finance cost due to refinancing	$1,180,000	[1],[2],[3]	($11,278,000)	[1],[2],[3]	$3,024,000	[1],[2],[3]
Prepayment and other costs associated with refinancing	1,861,000	[4]	166,000	[4]	4,896,000	[4]
Total debt extinguishment costs (gain)	3,041,000		-11,112,000		7,920,000
HUD Mortgage
Financing Activities and Borrowing Arrangements [Line Items]
Write off of deferred finance cost due to refinancing			11,300,000
Prepayment and other costs associated with refinancing	1,900,000		200,000
Gain from write-off of unamortized premium on the HUD loans	3,500,000						1,700,000
Number of HUD loans paid off							4
Number of HUD facilities	5		11
7% 2016 Notes
Financing Activities and Borrowing Arrangements [Line Items]
Write off of deferred finance cost due to refinancing					2,200,000
Prepayment and other costs associated with refinancing					4,900,000
Notes issued, interest rate					7.00%
Redemption of 7% 2016 notes					175,000,000
2011 Credit Facility
Financing Activities and Borrowing Arrangements [Line Items]
Write off of deferred finance cost due to refinancing					2,500,000
Line of credit facility terminated					475,000,000
2012 Credit Facility
Financing Activities and Borrowing Arrangements [Line Items]
Write off of deferred finance cost due to refinancing	2,600,000
Term Loan Facility 2013
Financing Activities and Borrowing Arrangements [Line Items]
Write off of deferred finance cost due to refinancing	$2,000,000
[1]	In 2013, we recorded an $11.3 million interest refinancing gain associated with the write-off of the unamortized premium for debt assumed on 11 HUD mortgage loans that we paid off in May 2013.
[2]	In 2012, we wrote-off: (a) $2.2 million deferred financing costs associated with the tender offer and redemption of our $175 million 7% 2016 Notes; and (b) $2.5 million deferred financing costs associated with the termination of our $475 million 2011 Credit Facility. These costs were offset by a $1.7 million gain resulting from the write-off of the unamortized premium on the four HUD loans that were paid off in the second quarter of 2012.
[3]	In 2014, we recorded:(a) $2.6 million write-off of deferred financing costs associated with the termination of the 2012 Credit Facilities, (b) $2.0 million write-off of deferred financing costs associated with the termination of our 2013 Term Loan Facility offset by (c) $3.5 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in September and December 2014.
[4]	In 2014, we made prepayment penalties of $1.9 million associated with five HUD mortgage loans that we paid off in September and October 2014. In 2013, we made prepayment penalties of $0.2 million associated with 11 HUD mortgage loans that we paid off in May 2013. In 2012, we incurred $4.9 million of prepayment penalties and other costs associated with the tender offer and redemption of our $175 million 7% 2016 Notes.

BORROWING_ARRANGEMENTS_Secured

BORROWING ARRANGEMENTS - Secured Borrowings (Narrative) (Detail) (USD $)

12 Months Ended

1 Months Ended

3 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

31-May-13

Jun. 30, 2010

Oct. 31, 2014

Oct. 31, 2011

Mar. 26, 2013

Sep. 30, 2014

Dec. 31, 2012

Mortgage

Facility

HUD

Facility

Facility

HUD

Borrowing Arrangements [Line Items]

Write-offs associated with deferred costs

$1,180,000

[1],[2],[3]

($11,278,000)

[1],[2],[3]

$3,024,000

[1],[2],[3]

Prepayment fee

1,861,000

[4]

166,000

[4]

4,896,000

[4]

2011 Credit Facility

Borrowing Arrangements [Line Items]

Write-offs associated with deferred costs

2,500,000

HUD Mortgage

Borrowing Arrangements [Line Items]

Write-offs associated with deferred costs

11,300,000

Prepayment fee

1,900,000

200,000

Secured borrowings | HUD mortgages assumed June 2010 (Paid-off)

Borrowing Arrangements [Line Items]

Payment to retire HUD mortgages

51,000,000

Number of HUD mortgages

11

Prepayment fee

200,000

Gain on retirement of HUD mortgages

11,100,000

Secured borrowings | HUD mortgages assumed June 2010

Borrowing Arrangements [Line Items]

Number of facilities

29

Assumption of debt for the acquisition

128,800,000

Assumed indebtedness, maturity date

January 2040 to January 2045

Fair value adjustment of HUD debt assumed

7,300,000

Unamortized premium

5,700,000

6,000,000

Amortization of the premium

400,000

400,000

400,000

Amortization of premium over the next five years

300,000

Secured borrowings | HUD mortgages assumed October 2011

Borrowing Arrangements [Line Items]

Payment to retire HUD mortgages

3,600,000

Number of HUD mortgages

1

Gain on extinguishment of the debt

27,000

Write-offs associated with deferred costs

200,000

Prepayment fee

200,000

Number of facilities

4

Assumption of debt for the acquisition

29,900,000

Assumed indebtedness, maturity date

March 2036 to September 2040

Fair value adjustment of HUD debt assumed

3,000,000

Unamortized premium

2,200,000

2,600,000

Amortization of the premium

200,000

200,000

200,000

Secured borrowings | HUD mortgages assumed October 2011 | Minimum

Borrowing Arrangements [Line Items]

Amortization of premium over the next five years

100,000

Secured borrowings | HUD mortgages assumed October 2011 | Maximum

Borrowing Arrangements [Line Items]

Amortization of premium over the next five years

200,000

Secured borrowings | HUD mortgages assumed December 2011

Borrowing Arrangements [Line Items]

Number of facilities

12

Unamortized premium

5,700,000

9,500,000

Amortization of the premium

500,000

600,000

100,000

Principal payment for mortgage

59,400,000

Amount of closing cost

700,000

Weighted average annual interest rate

5.55%

Reduction in annual interest rate for the refinanced debt

3.06%

Secured borrowings | HUD mortgages assumed December 2012

Borrowing Arrangements [Line Items]

Payment to retire HUD mortgages

36,100,000

Number of HUD mortgages

4

Gain on extinguishment of the debt

1,600,000

Write-offs associated with deferred costs

3,300,000

Prepayment fee

1,700,000

Assumption of debt for the acquisition

71,800,000

Assumed indebtedness, maturity date

April 2031 to February 2045

Fair value adjustment of HUD debt assumed

10,100,000

Amortization of premium over the next five years

$300,000

[1]

In 2013, we recorded an $11.3 million interest refinancing gain associated with the write-off of the unamortized premium for debt assumed on 11 HUD mortgage loans that we paid off in May 2013.

[2]

In 2012, we wrote-off: (a) $2.2 million deferred financing costs associated with the tender offer and redemption of our $175 million 7% 2016 Notes; and (b) $2.5 million deferred financing costs associated with the termination of our $475 million 2011 Credit Facility. These costs were offset by a $1.7 million gain resulting from the write-off of the unamortized premium on the four HUD loans that were paid off in the second quarter of 2012.

[3]

In 2014, we recorded:(a) $2.6 million write-off of deferred financing costs associated with the termination of the 2012 Credit Facilities, (b) $2.0 million write-off of deferred financing costs associated with the termination of our 2013 Term Loan Facility offset by (c) $3.5 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in September and December 2014.

[4]

In 2014, we made prepayment penalties of $1.9 million associated with five HUD mortgage loans that we paid off in September and October 2014. In 2013, we made prepayment penalties of $0.2 million associated with 11 HUD mortgage loans that we paid off in May 2013. In 2012, we incurred $4.9 million of prepayment penalties and other costs associated with the tender offer and redemption of our $175 million 7% 2016 Notes.

BORROWING_ARRANGEMENTS_Unsecur

BORROWING ARRANGEMENTS - Unsecured Borrowings (Narrative) (Detail 1) (USD $)	12 Months Ended						1 Months Ended
	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012		Jun. 27, 2014
Borrowing Arrangements [Line Items]
Revolving line of credit	$85,000,000		$326,000,000
Write Off Of Deferred Finance Cost Due To Refinancing	1,180,000	[1],[2],[3]	-11,278,000	[1],[2],[3]	3,024,000	[1],[2],[3]
2011 Credit Facility
Borrowing Arrangements [Line Items]
Write Off Of Deferred Finance Cost Due To Refinancing					2,500,000
Unsecured borrowings
Borrowing Arrangements [Line Items]
Credit facility, borrowing capacity							1,200,000,000
Unsecured borrowings | 2014 Revolving Credit Facility
Borrowing Arrangements [Line Items]
Credit facility, borrowing capacity							1,000,000,000
Revolving line of credit	85,000,000
Pricing of credit facility at LIBOR plus an applicable percentage	1.30%
Credit facility, description of variable rate basis	The Revolving Credit Facility is priced at LIBOR plus an applicable percentage (beginning at 130 basis points, with a range of 92.5 to 170 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings
Facility fee, basis spread on variable rate	0.25%
Facility fee, description of variable rate basis	facility fee based on the same ratings (initially 25 basis points, with a range of 12.5 to 30 basis points)
Debt maturity date	27-Jun-18
Unsecured borrowings | 2014 Revolving Credit Facility | Minimum
Borrowing Arrangements [Line Items]
Pricing of credit facility at LIBOR plus an applicable percentage	0.93%
Facility fee, basis spread on variable rate	0.13%
Unsecured borrowings | 2014 Revolving Credit Facility | Maximum
Borrowing Arrangements [Line Items]
Pricing of credit facility at LIBOR plus an applicable percentage	1.70%
Facility fee, basis spread on variable rate	0.30%
Unsecured borrowings | 2012 Revolving Credit Facility
Borrowing Arrangements [Line Items]
Credit facility, borrowing capacity							700,000,000
Unsecured borrowings | 2012 Credit Facilities
Borrowing Arrangements [Line Items]
Write Off Of Deferred Finance Cost Due To Refinancing							2,600,000
Unsecured borrowings | 2014 Term Loan Facility
Borrowing Arrangements [Line Items]
Pricing of credit facility at LIBOR plus an applicable percentage	1.50%
Credit facility, description of variable rate basis	The Term Loan Facility is also priced at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 195 basis points) based on our ratings from Standard & Poor's, Moody's and/or Fitch Ratings.
Debt maturity date	27-Jun-19
Unsecured borrowings | 2014 Term Loan Facility | Minimum
Borrowing Arrangements [Line Items]
Credit facility, borrowing capacity	200,000,000
Facility fee, basis spread on variable rate	1.00%
Unsecured borrowings | 2014 Term Loan Facility | Maximum
Borrowing Arrangements [Line Items]
Facility fee, basis spread on variable rate	1.95%
Unsecured borrowings | 2014 Credit Facilities
Borrowing Arrangements [Line Items]
Credit facility, potential borrowing capacity							550,000,000
Unsecured borrowings | 2014 Credit Facilities | Maximum
Borrowing Arrangements [Line Items]
Credit facility, potential borrowing capacity							$1,750,000,000
[1]	In 2013, we recorded an $11.3 million interest refinancing gain associated with the write-off of the unamortized premium for debt assumed on 11 HUD mortgage loans that we paid off in May 2013.
[2]	In 2012, we wrote-off: (a) $2.2 million deferred financing costs associated with the tender offer and redemption of our $175 million 7% 2016 Notes; and (b) $2.5 million deferred financing costs associated with the termination of our $475 million 2011 Credit Facility. These costs were offset by a $1.7 million gain resulting from the write-off of the unamortized premium on the four HUD loans that were paid off in the second quarter of 2012.
[3]	In 2014, we recorded:(a) $2.6 million write-off of deferred financing costs associated with the termination of the 2012 Credit Facilities, (b) $2.0 million write-off of deferred financing costs associated with the termination of our 2013 Term Loan Facility offset by (c) $3.5 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in September and December 2014.

BORROWING_ARRANGEMENTS_Unsecur1

BORROWING ARRANGEMENTS - Unsecured Borrowings - $200 Million Term Loan - 2013 (Narrative) (Detail 2) (USD $)	12 Months Ended						1 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012		Dec. 27, 2013	Jan. 31, 2014	Mar. 31, 2014
Borrowing Arrangements [Line Items]
Write-offs associated with deferred costs	$1,180	[1],[2],[3]	($11,278)	[1],[2],[3]	$3,024	[1],[2],[3]
Term Loan Facility 2013
Borrowing Arrangements [Line Items]
Write-offs associated with deferred costs	2,000
2024 notes
Borrowing Arrangements [Line Items]
Term loan	400,000
Unsecured borrowings | Term Loan Facility 2013
Borrowing Arrangements [Line Items]
Term loan							200,000	200,000
Pricing of credit facility at LIBOR plus an applicable percentage							1.75%
Debt maturity date							29-Feb-16
Write-offs associated with deferred costs	2,000
Credit facility, description of variable rate basis							The Term Loan Facility was priced at LIBOR plus an applicable percentage (beginning at 175 basis points, with a range of 110 to 230 basis points) based on the Company's ratings from Standard & Poor's, Moody's and/or Fitch Ratings.
Unsecured borrowings | Term Loan Facility 2013 | Minimum
Borrowing Arrangements [Line Items]
Pricing of credit facility at LIBOR plus an applicable percentage							1.10%
Unsecured borrowings | Term Loan Facility 2013 | Maximum
Borrowing Arrangements [Line Items]
Pricing of credit facility at LIBOR plus an applicable percentage							2.30%
Unsecured borrowings | 2024 notes
Borrowing Arrangements [Line Items]
Term loan	$400,000
Interest rate	4.95%								4.95%
[1]	In 2013, we recorded an $11.3 million interest refinancing gain associated with the write-off of the unamortized premium for debt assumed on 11 HUD mortgage loans that we paid off in May 2013.
[2]	In 2012, we wrote-off: (a) $2.2 million deferred financing costs associated with the tender offer and redemption of our $175 million 7% 2016 Notes; and (b) $2.5 million deferred financing costs associated with the termination of our $475 million 2011 Credit Facility. These costs were offset by a $1.7 million gain resulting from the write-off of the unamortized premium on the four HUD loans that were paid off in the second quarter of 2012.
[3]	In 2014, we recorded:(a) $2.6 million write-off of deferred financing costs associated with the termination of the 2012 Credit Facilities, (b) $2.0 million write-off of deferred financing costs associated with the termination of our 2013 Term Loan Facility offset by (c) $3.5 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in September and December 2014.

BORROWING_ARRANGEMENTS_Unsecur2

BORROWING ARRANGEMENTS - Unsecured Borrowings - $200 Million 7.5% Senior Notes due 2020 (Narrative) (Detail 3) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Feb. 09, 2010	Jun. 02, 2011	Oct. 20, 2010
In Thousands, unless otherwise specified	Facility
Borrowing Arrangements [Line Items]
Number of facilities owned	568
Total assets	$3,921,645	$3,462,216
Non-Guarantor Subsidiaries
Borrowing Arrangements [Line Items]
Total assets	377,439	388,053
7.50% Notes due 2020
Borrowing Arrangements [Line Items]
Long-term borrowing amount	200,000
2022 Notes
Borrowing Arrangements [Line Items]
Long-term borrowing amount	575,000
Unsecured borrowings | 7.50% Notes due 2020
Borrowing Arrangements [Line Items]
Long-term borrowing amount	200,000	200,000	200,000
Current Rate	7.50%		7.50%
Maximum percentage of redeemable notes	35.00%
Redemption price if redeemed in the first three years (in percent)	107.50%
Redemption price if the company undergoes change of control (in percent)	101.00%
Unsecured borrowings | 7.50% Notes due 2020 | Redemption during 12 months period beginning on February 15, 2015
Borrowing Arrangements [Line Items]
Redemption price percentage	103.75%
Unsecured borrowings | 7.50% Notes due 2020 | Redemption during 12 months period beginning on February 15, 2016
Borrowing Arrangements [Line Items]
Redemption price percentage	102.50%
Unsecured borrowings | 7.50% Notes due 2020 | Redemption during 12 months period beginning on February 15, 2017
Borrowing Arrangements [Line Items]
Redemption price percentage	101.25%
Unsecured borrowings | 7.50% Notes due 2020 | Redemption on or after February 15, 2018
Borrowing Arrangements [Line Items]
Redemption price percentage	100.00%
Unsecured borrowings | Exchange notes
Borrowing Arrangements [Line Items]
Notes issuable in exchange, face amount				575,000	200,000
Notes issuable in exchange, interest rate				6.75%	7.50%
Unsecured borrowings | 2022 Notes
Borrowing Arrangements [Line Items]
Long-term borrowing amount	575,000	575,000
Current Rate	6.75%
Maximum percentage of redeemable notes	35.00%
Redemption price if redeemed in the first three years (in percent)	106.75%
Redemption price if the company undergoes change of control (in percent)	101.00%
Unsecured borrowings | 2022 Notes | Non-Guarantor Subsidiaries
Borrowing Arrangements [Line Items]
Total assets	$377,400

BORROWING_ARRANGEMENTS_Unsecur3

BORROWING ARRANGEMENTS - Unsecured Borrowings - $575 Million 6.75% Senior Notes due 2022 (Narrative) (Detail 4) (USD $)	12 Months Ended	0 Months Ended
	Dec. 31, 2014	Oct. 04, 2010	Dec. 31, 2013	Nov. 23, 2010	Jun. 02, 2011	Oct. 20, 2010
Borrowing Arrangements [Line Items]
Total assets	$3,921,645,000		$3,462,216,000
Non-Guarantor Subsidiaries
Borrowing Arrangements [Line Items]
Total assets	377,439,000		388,053,000
2022 Notes
Borrowing Arrangements [Line Items]
Senior notes, principal amount	575,000,000
Unsecured borrowings | 2022 Notes
Borrowing Arrangements [Line Items]
Senior notes, principal amount	575,000,000		575,000,000
Current Rate	6.75%
Maximum percentage of redeemable notes	35.00%
Redemption price if redeemed in the first three years (in percent)	106.75%
Redemption price if the company undergoes change of control (in percent)	101.00%
Unsecured borrowings | 2022 Notes | Non-Guarantor Subsidiaries
Borrowing Arrangements [Line Items]
Total assets	377,400,000
Unsecured borrowings | 2022 Notes | Redemption during 12 month periods beginning on 15 th October 2015
Borrowing Arrangements [Line Items]
Redemption price percentage	103.38%
Unsecured borrowings | 2022 Notes | Redemption during 12 month periods beginning on 15 th october 2016
Borrowing Arrangements [Line Items]
Redemption price percentage	102.25%
Unsecured borrowings | 2022 Notes | Redemption during 12 month periods beginning on 15 th october 2017
Borrowing Arrangements [Line Items]
Redemption price percentage	101.13%
Unsecured borrowings | 2022 Notes | Redemption on or after 15 th october 2018
Borrowing Arrangements [Line Items]
Redemption price percentage	100.00%
Unsecured borrowings | Additional 2022 Notes
Borrowing Arrangements [Line Items]
Senior notes, principal amount				350,000,000
Current Rate				6.75%
Notes issued, issue price (in percent)	103.00%
Proceeds of issuance of notes payable	364,000,000
Unsecured borrowings | Senior notes due, 2014
Borrowing Arrangements [Line Items]
Senior notes, principal amount	310,000,000
Current Rate	7.00%
Unsecured borrowings | Exchange notes
Borrowing Arrangements [Line Items]
Notes issuable in exchange, face amount					575,000,000	200,000,000
Notes issuable in exchange, interest rate					6.75%	7.50%
Unsecured borrowings | Initial 2022 Notes
Borrowing Arrangements [Line Items]
Senior notes, principal amount		225,000,000
Current Rate		6.75%
Notes issued, issue price (in percent)		98.98%
Proceeds of issuance of notes payable		$223,000,000

BORROWING_ARRANGEMENTS_Narrati

BORROWING ARRANGEMENTS (Narrative) (Detail 5) (USD $)	12 Months Ended	0 Months Ended		12 Months Ended
	Dec. 31, 2013	Mar. 11, 2014	Sep. 11, 2014	Dec. 31, 2014	Mar. 19, 2012	Aug. 26, 2014	Aug. 15, 2012	Jun. 02, 2011	Oct. 20, 2010
Borrowing Arrangements [Line Items]
Total assets	$3,462,216,000			$3,921,645,000
Proceeds from Issuance of Long-term Debt	100,000,000
Non-Guarantor Subsidiaries
Borrowing Arrangements [Line Items]
Total assets	388,053,000			377,439,000
2024 Notes
Borrowing Arrangements [Line Items]
Senior notes, principal amount				400,000,000
2025 notes
Borrowing Arrangements [Line Items]
Senior notes, principal amount				250,000,000
Unsecured borrowings | 2024 Notes
Borrowing Arrangements [Line Items]
Senior notes, principal amount	400,000,000	400,000,000		400,000,000	400,000,000
Current Rate		4.95%		5.88%	5.88%
Redemption price percentage				100.00%
Maximum percentage of redeemable notes				35.00%
Redemption price if redeemed in the first three years (in percent)				105.88%
Redemption price if the company undergoes change of control (in percent)				101.00%
Notes issued, issue price (in percent)		98.58%
Debt instrument, issuance price, percentage of principal amount issued		98.58%
Proceeds from Issuance of Long-term Debt		394,300,000
Debt Instrument Paid Off		200,000,000
Unsecured borrowings | 2024 Notes | Non-Guarantor Subsidiaries
Borrowing Arrangements [Line Items]
Total assets				377,400,000
Notes issuable in exchange, face amount						400,000	400,000,000
Notes issuable in exchange, interest rate						4.95%	5.88%
Percentage of aggregate principal amount validly tendered		99.88%
Unsecured borrowings | 2024 Notes | Redemption during 12 month periods beginning on March 15, 2017
Borrowing Arrangements [Line Items]
Redemption price percentage				102.94%
Unsecured borrowings | 2024 Notes | Redemption during 12 month periods beginning on March 15, 2018
Borrowing Arrangements [Line Items]
Redemption price percentage				101.96%
Unsecured borrowings | 2024 Notes | Redemption during 12 month periods beginning on March 15, 2019
Borrowing Arrangements [Line Items]
Redemption price percentage				100.98%
Unsecured borrowings | 2024 Notes | Redemption on or after March 15, 2020
Borrowing Arrangements [Line Items]
Redemption price percentage				100.00%
Unsecured borrowings | Exchange notes
Borrowing Arrangements [Line Items]
Notes issuable in exchange, face amount								575,000,000	200,000,000
Notes issuable in exchange, interest rate								6.75%	7.50%
Unsecured borrowings | 2025 notes
Borrowing Arrangements [Line Items]
Senior notes, principal amount			250,000,000	250,000,000
Current Rate			4.50%	4.50%
Redemption price percentage				100.00%
Notes issued, issue price (in percent)				4.50%
Debt instrument, issuance price, percentage of principal amount issued			99.13%
Proceeds from Issuance of Long-term Debt			247,800,000
Principal amount of guarantee indebtedness for money borrowed				50,000,000
Unsecured borrowings | 2025 notes | Non-Guarantor Subsidiaries
Borrowing Arrangements [Line Items]
Total assets				$377,400,000

FINANCIAL_INSTRUMENTS_Detail

FINANCIAL INSTRUMENTS (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Assets:
Cash and cash equivalents	$4,489	$2,616	$1,711	$351
Restricted cash	29,076	31,759
Investment in direct financing leases	539,232	529,445
Mortgage notes receivable - net	648,079	241,515
Other investments - net	48,952	53,054
Liabilities:
Revolving line of credit	85,000	326,000
Term loan	200,000	200,000
HUD debt	251,454	298,531
Carrying Amount
Assets:
Cash and cash equivalents	4,489	2,616
Restricted cash	29,076	31,759
Investment in direct financing leases	539,232	529,445
Mortgage notes receivable - net	648,079	241,515
Other investments - net	48,952	53,054
Totals	1,269,828	858,389
Liabilities:
Revolving line of credit	85,000	326,000
Term loan	200,000	200,000
HUD debt	251,454	298,531
Subordinated debt	20,747	20,892
Totals	2,378,503	2,024,418
Carrying Amount | 7.50% Notes due 2020
Liabilities:
Notes Payable	198,235	197,890
Carrying Amount | 6.75% Notes due 2022
Liabilities:
Notes Payable	580,410	581,105
Carrying Amount | 5.875% Notes due 2024
Liabilities:
Notes Payable	400,000	400,000
Carrying Amount | 4.95% notes due 2024
Liabilities:
Notes Payable	394,768
Carrying Amount | 4.50% notes due 2025
Liabilities:
Notes Payable	247,889
Fair Value
Assets:
Cash and cash equivalents	4,489	2,616
Restricted cash	29,076	31,759
Investment in direct financing leases	539,232	529,445
Mortgage notes receivable - net	642,626	240,482
Other investments - net	49,513	50,124
Totals	1,264,936	854,426
Liabilities:
Revolving line of credit	85,000	326,000
Term loan	200,000	200,000
HUD debt	266,434	287,718
Subordinated debt	26,434	28,849
Totals	2,623,641	2,246,372
Fair Value | 7.50% Notes due 2020
Liabilities:
Notes Payable	264,269	256,852
Fair Value | 6.75% Notes due 2022
Liabilities:
Notes Payable	677,851	735,687
Fair Value | 5.875% Notes due 2024
Liabilities:
Notes Payable	449,242	411,266
Fair Value | 4.95% notes due 2024
Liabilities:
Notes Payable	410,358
Fair Value | 4.50% notes due 2025
Liabilities:
Notes Payable	$244,053

FINANCIAL_INSTRUMENTS_Parenthe

FINANCIAL INSTRUMENTS (Parentheticals) (Detail)	Dec. 31, 2014	Dec. 31, 2013
7.50% Notes due 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate	7.50%	7.50%
6.75% Notes due 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate	6.75%	6.75%
5.875% Notes due 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate	5.88%	5.88%
4.95% notes due 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate	4.95%
4.50% notes due 2025
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate	4.50%

TAXES_Narrative_Detail

TAXES (Narrative) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
	Subsidiary
	Shareholder
Income Tax Disclosure [Abstract]
Required dividend distribution as a percent of REIT taxable income	90.00%
Required dividend distribution by a REIT as a percent of net income from foreclosure property	90.00%
Required 75 percentage of gross income test from qualifying sources	75.00%
Required 95 percentage of gross income test from qualifying sources	95.00%
Required percentage of REIT qualifying assets	75.00%
Maximum ownership percentage of voting or value of any one security by REIT	10.00%
Maximum ownership percentage by REIT of either debt or equity securities of another company	5.00%
Maximum percentage of assets invested in one or more taxable REIT subsidiaries	25.00%
Minimum number of stockholders who own shares or interest in the REIT	100
Maximum percentage of interest in REIT that five or fewer individuals own directly or indirectly	50.00%
Minimum number of subsequent years the company may not be able to qualify as a REIT	4 years
Percentage of income subject to federal taxation	100.00%
Dividends paid	$258,501,000	$218,116,000	$182,190,000
Permitted ownership of a taxable REIT subsidiary ("TRS"), maximum percentage	100.00%
Number of taxable REIT subsidiaries	1
Net operating loss carry-forward	$1,000,000

RETIREMENT_ARRANGEMENTS_Narrat

RETIREMENT ARRANGEMENTS (Narrative) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Compensation Related Costs [Abstract]
Amounts charged to operations with respect to retirement arrangements	$300,000	$200,000	$200,000
Deferred stock units outstanding	$398,373	$40,566

STOCKHOLDERS_EQUITY_Narrative_

STOCKHOLDERS' EQUITY (Narrative) (Detail) (USD $)	12 Months Ended			21 Months Ended	30 Months Ended	0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014	Dec. 31, 2014	Oct. 07, 2013	Mar. 18, 2013	Jun. 19, 2012
Stockholders Equity Note [Line Items]
Issuance of common stock (in shares)		2,875,000
Stock issued	1,848,000	6,504,000	3,398,000
Net proceeds from issuance of common stock	$61,981,000	$278,373,000	$77,618,000
Dividend reinvestment plan (in shares)	2,084,000	1,930,000	5,063,000
250 Million Equity Shelf Program
Stockholders Equity Note [Line Items]
Future shares available to be issued				16,200,000
Stock issued	1,800,000			7,400,000
Issuance of common stock, average price per share	$34.33
Net proceeds from issuance of common stock	63,500,000			233,800,000
Sales price, equity distribution agreement							250,000,000
Managerial compensation from sales of shares, percent of gross sales price							2.00%
Commissions on sale of common stock	1,500,000			4,700,000
245 Million Equity Shelf Program
Stockholders Equity Note [Line Items]
Stock issued		1,000,000	2,600,000		3,600,000
Issuance of common stock, average price per share		$28.29	$24.10
Net proceeds from issuance of common stock		27,800,000	63,600,000		91,400,000
Sales price, equity distribution agreement							245,000,000
Commissions on sale of common stock		600,000	1,300,000		1,900,000
140 Million Equity Shelf Program
Stockholders Equity Note [Line Items]
Stock issued			759,000
Issuance of common stock, average price per share			$21.27
Net proceeds from issuance of common stock			16,100,000
Sales price, equity distribution agreement								140,000,000
Commissions on sale of common stock			300,000
Dividend Reinvestment and Common Stock Purchase Plan
Stockholders Equity Note [Line Items]
Stock issued	2,100,000	1,900,000	5,100,000
Net proceeds from issuance of common stock	71,500,000	55,800,000	111,900,000
2.875 Million Shares of Common Stock Offering
Stockholders Equity Note [Line Items]
Stock issued						2,875,000
Issuance of common stock, average price per share						$29.48
Net proceeds from issuance of common stock						$84,600,000

STOCKBASED_COMPENSATION_Detail

STOCK-BASED COMPENSATION - (Detail) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Number of Shares/Units
Non-vested	1,031,349
Weighted - Average Grant-Date Fair Value per Share
Non-vested	$17.25
Compensation Cost	$17.80
Restricted stock and RSUs
Number of Shares/Units
Non-vested	257,198		459,502		458,302
Granted	143,637		241,699		15,500
Vested	-90,901		-444,003		-14,300
Non-vested	309,934		257,198		459,502
Weighted - Average Grant-Date Fair Value per Share
Non-vested	$29.32		$22.33		$22.31
Granted	$30.70		$29.87		$20.29
Vested	$28.87		$22.38		$19.56
Non-vested	$30.08		$29.32		$22.33
Compensation Cost	$4.40	[1]	$7.20	[1]	$0.30	[1]
[1]	Total compensation cost to be recognized on the awards based on grant date fair value, which is based on the market price of the Company's common stock on the date of grant.

STOCKBASED_COMPENSATION_Detail1

STOCK-BASED COMPENSATION (Detail 1) (Performance restricted stock units, USD $)	12 Months Ended
	Dec. 31, 2014
Awards granted in January 1, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing Price on date of grant	$19.35
Dividend Yield	8.27%
Risk Free interest rate at time of grant, Minimum	0.03%
Risk Free interest rate at time of grant, Maximum	0.35%
Expected volatility, minimum	35.64%
Expected volatility, maximum	38.53%
Award granted in January 1, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing Price on date of grant	$23.85
Dividend Yield	4.24%
Risk Free interest rate at time of grant, Minimum	0.05%
Risk Free interest rate at time of grant, Maximum	0.43%
Expected volatility, minimum	15.56%
Expected volatility, maximum	23.83%
Awards granted in December 31, 2013 and January 1, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing Price on date of grant	$29.80
Dividend Yield	6.44%
Risk Free interest rate at time of grant, Minimum	0.04%
Risk Free interest rate at time of grant, Maximum	0.86%
Expected volatility, minimum	24.16%
Expected volatility, maximum	25.86%

STOCKBASED_COMPENSATION_Detail2

STOCK-BASED COMPENSATION (Detail 2) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Number of Shares/Units
Non-vested	1,031,349
Weighted - Average Grant-Date Fair Value per Share
Non-vested	$17.25
Compensation Cost	$17.80
Performance restricted stock units
Number of Shares/Units
Non-vested	1,038,024		372,735		372,735
Granted	309,168		665,289		124,244
Vested	-496,979	[1]		[2]	-124,244
Non-vested	850,213		1,038,024		372,735
Weighted - Average Grant-Date Fair Value per Share
Non-vested	$10.72		$11.36		$11.36
Granted	$11.46		$10.36		$9.61
Vested	$10.75	[1]		[2]	$9.61
Non-vested	$10.97		$10.72		$11.36
Compensation Cost	$3.50	[3]	$6.90	[3]	$1.20	[3]
[1]	In January 2014, the 124,244 PRSUs granted in January 2013 vested and were issued to the employees. The 372,735 PRSUs granted in 2011 vested 25% on March 31, June 30, September 30 and December 31, 2014.
[2]	Subsequent to December 31, 2013, the board of directors reviewed the performance measure for the 372,735 PRSUs granted in January 2011 and outstanding at December 31, 2012 as well as the 124,244 shares granted in January 2013 and determined the PRSUs were earned.
[3]	Total compensation cost to be recognized on the awards was based on grant date fair value or the modification date fair value.

STOCKBASED_COMPENSATION_Detail3

STOCK-BASED COMPENSATION (Detail 3) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares/Units	1,031,349
Grant Date Average Fair Value Per Unit/ Share	$17.25
Compensation Cost	$17.80
Unrecognized Compensation Cost	11.9
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2013
Shares/Units	213,741
Grant Date Average Fair Value Per Unit/ Share	$29.80
Compensation Cost	6.4
Weighted Average Period of Expense Recognition	36 months
Unrecognized Compensation Cost	4.2
Restricted Stock Units Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2014
Shares/Units	122,137
Grant Date Average Fair Value Per Unit/ Share	$29.80
Compensation Cost	3.6
Weighted Average Period of Expense Recognition	36 months
Unrecognized Compensation Cost	2.4
Performance Restricted Stock Units | 2015 Transition TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2013
Shares/Units	77,369
Grant Date Average Fair Value Per Unit/ Share	$7.48
Compensation Cost	0.6
Weighted Average Period of Expense Recognition	24 months
Unrecognized Compensation Cost	0.3
Performance Restricted Stock Units | 2016 Transition TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2013
Shares/Units	115,785
Grant Date Average Fair Value Per Unit/ Share	$8.67
Compensation Cost	1
Weighted Average Period of Expense Recognition	36 months
Unrecognized Compensation Cost	0.7
Performance Restricted Stock Units | 2015 Transition Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2013
Shares/Units	77,368
Grant Date Average Fair Value Per Unit/ Share	$13.06
Compensation Cost	1
Weighted Average Period of Expense Recognition	24 months
Unrecognized Compensation Cost	0.5
Performance Restricted Stock Units | 2016 Transition Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2013
Shares/Units	115,781
Grant Date Average Fair Value Per Unit/ Share	$14.25
Compensation Cost	1.7
Weighted Average Period of Expense Recognition	36 months
Unrecognized Compensation Cost	1.1
Performance Restricted Stock Units | 2016 TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2014
Shares/Units	154,584
Grant Date Average Fair Value Per Unit/ Share	$8.67
Compensation Cost	1.3
Weighted Average Period of Expense Recognition	48 months
Unrecognized Compensation Cost	1
Performance Restricted Stock Units | 2016 Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2014
Shares/Units	154,584
Grant Date Average Fair Value Per Unit/ Share	$14.25
Compensation Cost	2.2
Weighted Average Period of Expense Recognition	48 months
Unrecognized Compensation Cost	$1.70

STOCKBASED_COMPENSATION_Narrat

STOCK-BASED COMPENSATION (Narrative) (Detail)

12 Months Ended

1 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2014

Jan. 31, 2011

Jan. 31, 2014

Jan. 31, 2013

Jan. 31, 2012

Dec. 31, 2013

Dec. 31, 2011

Type_Award

Employee

Employee

Employee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares/Units

1,031,349

1,031,349

Number of types of share based awards

3

Performance restricted stock units

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock awards, vesting percent

25.00%

Stock granted

309,168

665,289

124,244

Shares of stock vested

496,979

[1]

[2]

124,244

Shares/Units

850,213

1,038,024

372,735

850,213

1,038,024

372,735

Performance restricted stock units | Multi-year Absolute TSR

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock granted, number of employees

6

Stock awards, vesting percent

25.00%

Stock granted

279,552

Performance restricted stock units | Multi-year Relative TSR

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock granted, number of employees

6

Stock awards, vesting percent

25.00%

Stock granted

93,183

Performance restricted stock units | Annual TSR

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock granted, number of employees

6

6

6

Stock granted

124,244

124,244

124,244

Shares forfeited

124,244

Shares of stock vested

124,244

124,244

Stock awards, vesting year

2011

Performance restricted stock units | 2014 TSR

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock awards, vesting date

31-Dec-14

Shares/Units

77,371

77,371

Stock awards, vesting year

2014

Vesting period, years

1 year

Performance restricted stock units | 2015 TSR

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock awards, vesting date

31-Dec-15

Shares/Units

77,369

77,369

Stock awards, vesting year

2015

Vesting period, years

2 years

Performance restricted stock units | 2016 TSR

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock awards, vesting date

31-Dec-16

31-Dec-16

Stock granted

154,584

Shares/Units

115,785

115,785

Stock awards, vesting year

2016

2016

Vesting period, years

3 years

3 years

Performance restricted stock units | 2014 Relative TSR

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock awards, vesting date

31-Dec-14

Shares/Units

77,371

77,371

Stock awards, vesting year

2014

Vesting period, years

1 year

Performance restricted stock units | 2015 Relative TSR

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock awards, vesting date

31-Dec-15

Shares/Units

77,368

77,368

Stock awards, vesting year

2015

Vesting period, years

2 years

Performance restricted stock units | 2016 Relative TSR

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock awards, vesting date

31-Dec-16

31-Dec-16

Stock granted

154,584

Shares/Units

115,781

115,781

Stock awards, vesting year

2016

2016

Vesting period, years

3 years

3 years

Restricted stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock granted, number of employees

6

Stock awards, vesting date

31-Dec-13

Stock granted

428,503

Shares of stock vested

428,503

Restricted Stock Units

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock granted, number of employees

6

6

Stock awards, vesting date

31-Dec-16

31-Dec-16

Stock granted

122,137

213,741

Shares/Units

213,741

213,741

Stock awards, vesting year

2016

Vesting period, years

3 years

[1]

In January 2014, the 124,244 PRSUs granted in January 2013 vested and were issued to the employees. The 372,735 PRSUs granted in 2011 vested 25% on March 31, June 30, September 30 and December 31, 2014.

[2]

Subsequent to December 31, 2013, the board of directors reviewed the performance measure for the 372,735 PRSUs granted in January 2011 and outstanding at December 31, 2012 as well as the 124,244 shares granted in January 2013 and determined the PRSUs were earned.

STOCKBASED_COMPENSATION_Narrat1

STOCK-BASED COMPENSATION (Narrative) (Detail 1) (USD $)	12 Months Ended			1 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jan. 31, 2014	Dec. 31, 2013	Jun. 30, 2013	Jan. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Value fo shares issued net of tax withholdings	$3.60	$5.80	$1.20
Employees, directors and consultants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common shares reserved for future issuance	2,646,977
2013 Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common shares reserved for future issuance						3,000,000
Performance restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vested and issued to employees				124,244
Performance restricted stock units | Board of directors | Subsequent event
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Review of performance measure for number of granted and outstanding share-based awards							61,769
Performance restricted stock units | Awards granted in January 1, 2011 | Vesting on March 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards, vesting percentage		25.00%
Performance restricted stock units | Awards granted in January 1, 2011 | Vesting on June 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards, vesting percentage					25.00%
Performance restricted stock units | Awards granted in January 1, 2011 | Vesting on September 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards, vesting percentage		25.00%
Performance restricted stock units | Awards granted in January 1, 2011 | Vesting on December 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards, vesting percentage		25.00%
Performance restricted stock units | Awards granted in January 1, 2011 | Board of directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Review of performance measure for number of granted and outstanding share-based awards		372,735			372,735
Performance restricted stock units | Award granted in January 1, 2013 | Board of directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Review of performance measure for number of granted and outstanding share-based awards		124,244			124,244

DIVIDENDS_Detail

DIVIDENDS (Detail) (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Dividends [Line Items]
Common dividends (in dollars per share)	$0.52	$0.51	$0.50	$0.49	$0.48	$0.47	$0.46	$0.45	$2.02	$1.86	$1.69
Ordinary income
Dividends [Line Items]
Common dividends (in dollars per share)									$1.83	$1.54	$0.88
Return of capital
Dividends [Line Items]
Common dividends (in dollars per share)									$0.19	$0.32	$0.81

DIVIDENDS_Narrative_Detail

DIVIDENDS (Narrative) (Detail) (USD $)	0 Months Ended		1 Months Ended	0 Months Ended
	Oct. 16, 2014	Jul. 15, 2014	Apr. 18, 2014	Jan. 15, 2014	Jan. 14, 2015
Dividends [Line Items]
Common stock dividend declared, per share	$0.52	$0.51	$0.50	$0.49
Increase in quarterly common dividend, per share	$0.01	$0.01	$0.01	$0.01
Dividends declared, date of declaration	16-Oct-14	15-Jul-14	18-Apr-14	15-Jan-14
Dividends declared, date of payment	17-Nov-14	15-Aug-14	15-May-14	17-Feb-14
Dividends declared, date of record	31-Oct-14	31-Jul-14	30-Apr-14	31-Jan-14
Subsequent event
Dividends [Line Items]
Common stock dividend declared, per share					$0.53
Increase in quarterly common dividend, per share					$0.01
Dividends declared, date of declaration					14-Jan-15
Dividends declared, date of payment					16-Feb-15
Dividends declared, date of record					2-Feb-15

SUMMARY_OF_QUARTERLY_RESULTS_U2

SUMMARY OF QUARTERLY RESULTS (UNAUDITED) (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Quarterly Financial Information Disclosure [Abstract]
Revenues	$131,321	$130,665	$121,800	$121,001	$111,137	$103,301	$102,515	$101,761	$504,787	$418,714	$350,460
Net income	56,990	61,713	46,817	55,829	47,206	38,137	49,058	38,120	221,349	172,521	120,698
Net income available to common stockholders	$56,990	$61,713	$46,817	$55,829	$47,206	$38,137	$49,058	$38,120	$221,349	$172,521	$120,698
Net income available to common per share:
Basic net income	$0.45	$0.48	$0.37	$0.45	$0.39	$0.32	$0.42	$0.34	$1.75	$1.47	$1.12
Diluted net income	$0.44	$0.48	$0.37	$0.45	$0.38	$0.32	$0.42	$0.34	$1.74	$1.46	$1.12
Cash dividends paid on common stock	$0.52	$0.51	$0.50	$0.49	$0.48	$0.47	$0.46	$0.45	$2.02	$1.86	$1.69

EARNINGS_PER_SHARE_Detail

EARNINGS PER SHARE (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Numerator:
Net income	$56,990	$61,713	$46,817	$55,829	$47,206	$38,137	$49,058	$38,120	$221,349	$172,521	$120,698
Numerator for net income available to common per share - basic and diluted	$56,990	$61,713	$46,817	$55,829	$47,206	$38,137	$49,058	$38,120	$221,349	$172,521	$120,698
Denominator:
Denominator for basic earnings per share									126,550	117,257	107,591
Effect of dilutive securities:
Common stock equivalents									744	843	420
Denominator for diluted earnings per share									127,294	118,100	108,011
Earnings per share - basic:
Net income - basic	$0.45	$0.48	$0.37	$0.45	$0.39	$0.32	$0.42	$0.34	$1.75	$1.47	$1.12
Earnings per share - diluted:
Net income - diluted	$0.44	$0.48	$0.37	$0.45	$0.38	$0.32	$0.42	$0.34	$1.74	$1.46	$1.12

CONSOLIDATING_FINANCIAL_STATEM2

CONSOLIDATING FINANCIAL STATEMENTS (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Real estate properties
Land and buildings	$3,223,785	$3,099,547
Less accumulated depreciation	-821,712	-707,410
Real estate properties - net	2,402,073	2,392,137
Investment in direct financing leases	539,232	529,445
Mortgage notes receivable	648,079	241,515
Real estate properties, total	3,589,384	3,163,097
Other investments	48,952	53,054
Total investments	3,638,336	3,216,151
Assets held for sale - net	12,792	1,356
Total investments	3,651,128	3,217,507
Cash and cash equivalents	4,489	2,616	1,711	351
Restricted cash	29,076	31,759
Accounts receivable - net	168,176	147,504
Investment in affiliates
Other assets	68,776	62,830
Total assets	3,921,645	3,462,216
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit	85,000	326,000
Term loan	200,000	200,000
Secured borrowings	251,454	298,531
Unsecured borrowings - net	1,842,049	1,199,887
Accrued expenses and other liabilities	141,815	137,695
Intercompany payable
Total liabilities	2,520,318	2,162,113
Stockholders' equity:
Common stock	12,761	12,353
Common stock - additional paid-in-capital	2,136,234	1,998,169
Cumulative net earnings	1,147,998	926,649
Cumulative dividends paid	-1,895,666	-1,637,068
Total stockholders' equity	1,401,327	1,300,103	1,011,329	878,484
Total liabilities and stockholders' equity	3,921,645	3,462,216
Issuer & Subsidiary Guarantors
Real estate properties
Land and buildings	2,834,498	2,712,652
Less accumulated depreciation	-754,517	-656,988
Real estate properties - net	2,079,981	2,055,664
Investment in direct financing leases	539,232	529,445
Mortgage notes receivable	648,079	241,515
Real estate properties, total	3,267,292	2,826,624
Other investments	48,952	53,054
Total investments	3,316,244	2,879,678
Assets held for sale - net	12,792	1,356
Total investments	3,329,036	2,881,034
Cash and cash equivalents	4,489	2,616
Restricted cash	7,016	8,812
Accounts receivable - net	160,789	141,704
Investment in affiliates	73,622	78,075
Other assets	42,876	39,997
Total assets	3,617,828	3,152,238
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit	85,000	326,000
Term loan	200,000	200,000
Secured borrowings		41,876
Unsecured borrowings - net	1,821,302	1,178,995
Accrued expenses and other liabilities	110,199	105,264
Intercompany payable
Total liabilities	2,216,501	1,852,135
Stockholders' equity:
Common stock	12,761	12,353
Common stock - additional paid-in-capital	2,136,234	1,998,169
Cumulative net earnings	1,147,998	926,649
Cumulative dividends paid	-1,895,666	-1,637,068
Total stockholders' equity	1,401,327	1,300,103
Total liabilities and stockholders' equity	3,617,828	3,152,238
Non - Guarantor Subsidiaries
Real estate properties
Land and buildings	389,287	386,895
Less accumulated depreciation	-67,195	-50,422
Real estate properties - net	322,092	336,473
Investment in direct financing leases
Mortgage notes receivable
Real estate properties, total	322,092	336,473
Other investments
Total investments	322,092	336,473
Assets held for sale - net
Total investments	322,092	336,473
Cash and cash equivalents
Restricted cash	22,060	22,947
Accounts receivable - net	7,387	5,800
Investment in affiliates
Other assets	25,900	22,833
Total assets	377,439	388,053
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit
Term loan
Secured borrowings	251,454	256,655
Unsecured borrowings - net	20,747	20,892
Accrued expenses and other liabilities	31,616	32,431
Intercompany payable	40,309	56,994
Total liabilities	344,126	366,972
Stockholders' equity:
Common stock
Common stock - additional paid-in-capital
Cumulative net earnings	33,313	21,081
Cumulative dividends paid
Total stockholders' equity	33,313	21,081
Total liabilities and stockholders' equity	377,439	388,053
Elimination Company
Real estate properties
Land and buildings
Less accumulated depreciation
Real estate properties - net
Investment in direct financing leases
Mortgage notes receivable
Real estate properties, total
Other investments
Total investments
Assets held for sale - net
Total investments
Cash and cash equivalents
Restricted cash
Accounts receivable - net
Investment in affiliates	-73,622	-78,075
Other assets
Total assets	-73,622	-78,075
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit
Term loan
Secured borrowings
Unsecured borrowings - net
Accrued expenses and other liabilities
Intercompany payable	-40,309	-56,994
Total liabilities	-40,309	-56,994
Stockholders' equity:
Common stock
Common stock - additional paid-in-capital
Cumulative net earnings	-33,313	-21,081
Cumulative dividends paid
Total stockholders' equity	-33,313	-21,081
Total liabilities and stockholders' equity	($73,622)	($78,075)

CONSOLIDATING_FINANCIAL_STATEM3

CONSOLIDATING FINANCIAL STATEMENTS (Detail 1) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenues
Rental income									$388,443	$375,135	$314,592
Income from direct financing leases									56,719	5,203
Mortgage interest income									53,007	29,351	30,446
Other investment income - net									6,618	9,025	5,422
Total operating revenues	131,321	130,665	121,800	121,001	111,137	103,301	102,515	101,761	504,787	418,714	350,460
Expenses
Depreciation and amortization									123,257	128,646	112,983
General and administrative									25,888	21,588	21,330
Acquisition costs									3,948	245	909
Impairment on real estate properties									3,660	415	272
Provision for uncollectible mortgages, notes and accounts receivable									2,723	2,141
Total operating expenses									159,476	153,035	135,494
Income before other income and expense									345,311	265,679	214,966
Other income (expense)
Interest income									44	41	29
Interest expense									-119,369	-100,381	-95,527
Interest - amortization of deferred financing costs									-4,459	-2,779	-2,649
Interest - refinancing (costs) gain									-3,041	11,112	-7,920
Equity in earnings
Total other expense									-126,825	-92,007	-106,067
Income before gain on assets sold									218,486	173,672	108,899
Gain (loss) on assets sold - net									2,863	-1,151	11,799
Net income available to common stockholders	56,990	61,713	46,817	55,829	47,206	38,137	49,058	38,120	221,349	172,521	120,698
Issuer & Subsidiary Guarantors
Revenues
Rental income									346,479	333,015	279,458
Income from direct financing leases									56,719	5,203
Mortgage interest income									53,007	29,351	30,446
Other investment income - net									6,618	9,025	5,422
Total operating revenues									462,823	376,594	315,326
Expenses
Depreciation and amortization									106,484	110,535	97,057
General and administrative									25,546	21,263	21,025
Acquisition costs									3,948	245	909
Impairment on real estate properties									3,660	415	272
Provision for uncollectible mortgages, notes and accounts receivable									2,723	2,141
Total operating expenses									142,361	134,599	119,263
Income before other income and expense									320,462	241,995	196,063
Other income (expense)
Interest income									19	17	7
Interest expense									-106,748	-87,240	-82,691
Interest - amortization of deferred financing costs									-4,438	-2,763	-2,649
Interest - refinancing (costs) gain									-3,041	11,112	-7,920
Equity in earnings									12,232	10,551	6,089
Total other expense									-101,976	-68,323	-87,164
Income before gain on assets sold									218,486	173,672	108,899
Gain (loss) on assets sold - net									2,863	-1,151	11,799
Net income available to common stockholders									221,349	172,521	120,698
Non - Guarantor Subsidiaries
Revenues
Rental income									41,964	42,120	35,134
Income from direct financing leases
Mortgage interest income											35,134
Other investment income - net
Total operating revenues									41,964	42,120	35,134
Expenses
Depreciation and amortization									16,773	18,111	15,926
General and administrative									342	325	305
Acquisition costs
Impairment on real estate properties
Provision for uncollectible mortgages, notes and accounts receivable
Total operating expenses									17,115	18,436	16,231
Income before other income and expense									24,849	23,684	18,903
Other income (expense)
Interest income									25	24	22
Interest expense									-12,621	-13,141	-12,836
Interest - amortization of deferred financing costs									-21	-16
Interest - refinancing (costs) gain
Equity in earnings
Total other expense									-12,617	-13,133	-12,814
Income before gain on assets sold									12,232	10,551	6,089
Gain (loss) on assets sold - net
Net income available to common stockholders									12,232	10,551	6,089
Elimination Company
Revenues
Rental income
Income from direct financing leases
Mortgage interest income
Other investment income - net
Total operating revenues
Expenses
Depreciation and amortization
General and administrative
Acquisition costs
Impairment on real estate properties
Provision for uncollectible mortgages, notes and accounts receivable
Total operating expenses
Income before other income and expense
Other income (expense)
Interest income
Interest expense
Interest - amortization of deferred financing costs
Interest - refinancing (costs) gain
Equity in earnings									-12,232	-10,551	-6,089
Total other expense									-12,232	-10,551	-6,089
Income before gain on assets sold									-12,232	-10,551	-6,089
Gain (loss) on assets sold - net
Net income available to common stockholders									($12,232)	($10,551)	($6,089)

CONSOLIDATING_FINANCIAL_STATEM4

CONSOLIDATING FINANCIAL STATEMENTS (Narrative) (Detail) (USD $)	12 Months Ended			1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Oct. 31, 2014	Sep. 30, 2014	Mar. 26, 2013	Dec. 31, 2011	Jun. 29, 2010	Jul. 31, 2013	Jul. 31, 2012
						Property	Subsidiary	Subsidiary	Subsidiary	Subsidiary
Non - Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Principal payment for mortgage	$4,400,000	$4,000,000	$3,100,000
Ownership percent of the subsidiary guarantors (in percent)	100.00%
Capital Source | Guarantor subsidiaries
Condensed Financial Statements, Captions [Line Items]
Number of subsidiaries acquired and designated as restricted							5	12
Capital Source | Unrestricted Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Number of subsidiaries acquired and designated as unrestricted							20	39
7% 2016 Notes
Condensed Financial Statements, Captions [Line Items]
Rate on senior notes			7.00%
7.50% Notes due 2020
Condensed Financial Statements, Captions [Line Items]
Senior notes, principal amount	200,000,000
Rate on senior notes	7.50%	7.50%
6.75% Notes due 2022
Condensed Financial Statements, Captions [Line Items]
Senior notes, principal amount	575,000,000
Rate on senior notes	6.75%	6.75%
5.875% Notes due 2024
Condensed Financial Statements, Captions [Line Items]
Senior notes, principal amount	400,000,000
Rate on senior notes	5.88%	5.88%
4.95% Notes due 2024
Condensed Financial Statements, Captions [Line Items]
Senior notes, principal amount	400,000,000
Rate on senior notes	4.95%
4.50% notes due 2025
Condensed Financial Statements, Captions [Line Items]
Senior notes, principal amount	250,000,000
Rate on senior notes	4.50%
HUD debt | Capital Source
Condensed Financial Statements, Captions [Line Items]
Number of subsidiaries removed									11	5
HUD Mortgage Debt Refinancing | Non - Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Principal payment for mortgage				3,400,000	34,300,000	58,700,000
Closing cost						700,000
Number Of Mortgage Debt Repaid						12
Noncash write off of unamortized premium				200,000	3,300,000
Prepayment fees				$200,000	$1,700,000

SUBSEQUENT_EVENTS_Narrative_De

SUBSEQUENT EVENTS (Narrative) (Detail) (Unsecured borrowings, USD $)	Jun. 27, 2014	Jan. 31, 2015
In Millions, unless otherwise specified
Subsequent Event [Line Items]
Credit facility, borrowing capacity	$1,200
2014 Credit Facilities
Subsequent Event [Line Items]
Credit facility, potential borrowing capacity	550
2014 Revolving Credit Facility
Subsequent Event [Line Items]
Credit facility, borrowing capacity	1,000
Subsequent event | 2014 Credit Facilities
Subsequent Event [Line Items]
Credit facility, borrowing capacity		1,750
Credit facility, potential borrowing capacity		2,000
Subsequent event | 2014 Revolving Credit Facility
Subsequent Event [Line Items]
Credit facility, borrowing capacity		1,250
Credit facility, potential borrowing capacity		250
Subsequent event | 2014 Term Loan Facility
Subsequent Event [Line Items]
Credit facility, borrowing capacity		200
Credit facility, potential borrowing capacity		250
Line of credit incremental loan facility		$300

SUBSEQUENT_EVENTS_Narrative_De1

SUBSEQUENT EVENTS (Narrative) (Detail 1) (USD $)	12 Months Ended			0 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Feb. 09, 2015
Subsequent Event [Line Items]
Stock issued	1,848,000	6,504,000	3,398,000
Net proceeds from issuance of common stock	$61,981	$278,373	$77,618
Subsequent event | 7.50% senior notes due 2020 (callable February 2015)
Subsequent Event [Line Items]
Loan amount				200,000
Percentage of interest rate received				7.50%
Subsequent event | 10.925 Million Shares of Common Stock
Subsequent Event [Line Items]
Issuance of common stock, average price per share				$42
Stock issued				10,925,000
Net proceeds from issuance of common stock				439,000
Loan amount				$200,000
Percentage of interest rate received				7.50%

SCHEDULE_III_REAL_ESTATE_AND_A1

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	$3,078,468,732
Cost Capitalized Subsequent to Acquisition Improvements	170,591,410
Cost Capitalized Subsequent to Acquisition Impairment	-21,497,993
Cost Capitalized Subsequent to Acquisition Other	-3,776,854
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	3,223,785,295		3,099,547,182	3,038,552,898	2,537,038,892
Accumulated Depreciation	821,711,991		707,409,888	580,373,211	470,420,023
Genesis Healthcare
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	313,367,810	[1]
Cost Capitalized Subsequent to Acquisition Improvements	36,922,406	[1]
Cost Capitalized Subsequent to Acquisition Impairment	-8,257,521	[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	342,032,695	[1],[2]
Accumulated Depreciation	138,420,835	[1],[3]
Genesis Healthcare | Alabama
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	23,584,956	[1]
Cost Capitalized Subsequent to Acquisition Improvements	6,523,220	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	30,108,176	[1],[2]
Accumulated Depreciation	14,821,233	[1],[3]
Date Of Construction	1964-1974	[1]
Date Acquired	1997	[1]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Genesis Healthcare | California
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	15,618,263	[1]
Cost Capitalized Subsequent to Acquisition Improvements	26,652	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	15,644,915	[1],[2]
Accumulated Depreciation	7,729,889	[1],[3]
Date Of Construction	1927-1972	[1]
Date Acquired	1997	[1]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Genesis Healthcare | Colorado
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	38,341,877	[1]
Cost Capitalized Subsequent to Acquisition Improvements	5,444,311	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	43,786,188	[1],[2]
Accumulated Depreciation	10,871,806	[1],[3]
Date Of Construction	1963-1975	[1]
Date Acquired	2006	[1]
Life on Which Depreciation in Latest Income Statements is Computed	39 years	[1]
Genesis Healthcare | Idaho
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	15,511,569	[1]
Cost Capitalized Subsequent to Acquisition Improvements	974,011	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	16,485,580	[1],[2]
Accumulated Depreciation	4,975,092	[1],[3]
Date Of Construction	1920-1987	[1]
Date Acquired	1997-2006	[1]
Genesis Healthcare | Idaho | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Genesis Healthcare | Idaho | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years	[1]
Genesis Healthcare | Massachusetts
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	57,139,658	[1]
Cost Capitalized Subsequent to Acquisition Improvements	2,660,093	[1]
Cost Capitalized Subsequent to Acquisition Impairment	-8,257,521	[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	51,542,230	[1],[2]
Accumulated Depreciation	19,343,167	[1],[3]
Date Of Construction	1964-1993	[1]
Date Acquired	1997-2010	[1]
Genesis Healthcare | Massachusetts | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Genesis Healthcare | Massachusetts | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years	[1]
Genesis Healthcare | New Hampshire
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	21,619,503	[1]
Cost Capitalized Subsequent to Acquisition Improvements	1,462,797	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	23,082,300	[1],[2]
Accumulated Depreciation	7,194,705	[1],[3]
Date Of Construction	1963-1999	[1]
Date Acquired	1998-2006	[1]
Genesis Healthcare | New Hampshire | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Genesis Healthcare | New Hampshire | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years	[1]
Genesis Healthcare | North Carolina
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	22,652,488	[1]
Cost Capitalized Subsequent to Acquisition Improvements	3,550,986	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	26,203,474	[1],[2]
Accumulated Depreciation	15,217,007	[1],[3]
Date Of Construction	1964-1986	[1]
Date Acquired	1994-1997	[1]
Genesis Healthcare | North Carolina | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	30 years	[1]
Genesis Healthcare | North Carolina | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Genesis Healthcare | Ohio
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	11,653,451	[1]
Cost Capitalized Subsequent to Acquisition Improvements	20,246	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	11,673,697	[1],[2]
Accumulated Depreciation	5,874,319	[1],[3]
Date Of Construction	1968-1983	[1]
Date Acquired	1997	[1]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Genesis Healthcare | Rhode Island
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	38,740,812	[1]
Cost Capitalized Subsequent to Acquisition Improvements	4,792,882	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	43,533,694	[1],[2]
Accumulated Depreciation	13,106,970	[1],[3]
Date Of Construction	1965-1981	[1]
Date Acquired	2006	[1]
Genesis Healthcare | Rhode Island | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years	[1]
Genesis Healthcare | Rhode Island | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years	[1]
Genesis Healthcare | Tennessee
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	7,905,139	[1]
Cost Capitalized Subsequent to Acquisition Improvements	2,537,508	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	10,442,647	[1],[2]
Accumulated Depreciation	5,769,691	[1],[3]
Date Of Construction	1984-1985	[1]
Date Acquired	1994	[1]
Life on Which Depreciation in Latest Income Statements is Computed	30 years	[1]
Genesis Healthcare | Vermont
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	6,322,888	[1]
Cost Capitalized Subsequent to Acquisition Improvements	602,296	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	6,925,184	[1],[2]
Accumulated Depreciation	2,054,957	[1],[3]
Date Of Construction	1971	[1]
Date Acquired	2004	[1]
Life on Which Depreciation in Latest Income Statements is Computed	39 years	[1]
Genesis Healthcare | Washington
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	10,000,000	[1]
Cost Capitalized Subsequent to Acquisition Improvements	1,798,844	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	11,798,844	[1],[2]
Accumulated Depreciation	10,538,065	[1],[3]
Date Of Construction	1965	[1]
Date Acquired	1995	[1]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Genesis Healthcare | West Virginia
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	44,277,206	[1]
Cost Capitalized Subsequent to Acquisition Improvements	6,528,560	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	50,805,766	[1],[2]
Accumulated Depreciation	20,923,934	[1],[3]
Date Of Construction	1961-1986	[1]
Date Acquired	1997-2008	[1]
Genesis Healthcare | West Virginia | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years	[1]
Genesis Healthcare | West Virginia | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Health And Hospital Corporation
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	306,144,765	[1]
Cost Capitalized Subsequent to Acquisition Improvements	394,818	[1]
Cost Capitalized Subsequent to Acquisition Impairment	-1,820,624	[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	304,718,959	[1],[2]
Accumulated Depreciation	36,832,728	[1],[3]
Health And Hospital Corporation | Indiana
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	306,144,765	[1]
Cost Capitalized Subsequent to Acquisition Improvements	394,818	[1]
Cost Capitalized Subsequent to Acquisition Impairment	-1,820,624	[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	304,718,959	[1],[2]
Accumulated Depreciation	36,832,728	[1],[3]
Date Of Construction	1942-2001	[1]
Date Acquired	1992-2013	[1]
Health And Hospital Corporation | Indiana | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Health And Hospital Corporation | Indiana | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	40 years	[1]
Communicare Health Services, Inc
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	239,012,824	[1]
Cost Capitalized Subsequent to Acquisition Improvements	38,974,404	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	277,987,228	[1],[2]
Accumulated Depreciation	76,900,919	[1],[3]
Communicare Health Services, Inc | Ohio
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	218,726,757	[1]
Cost Capitalized Subsequent to Acquisition Improvements	27,693,288	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	246,420,045	[1],[2]
Accumulated Depreciation	69,849,801	[1],[3]
Date Of Construction	1927-2008	[1]
Date Acquired	1998-2008	[1]
Communicare Health Services, Inc | Ohio | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Communicare Health Services, Inc | Ohio | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years	[1]
Communicare Health Services, Inc | Pennsylvania
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	20,286,067	[1]
Cost Capitalized Subsequent to Acquisition Improvements	11,281,116	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	31,567,183	[1],[2]
Accumulated Depreciation	7,051,118	[1],[3]
Date Of Construction	1950-1964	[1]
Date Acquired	2005	[1]
Life on Which Depreciation in Latest Income Statements is Computed	39 years	[1]
Airamid Health Management
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	255,124,627	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	255,124,627	[1],[2]
Accumulated Depreciation	60,541,662	[1],[3]
Airamid Health Management | Florida
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	240,352,759	[1],[4]
Cost Capitalized Subsequent to Acquisition Improvements		[1],[4]
Cost Capitalized Subsequent to Acquisition Impairment		[1],[4]
Cost Capitalized Subsequent to Acquisition Other		[1],[4]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	240,352,759	[1],[2],[4]
Accumulated Depreciation	57,122,266	[1],[3],[4]
Date Of Construction	1951-1999	[1],[4]
Date Acquired	2009-2010	[1],[4]
Airamid Health Management | Florida | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1],[4]
Airamid Health Management | Florida | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	37 years	[1],[4]
Airamid Health Management | Pennsylvania
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	14,771,868	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	14,771,868	[1],[2]
Accumulated Depreciation	3,419,396	[1],[3]
Date Of Construction	1969	[1]
Date Acquired	2009	[1]
Life on Which Depreciation in Latest Income Statements is Computed	26 years	[1]
Signature Holdings II, LLC
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	218,609,262	[1]
Cost Capitalized Subsequent to Acquisition Improvements	20,206,639	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	238,815,901	[1],[2]
Accumulated Depreciation	70,854,448	[1],[3]
Signature Holdings II, LLC | Florida
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	119,332,120	[1]
Cost Capitalized Subsequent to Acquisition Improvements	9,474,286	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	128,806,406	[1],[2]
Accumulated Depreciation	37,781,526	[1],[3]
Date Of Construction	1940-1991	[1]
Date Acquired	1996-2010	[1]
Signature Holdings II, LLC | Florida | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Signature Holdings II, LLC | Florida | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years	[1]
Signature Holdings II, LLC | Georgia
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	14,679,314	[1]
Cost Capitalized Subsequent to Acquisition Improvements	3,950,028	[1]
Cost Capitalized Subsequent to Acquisition Impairment	0	[1]
Cost Capitalized Subsequent to Acquisition Other	0	[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	18,629,342	[1],[2]
Accumulated Depreciation	6,900,424	[1],[3]
Date Of Construction	1964-1970	[1]
Date Acquired	2007	[1]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Signature Holdings II, LLC | Kentucky
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	44,737,440	[1]
Cost Capitalized Subsequent to Acquisition Improvements	4,174,496	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	48,911,936	[1],[2]
Accumulated Depreciation	14,884,149	[1],[3]
Date Of Construction	1964-1978	[1]
Date Acquired	1999-2010	[1]
Signature Holdings II, LLC | Kentucky | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Signature Holdings II, LLC | Kentucky | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Signature Holdings II, LLC | Maryland
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	28,629,686	[1]
Cost Capitalized Subsequent to Acquisition Improvements	1,787,838	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	30,417,524	[1],[2]
Accumulated Depreciation	7,125,335	[1],[3]
Date Of Construction	1959-1985	[1]
Date Acquired	2010	[1]
Signature Holdings II, LLC | Maryland | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	26 years	[1]
Signature Holdings II, LLC | Maryland | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	30 years	[1]
Signature Holdings II, LLC | Tennessee
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	11,230,702	[1]
Cost Capitalized Subsequent to Acquisition Improvements	819,991	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	12,050,693	[1],[2]
Accumulated Depreciation	4,163,014	[1],[3]
Date Of Construction	1982-2014	[1]
Date Acquired	2007-2014	[1]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
S&F Management Company, LLC
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	217,072,748	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	217,072,748	[1]
Accumulated Depreciation	14,953,483	[1]
S&F Management Company, LLC | Arizona
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	69,342,862	[1],[4]
Cost Capitalized Subsequent to Acquisition Improvements		[1],[4]
Cost Capitalized Subsequent to Acquisition Impairment		[1],[4]
Cost Capitalized Subsequent to Acquisition Other		[1],[4]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	69,342,862	[1],[2],[4]
Accumulated Depreciation	4,115,975	[1],[3],[4]
Date Of Construction	1949-1999	[1],[4]
Date Acquired	2012-2014	[1],[4]
S&F Management Company, LLC | Arizona | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	35 years	[1],[4]
S&F Management Company, LLC | Arizona | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	40 years	[1],[4]
S&F Management Company, LLC | California
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	147,729,886	[1],[4]
Cost Capitalized Subsequent to Acquisition Improvements		[1],[4]
Cost Capitalized Subsequent to Acquisition Impairment		[1],[4]
Cost Capitalized Subsequent to Acquisition Other		[1],[4]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	147,729,886	[1],[2],[4]
Accumulated Depreciation	10,837,508	[1],[3],[4]
Date Of Construction	1939-1970	[1],[4]
Date Acquired	2012	[1],[4]
S&F Management Company, LLC | California | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1],[4]
S&F Management Company, LLC | California | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	35 years	[1],[4]
Affiliates of Capital Funding Group, Inc.
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	213,886,423	[1]
Cost Capitalized Subsequent to Acquisition Improvements	2,391,661	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	216,278,084	[1],[2]
Accumulated Depreciation	18,049,015	[1],[3]
Affiliates of Capital Funding Group, Inc. | Arkansas
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	114,174,172	[1],[4]
Cost Capitalized Subsequent to Acquisition Improvements	2,391,661	[1],[4]
Cost Capitalized Subsequent to Acquisition Impairment	0	[1],[4]
Cost Capitalized Subsequent to Acquisition Other	0	[1],[4]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	116,565,833	[1],[2],[4]
Accumulated Depreciation	11,716,057	[1],[4]
Date Of Construction	1960-2000	[1],[4]
Date Acquired	2011-2014	[1],[4]
Affiliates of Capital Funding Group, Inc. | Arkansas | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1],[4]
Affiliates of Capital Funding Group, Inc. | Arkansas | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	40 years	[1],[4]
Affiliates of Capital Funding Group, Inc. | Colorado
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	5,482,855	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	5,482,855	[1],[2]
Accumulated Depreciation	918,618	[1],[3]
Date Of Construction	1961	[1]
Date Acquired	2011	[1]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Affiliates of Capital Funding Group, Inc. | Florida
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	14,636,992	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	14,636,992	[1],[2]
Accumulated Depreciation	1,302,106	[1],[3]
Date Of Construction	1985	[1]
Date Acquired	2011	[1]
Life on Which Depreciation in Latest Income Statements is Computed	40 years	[1]
Affiliates of Capital Funding Group, Inc. | Michigan
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	16,500,317	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	16,500,317	[1],[2]
Accumulated Depreciation	2,247,027	[1],[3]
Date Of Construction	1964-1973	[1]
Date Acquired	2011	[1]
Life on Which Depreciation in Latest Income Statements is Computed	25 years	[1]
Affiliates of Capital Funding Group, Inc. | Oregon
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	13,949,716	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	13,949,716	[1],[2]
Accumulated Depreciation	43,789	[1],[3]
Date Of Construction	2004	[1]
Date Acquired	2014	[1]
Life on Which Depreciation in Latest Income Statements is Computed	40 years	[1]
Affiliates of Capital Funding Group, Inc. | Pennsylvania
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	37,133,751	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	37,133,751	[1],[2]
Accumulated Depreciation	109,767	[1],[3]
Date Of Construction	1965-2012	[1]
Date Acquired	2014	[1]
Life on Which Depreciation in Latest Income Statements is Computed	40 years	[1]
Affiliates of Capital Funding Group, Inc. | Wisconsin
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	12,008,620	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	12,008,620	[1],[2]
Accumulated Depreciation	1,711,651	[1],[3]
Date Of Construction	1964	[1]
Date Acquired	2011	[1]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	1,315,250,273	[1]
Cost Capitalized Subsequent to Acquisition Improvements	71,701,482	[1]
Cost Capitalized Subsequent to Acquisition Impairment	-11,419,848	[1]
Cost Capitalized Subsequent to Acquisition Other	-3,776,854	[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	1,371,755,053	[1],[2]
Accumulated Depreciation	405,158,901	[1],[3]
Other | Alabama
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	17,939,710	[1]
Cost Capitalized Subsequent to Acquisition Improvements	6,392,567	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	24,332,277	[1],[2]
Accumulated Depreciation	13,870,762	[1],[3]
Date Of Construction	1960-1986	[1]
Date Acquired	1992-2010	[1]
Other | Alabama | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | Alabama | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	31 years 6 months	[1]
Other | Arizona
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	34,318,094	[1]
Cost Capitalized Subsequent to Acquisition Improvements	5,712,049	[1]
Cost Capitalized Subsequent to Acquisition Impairment	-6,603,745	[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	33,426,398	[1],[2]
Accumulated Depreciation	13,004,473	[1],[3]
Date Of Construction	1983-1985	[1]
Date Acquired	1998-2010	[1]
Other | Arizona | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	29 years	[1]
Other | Arizona | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Other | Arkansas
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	36,023,409	[1]
Cost Capitalized Subsequent to Acquisition Improvements	8,856,328	[1]
Cost Capitalized Subsequent to Acquisition Impairment	-36,350	[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	44,843,387	[1],[2]
Accumulated Depreciation	29,105,302	[1],[3]
Date Of Construction	1967-1988	[1]
Date Acquired	1992	[1]
Life on Which Depreciation in Latest Income Statements is Computed	31 years 6 months	[1]
Other | California
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	21,879,146	[1]
Cost Capitalized Subsequent to Acquisition Improvements	1,778,353	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	23,657,499	[1],[2]
Accumulated Depreciation	9,392,234	[1],[3]
Date Of Construction	1950-1990	[1]
Date Acquired	1997-2010	[1]
Other | California | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | California | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Other | Colorado
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	28,044,216	[1]
Cost Capitalized Subsequent to Acquisition Improvements	2,346,167	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	30,390,383	[1],[2]
Accumulated Depreciation	10,862,485	[1],[3]
Date Of Construction	1958-1973	[1]
Date Acquired	1998-2010	[1]
Other | Colorado | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | Colorado | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Other | Florida
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	215,032,053	[1]
Cost Capitalized Subsequent to Acquisition Improvements	7,414,141	[1]
Cost Capitalized Subsequent to Acquisition Impairment	-970,000	[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	221,476,194	[1],[2]
Accumulated Depreciation	57,375,253	[1],[3]
Date Of Construction	1933-2007	[1]
Date Acquired	1992-2013	[1]
Other | Florida | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | Florida | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	40 years	[1]
Other | Georgia
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	17,617,507	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	17,617,507	[1],[2]
Accumulated Depreciation	2,997,315	[1],[3]
Date Of Construction	1967-1971	[1]
Date Acquired	1998-2014	[1]
Other | Georgia | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	30 years	[1]
Other | Georgia | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	37 years 6 months	[1]
Other | Idaho
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	6,193,698	[1]
Cost Capitalized Subsequent to Acquisition Improvements	100,000	[1]
Cost Capitalized Subsequent to Acquisition Impairment	0	[1]
Cost Capitalized Subsequent to Acquisition Other	0	[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	6,293,698	[1],[2]
Accumulated Depreciation	2,829,241	[1],[3]
Date Of Construction	1988	[1]
Date Acquired	1999	[1]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | Illinois
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	13,961,501	[1]
Cost Capitalized Subsequent to Acquisition Improvements	444,484	[1]
Cost Capitalized Subsequent to Acquisition Impairment	0	[1]
Cost Capitalized Subsequent to Acquisition Other	0	[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	14,405,985	[1],[2]
Accumulated Depreciation	7,313,022	[1],[3]
Date Of Construction	1926-1990	[1]
Date Acquired	1996-1999	[1]
Other | Illinois | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	30 years	[1]
Other | Illinois | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Other | Indiana
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	37,220,697	[1]
Cost Capitalized Subsequent to Acquisition Improvements	1,897,203	[1]
Cost Capitalized Subsequent to Acquisition Impairment	-1,580,474	[1]
Cost Capitalized Subsequent to Acquisition Other	-1,956,998	[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	35,580,428	[1],[2]
Accumulated Depreciation	9,191,091	[1],[3]
Date Of Construction	1923-1996	[1]
Date Acquired	1992-2012	[1]
Other | Indiana | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | Indiana | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	38 years	[1]
Other | Iowa
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	19,116,936	[1]
Cost Capitalized Subsequent to Acquisition Improvements	2,084,807	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	21,201,743	[1],[2]
Accumulated Depreciation	7,872,936	[1],[3]
Date Of Construction	1965-1983	[1]
Date Acquired	1997-2010	[1]
Other | Iowa | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	23 years	[1]
Other | Iowa | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Other | Kansas
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	3,210,020	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	3,210,020	[1],[2]
Accumulated Depreciation	863,861	[1],[3]
Date Of Construction	1985	[1]
Date Acquired	2010	[1]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | Kentucky
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	15,151,027	[1]
Cost Capitalized Subsequent to Acquisition Improvements	4,148,392	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	19,299,419	[1],[2]
Accumulated Depreciation	10,980,212	[1],[3]
Date Of Construction	1948-1995	[1]
Date Acquired	1994-1995	[1]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Other | Louisiana
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	55,046,915	[1]
Cost Capitalized Subsequent to Acquisition Improvements	1,748,900	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	56,795,815	[1],[2]
Accumulated Depreciation	14,938,189	[1],[3]
Date Of Construction	1957-1983	[1]
Date Acquired	1997-2006	[1]
Other | Louisiana | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Other | Louisiana | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years	[1]
Other | Maryland
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	48,731,498	[1],[4]
Cost Capitalized Subsequent to Acquisition Improvements		[1],[4]
Cost Capitalized Subsequent to Acquisition Impairment		[1],[4]
Cost Capitalized Subsequent to Acquisition Other		[1],[4]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	48,731,498	[1],[2],[4]
Accumulated Depreciation	6,605,884	[1],[3],[4]
Date Of Construction	1921-1969	[1]
Date Acquired	2011	[1]
Other | Maryland | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years	[1],[4]
Other | Maryland | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	30 years	[1],[4]
Other | Massachusetts
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	5,804,554	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	5,804,554	[1],[2]
Accumulated Depreciation	1,724,429	[1],[3]
Date Of Construction	1964	[1]
Date Acquired	2009	[1]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | Michigan
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	20,000,000	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	20,000,000	[1],[2]
Accumulated Depreciation	1,518,996	[1],[3]
Date Of Construction	1974	[1]
Date Acquired	2012	[1]
Life on Which Depreciation in Latest Income Statements is Computed	30 years	[1]
Other | Mississippi
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	52,416,905	[1]
Cost Capitalized Subsequent to Acquisition Improvements	826,654	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	53,243,559	[1],[2]
Accumulated Depreciation	10,715,897	[1],[3]
Date Of Construction	1962-1988	[1]
Date Acquired	2009-2010	[1]
Other | Mississippi | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | Mississippi | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	40 years	[1]
Other | Missouri
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	12,301,560	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment	-149,386	[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	12,152,174	[1],[2]
Accumulated Depreciation	5,586,269	[1],[3]
Date Of Construction	1965-1989	[1]
Date Acquired	1999	[1]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Other | Nevada
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	20,926,778	[1]
Cost Capitalized Subsequent to Acquisition Improvements	3,034,207	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	23,960,985	[1],[2]
Accumulated Depreciation	5,014,282	[1],[3]
Date Of Construction	1972-1978	[1]
Date Acquired	2009	[1]
Other | Nevada | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	26 years	[1]
Other | Nevada | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	27 years	[1]
Other | New Mexico
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	7,097,600	[1]
Cost Capitalized Subsequent to Acquisition Improvements	130,323	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	7,227,923	[1],[2]
Accumulated Depreciation	2,547,285	[1],[3]
Date Of Construction	1972-1989	[1]
Date Acquired	2008-2010	[1]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | North Carolina
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	33,092,980	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	33,092,980	[1],[2]
Accumulated Depreciation	6,919,451	[1],[3]
Date Of Construction	1969-1987	[1]
Date Acquired	2010	[1]
Other | North Carolina | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years	[1]
Other | North Carolina | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	36 years	[1]
Other | Ohio
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	102,938,384	[1]
Cost Capitalized Subsequent to Acquisition Improvements	6,260,958	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	109,199,342	[1],[2]
Accumulated Depreciation	32,553,336	[1],[3]
Date Of Construction	1962-1998	[1]
Date Acquired	1994-2010	[1]
Other | Ohio | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | Ohio | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years	[1]
Other | Oklahoma
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	24,136,703	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	24,136,703	[1],[2]
Accumulated Depreciation	4,610,313	[1],[3]
Date Of Construction	1965-2013	[1]
Date Acquired	2010-2012	[1]
Other | Oklahoma | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | Oklahoma | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years	[1]
Other | Pennsylvania
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	138,881,687	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	138,881,687	[1],[2]
Accumulated Depreciation	42,133,904	[1],[3]
Date Of Construction	1942-2001	[1]
Date Acquired	1998-2009	[1]
Other | Pennsylvania | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | Pennsylvania | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years	[1]
Other | South Carolina
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	26,982,493	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	26,982,493	[1],[2]
Accumulated Depreciation	629,844	[1],[3]
Date Of Construction	1959-1961	[1]
Date Acquired	2014	[1]
Other | South Carolina | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | South Carolina | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years	[1]
Other | Tennessee
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	94,531,371	[1]
Cost Capitalized Subsequent to Acquisition Improvements	2,359,950	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	96,891,321	[1],[2]
Accumulated Depreciation	31,396,301	[1],[3]
Date Of Construction	1958-1983	[1]
Date Acquired	1992-2010	[1]
Other | Tennessee | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | Tennessee | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	31 years 6 months	[1]
Other | Texas
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	157,784,829	[1]
Cost Capitalized Subsequent to Acquisition Improvements	15,763,105	[1]
Cost Capitalized Subsequent to Acquisition Impairment	-2,079,893	[1]
Cost Capitalized Subsequent to Acquisition Other	-1,819,856	[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	169,648,185	[1],[2]
Accumulated Depreciation	48,827,817	[1],[3]
Date Of Construction	1952-2010	[1]
Date Acquired	1997-2014	[1]
Other | Texas | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
Other | Texas | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	40 years	[1]
Other | Washington
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	5,673,693	[1]
Cost Capitalized Subsequent to Acquisition Improvements	54,253	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	5,727,946	[1],[2]
Accumulated Depreciation	2,544,879	[1],[3]
Date Of Construction	1999	[1]
Date Acquired	1999	[1]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Other | West Virginia
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	24,641,423	[1]
Cost Capitalized Subsequent to Acquisition Improvements	348,641	[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	24,990,064	[1],[2]
Accumulated Depreciation	5,930,519	[1],[3]
Date Of Construction	1961-1996	[1]
Date Acquired	1994-2011	[1]
Other | West Virginia | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years	[1]
Other | West Virginia | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years	[1]
Other | Wisconsin
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Buildings and Land Improvements	18,552,886	[1]
Cost Capitalized Subsequent to Acquisition Improvements		[1]
Cost Capitalized Subsequent to Acquisition Impairment		[1]
Cost Capitalized Subsequent to Acquisition Other		[1]
Total Gross Amount at Which Carried at Close of Period Buildings and Land Improvements	18,552,886	[1],[2]
Accumulated Depreciation	$5,303,119	[1],[3]
Date Of Construction	1964-1972	[1]
Date Acquired	2009-2010	[1]
Life on Which Depreciation in Latest Income Statements is Computed	20 years	[1]
[1]	The real estate included in this schedule is being used in either the operation of long-term care facilities (LTC), assisted living facilities (AL), independent living facilities (ILF) or specialty hospitals (SH) located in the states indicated.
[2]	Year Ended December 31, 2012 2013 2014 Balance at beginning of period $2,537,038,892 $3,038,552,898 $3,099,547,182 Acquisitions 491,207,838 35,529,419 131,689,483 Impairment (414,687) (3,660,381) Improvements 29,436,456 31,346,919 17,916,855 Disposals/other (19,130,288) (5,467,367) (21,707,844) Balance at close of period $3,038,552,898 $3,099,547,182 $3,223,785,295
[3]	2012 2013 2014 Balance at beginning of period $470,420,023 $580,373,211 $707,409,888 Provisions for depreciation 112,871,408 128,523,788 123,141,880 Dispositions/other (2,918,220) (1,487,111) (8,839,777) Balance at close of period $580,373,211 $707,409,888 $821,711,991
[4]	Certain of the real estate indicated are security for the HUD loan borrowings totaling $251,454,346, including FMV of $13,573,496, at December 31, 2014.

SCHEDULE_III_REAL_ESTATE_AND_A2

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION (Detail 1) (Hud Subordinated Debt, USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Hud Subordinated Debt
Debt Instrument [Line Items]
Carrying value of real estate assets, security for borrowings	$251,454,346
Fair market value of real estate assets, security for borrowings	$13,573,496

SCHEDULE_III_REAL_ESTATE_AND_A3

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION (Detail 2) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
SEC Schedule III, Reconciliation of Carrying Amount of Real Estate Investments [Roll Forward]
Balance at beginning of period	$3,099,547,182	$3,038,552,898	$2,537,038,892
Acquisitions	131,689,483	35,529,419	491,207,838
Impairment		-3,660,381	-414,687
Improvements	17,916,855	31,346,919	29,436,456
Disposals/other	-21,707,844	-5,467,367	-19,130,288
Balance at close of period	3,223,785,295	3,099,547,182	3,038,552,898
Reconciliation of real estate accumulated depreciation
Balance at beginning of period	707,409,888	580,373,211	470,420,023
Provisions for depreciation	123,141,880	128,523,788	112,871,408
Dispositions/other	-8,839,777	-1,487,111	-2,918,220
Balance at close of period	$821,711,991	$707,409,888	$580,373,211

SCHEDULE_III_REAL_ESTATE_AND_A4

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION (Detail 3) (USD $)	Dec. 31, 2014
In Millions, unless otherwise specified
Real Estate and Accumulated Depreciation Disclosure [Abstract]
Reported amount of real estate in excess of the tax basis	$57.90

SCHEDULE_IV_MORTGAGE_LOANS_ON_1

SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014
Mortgage Loans on Real Estate [Line Items]
Face Amount of Mortgages	$653,608,667
Carrying Amount of Mortgages	648,078,550
Florida | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.82%	[1]
Final Maturity Date	2030	[1]
Periodic Payment Terms	Interest payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	15,900,000	[1]
Carrying Amount of Mortgages	15,880,156	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
Maryland | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	11.00%	[1]
Final Maturity Date	2023	[1]
Periodic Payment Terms	Interest payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	74,927,751	[1]
Carrying Amount of Mortgages	69,927,759	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
Maryland | Group 2
Mortgage Loans on Real Estate [Line Items]
Interest Rate	12.00%	[1]
Final Maturity Date	2046	[1]
Periodic Payment Terms	Interest payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	10,000,000	[1]
Carrying Amount of Mortgages	10,000,000	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
Maryland | Group 3
Mortgage Loans on Real Estate [Line Items]
Interest Rate	12.00%	[1]
Final Maturity Date	2046	[1]
Periodic Payment Terms	Interest payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	9,500,000	[1]
Carrying Amount of Mortgages	9,500,000	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
Maryland | Group 4
Mortgage Loans on Real Estate [Line Items]
Interest Rate	12.00%	[1]
Final Maturity Date	2046	[1]
Periodic Payment Terms	Interest payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	5,500,000	[1]
Carrying Amount of Mortgages	5,500,000	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
Michigan | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	9.00%	[1]
Final Maturity Date	2029	[1]
Periodic Payment Terms	Interest plus $90,000 of principal payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	415,000,000	[1]
Carrying Amount of Mortgages	414,550,050	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
Michigan | Group 2
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.25%	[1]
Final Maturity Date	2021	[1]
Periodic Payment Terms	Interest payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	1,325,921	[1]
Carrying Amount of Mortgages	1,325,921	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
Michigan | Group 3
Mortgage Loans on Real Estate [Line Items]
Interest Rate	12.00%	[1]
Final Maturity Date	2046	[1]
Periodic Payment Terms	Interest payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	1,500,000	[1]
Carrying Amount of Mortgages	1,500,000	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
Ohio | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	9.50%	[1]
Final Maturity Date	2024	[1]
Periodic Payment Terms	Interest payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	112,500,000	[1]
Carrying Amount of Mortgages	112,500,000	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
Ohio | Group 2
Mortgage Loans on Real Estate [Line Items]
Interest Rate	12.00%	[1]
Final Maturity Date	2022	[1]
Periodic Payment Terms	Interest plus $2,100 of principal payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	6,112,406	[1]
Carrying Amount of Mortgages	6,052,075	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
Ohio | Group 3
Mortgage Loans on Real Estate [Line Items]
Interest Rate	12.00%	[1]
Final Maturity Date	2022	[1]
Periodic Payment Terms	Interest payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	345,011	[1]
Carrying Amount of Mortgages	345,011	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
Ohio | Group 4
Mortgage Loans on Real Estate [Line Items]
Interest Rate	12.00%	[1]
Final Maturity Date	2022	[1]
Periodic Payment Terms	Interest payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	796,397	[1]
Carrying Amount of Mortgages	796,397	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
Ohio | Group 5
Mortgage Loans on Real Estate [Line Items]
Interest Rate	12.00%	[1]
Final Maturity Date	2022	[1]
Periodic Payment Terms	Interest payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	112,100	[1]
Carrying Amount of Mortgages	112,100	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
Ohio | Group 6
Mortgage Loans on Real Estate [Line Items]
Interest Rate	12.00%	[1]
Final Maturity Date	2022	[1]
Periodic Payment Terms	Interest payable monthly	[1]
Prior Liens	0	[1]
Face Amount of Mortgages	89,081	[1]
Carrying Amount of Mortgages	89,081	[1],[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest		[1]
[1]	Mortgage loans included in this schedule represent first mortgages on facilities used in the delivery of long-term healthcare of which such facilities are located in the states indicated.
[2]	The aggregate cost for federal income tax purposes is equal to the carrying amount.
[3]	Year Ended December 31, 2012 2013 2014 Balance at beginning of period $238,674,601 $238,621,161 $241,514,812 Additions during period - Placements 11,967,892 3,378,357 412,306,456 Deductions during period - collection of principal/other (12,021,332) (484,706) (5,742,718) Balance at close of period $238,621,161 $241,514,812 $648,078,550

SCHEDULE_IV_MORTGAGE_LOANS_ON_2

SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE (Detail 1) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Movement in Mortgage Loans on Real Estate [Roll Forward]
Balance at beginning of period	$241,514,812	$238,621,161	$238,674,601
Additions during period - Placements	529,547,836	3,378,357	11,967,892
Deductions during period - collection of principal/other	-122,984,098	-484,706	-12,021,332
Balance at close of period	$648,078,550	$241,514,812	$238,621,161